Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3012336	p-haptog	g/l (g/l)	9499	15067	0.00%
3012336	s-haptog	g/l (g/l)	5756	9092	0.89%
3012336	p-haptog	— (—)	2392	4019	100.00%	Distribution not available
3012336	s-haptog	— (—)	1583	2497	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Antihypertensive medication - note that there are other indications

1793

3393

2.97

322.35

2.1

1.8

1.44

1.32

g/l

5.05

1562

2923

Type 2 diabetes

3558

10308

2.11

320.47

1.8

1.7

1.65

1.47

g/l

19.78

3090

8699

Glucagon-like peptide-1 (GLP-1) analogues

2426

8648

2.44

320.44

1.7

1.72

1.51

g/l

20.83

2079

7306

Diabetes medication

3715

11227

2.07

319.90

1.8

1.7

1.64

1.47

g/l

19.38

3235

9494

Complications of medical and surgical care

2843

12660

2.22

316.13

1.9

1.7

1.57

1.53

g/l

1.49

2433

10783

Chronic periodontitis

861

2155

4.47

314.72

2.3

1.6

1.54

1.56

g/l

0.22

773

1828

Insulin, fast-acting

1646

6096

2.87

314.50

1.9

1.7

1.60

1.50

g/l

3.73

1460

5156

ILD medications: azathioprine

733

1614

4.96

312.87

2.3

1.5

1.48

1.50

g/l

0.20

660

1359

Any reimbursement code in KELA

1658

2756

3.09

309.13

1.9

1.8

1.48

1.28

g/l

10.31

1440

2326

Peripheral artery disease

2175

7362

2.54

307.80

1.8

1.6

1.72

1.55

g/l

12.35

1895

6195

Dialysis

555

418

20.61

307.65

2.6

1.8

1.50

1.52

g/l

0.17

526

362

Gout, FINNGEN

1667

5596

3.28

307.65

1.9

1.6

1.62

1.53

g/l

3.61

1478

4707

Diseases of oesophagus, stomach and duodenum

4299

11549

2.35

307.65

1.7

1.51

1.53

g/l

1.05

3714

9817

First line medication for Crohn's disease

4739

10192

2.64

307.65

2.0

1.6

1.55

1.47

g/l

5.94

4111

8629

Other heart diseases

2006

2723

5.14

307.65

2.0

1.6

1.52

1.41

g/l

3.61

1707

2301

Other bacterial diseases

5346

10255

3.88

307.65

2.0

1.6

1.67

1.46

g/l

32.92

4625

8670

Unspecified kidney failure

970

1428

8.71

307.65

2.2

1.5

1.61

1.53

g/l

1.38

874

1177

Diseases of arteries, arterioles and capillaries

3146

9776

2.54

307.65

1.8

1.6

1.63

1.55

g/l

3.87

2710

8267

Hypertensive heart and/or renal disease

1341

2982

3.78

307.65

1.9

1.6

1.61

1.51

g/l

2.75

1159

2488

Benign neoplasm: Colon

2205

5982

3.01

307.65

1.7

1.6

1.58

1.56

g/l

0.36

1914

5071

Cerebrovascular diseases (FINNGEN)

1087

1890

4.32

307.65

1.9

1.6

1.60

1.49

g/l

2.30

929

1580

Implicit bacterial Sepsis

2686

6182

4.48

307.65

2.0

1.5

1.66

1.53

g/l

8.09

2319

5191

Metabolic disorders

4156

9796

2.76

307.65

1.8

1.7

1.58

1.51

g/l

3.24

3600

8265

Complications of surgical and medical care, not elsewhere classified

3851

12945

2.21

307.65

1.9

1.7

1.57

1.52

g/l

2.78

3297

11021

Iron deficiency anaemia

3405

6476

6.07

307.65

1.7

1.6

1.57

1.54

g/l

0.73

2918

5482

Nutritional anaemias

3783

7782

5.42

307.65

1.7

1.6

1.56

1.55

g/l

0.22

3225

6582

Primary_lymphoid and hematopoietic malignant neoplasms

1659

3907

4.86

307.65

2.3

1.6

1.44

1.53

g/l

2.82

1421

3327

Atrial fibrillation and flutter

1344

1784

5.23

307.65

1.9

1.5

1.52

g/l

0.03

1150

1491

Diseases of arteries, arterioles and capillaries (FINNGEN)

1341

1487

6.92

307.65

1.9

1.6

1.65

1.52

g/l

3.17

1166

1241

Glomerular disorders in diseases classified elsewhere

1310

1773

9.91

307.65

2.6

1.6

1.58

1.52

g/l

1.09

1217

1510

Dentinal caries

1346

3141

4.71

307.65

2.3

1.7

1.52

1.51

g/l

0.05

1181

2675

Purpura and other haemorrhagic conditions

873

2004

4.98

307.65

2.4

1.7

1.29

1.54

g/l

10.20

736

1726

Hypertensive diseases

2965

5854

2.98

307.65

2.0

1.7

1.54

1.48

g/l

2.35

2574

4913

Insulin medication

2706

9124

2.67

307.65

1.9

1.7

1.64

1.49

g/l

13.04

2385

7689

Care involving dialysis

1370

1038

23.05

307.65

2.7

1.6

1.52

1.48

g/l

0.63

1291

895

Heart failure, strict

3555

7749

3.64

307.65

1.8

1.6

1.57

1.58

g/l

0.10

3056

6555

Lymphoid leukaemia

508

782

8.32

307.65

3.0

1.7

1.23

1.47

g/l

5.90

442

667

Disorders resulting from impaired renal tubular function

473

469

15.65

307.65

2.4

2.0

1.57

1.58

g/l

0.04

438

414

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

411

502

11.45

307.65

2.2

1.6

1.22

1.50

g/l

5.39

349

425

Diabetes, varying definitions

3727

10700

2.15

307.65

1.9

1.7

1.63

1.46

g/l

18.20

3256

9040

Used for control exclusion in common control thyroid runs

3877

9667

2.09

307.65

2.0

1.6

1.48

1.51

g/l

1.04

3348

8226

Any gastric operation

2982

4922

3.15

307.65

1.9

1.6

1.49

1.41

g/l

3.78

2560

4210

Disorders of lipoprotein metabolism and other lipidaemias

3290

8920

2.42

307.65

1.7

1.63

1.54

g/l

5.04

2828

7521

Bacterial infection, other or unspecified

3514

7685

4.60

307.65

1.9

1.5

1.73

1.48

g/l

30.38

3031

6478

Aplastic and other anaemias

5360

6376

10.28

307.65

2.0

1.5

1.52

1.58

g/l

3.09

4612

5346

All pneumoniae

4394

11649

2.73

307.65

1.9

1.7

1.65

1.46

g/l

25.57

3805

9918

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4122

10854

2.70

307.65

2.0

1.7

1.49

1.54

g/l

2.13

3545

9266

Examination and observation for other reasons

2617

5631

2.96

307.65

1.8

1.6

1.47

1.52

g/l

1.34

2263

4760

Iron deficiency anaemia secondary to blood loss (chronic)

1170

2296

5.93

307.65

1.9

1.7

1.48

1.53

g/l

0.94

1018

1950

Chronic kidney disease

3536

4734

9.79

307.65

2.2

1.5

1.58

1.53

g/l

2.13

3216

3914

Pure hypercholesterolaemia

2895

8493

2.39

307.65

1.7

1.64

1.55

g/l

5.40

2491

7160

Diabetic nephropathy, excluding more controls

1106

2079

5.27

307.65

2.2

1.7

1.64

1.62

g/l

0.32

1031

1753

General symptoms and signs

4303

9009

2.48

307.65

1.9

1.7

1.54

1.48

g/l

2.94

3709

7664

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

657

1261

6.37

307.65

2.3

1.5

1.42

1.51

g/l

1.33

562

1074

Dialysis, with operation codes

1899

1622

18.02

307.65

2.7

1.6

1.51

1.53

g/l

0.26

1768

1368

Glomerular diseases

1708

2766

7.64

307.65

2.5

1.6

1.58

1.53

g/l

1.35

1577

2356

Gout

1667

4581

3.67

307.65

1.9

1.6

1.62

1.54

g/l

2.53

1478

3887

Other disorders of fluid, electrolyte and acid-base balance

1669

4669

3.78

307.65

1.7

1.6

1.63

1.55

g/l

2.79

1461

3937

L04AX Other immunosuppressants

2163

8976

2.52

307.65

1.8

1.7

1.54

1.52

g/l

0.49

1876

7691

Haemolytic anaemias

537

420

21.53

307.65

7.4

1.6

0.90

1.49

g/l

20.94

398

370

Secondary hypertension

796

575

17.43

307.65

2.4

1.5

1.47

1.48

g/l

0.10

725

472

L04AA Selective immunosuppressants

1411

2942

5.45

307.65

2.3

1.7

1.50

1.55

g/l

0.87

1289

2508

Hypertensive diseases (excluding secondary)

1955

2622

4.54

307.65

2.1

1.6

1.52

1.43

g/l

2.68

1719

2211

Extracorporeal dialysis

945

878

18.16

307.65

2.9

1.8

1.53

1.51

g/l

0.21

883

764

Insulin, intermediate and long-acting

2458

10225

2.49

307.65

1.8

1.6

1.65

1.52

g/l

8.90

2165

8654

Second line medication for Crohn's disease

2210

9195

2.52

307.65

1.8

1.7

1.54

1.52

g/l

0.59

1920

7876

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4035

9399

2.82

307.65

1.9

1.7

1.64

1.45

g/l

23.81

3497

8019

Pneumonias (Asthma/COPD co-morbidities)

4384

11569

2.75

307.65

1.9

1.6

1.65

1.46

g/l

25.64

3799

9842

Other diseases of blood and blood-forming organs, wide

1183

3459

3.77

307.65

2.2

1.6

1.38

1.57

g/l

8.01

1007

2950

Other and unspecified iron deficiency

2788

4899

6.75

307.65

1.7

1.6

1.58

1.53

g/l

1.82

2384

4157

Other and unspecified anaemias

5001

5984

10.51

307.65

2.0

1.5

1.52

1.58

g/l

2.32

4285

5025

Presence of cardiac and vascular implants and grafts

2324

6683

2.82

307.65

1.8

1.6

1.49

1.60

g/l

5.37

1912

5667

Heart failure, not strict

4863

7570

4.91

307.65

2.0

1.5

1.57

1.56

g/l

0.13

4246

6367

Other dialysis

452

387

19.68

307.65

2.6

1.9

1.50

1.53

g/l

0.20

432

334

Cardiovascular diseases (excluding rheumatic etc)

2098

3500

3.59

307.65

2.1

1.7

1.49

1.33

g/l

8.68

1827

2988

ILD medications: immunosuppressive drugs

3252

8356

4.01

307.65

2.1

1.6

1.51

1.50

g/l

0.04

2870

7081

Preparatory care for dialysis

818

604

28.81

307.65

2.6

1.9

1.54

1.55

g/l

0.08

790

529

Other diseases of intestines

3765

10819

2.08

307.65

1.7

1.8

1.54

1.49

g/l

2.30

3245

9214

Primary_lymphoid and hematopoietic malignant neoplasms

1659

4213

4.50

307.65

2.3

1.5

1.44

1.57

g/l

5.28

1421

3580

Non-rheumatic valve diseases

2467

5103

3.81

307.65

1.8

1.6

1.41

1.60

g/l

14.57

1994

4338

Heart failure and bmi 25plus

2019

4050

3.79

307.65

1.8

1.6

1.64

1.62

g/l

0.18

1733

3396

Persons encountering health services for specific procedures and health care

4707

11285

2.70

307.65

2.0

1.6

1.58

1.49

g/l

7.11

4110

9535

Valvular operations

841

1976

4.76

307.65

2.0

1.5

1.18

1.60

g/l

24.41

600

1679

Type 2 diabetes, wide definition

3516

9163

2.63

307.65

1.7

1.67

1.49

g/l

19.81

3040

7718

Hypertension, essential

2919

5729

3.03

307.65

1.9

1.7

1.57

1.48

g/l

3.76

2528

4804

Continuous positive airway pressure

936

1661

5.27

307.65

1.9

1.7

1.64

1.50

g/l

3.38

812

1400

Nephropathy related operations

1757

1814

14.62

307.65

2.7

1.6

1.50

1.56

g/l

1.23

1634

1540

Ulcer of lower limb, not elsewhere classified

1000

2369

4.94

307.65

1.9

1.6

1.70

1.56

g/l

4.10

889

2023

Autoimmune diseases

4206

10251

2.16

307.65

2.0

1.6

1.48

1.51

g/l

1.02

3640

8732

Kidney transplant status

727

589

19.20

307.65

2.8

1.8

1.44

1.49

g/l

0.61

691

509

Diverticular disease of intestine

2936

8458

2.41

307.65

1.7

1.6

1.61

1.56

g/l

1.76

2521

7171

Diabetes, insulin treatment (Kela reimbursement)

3747

11330

2.09

307.65

1.8

1.7

1.65

1.49

g/l

16.51

3256

9577

Erysipelas

2408

8157

2.85

307.65

1.8

1.5

1.67

1.49

g/l

14.80

2052

6889

L04AD Calcineurin inhibitors

1105

1278

11.33

307.65

2.6

1.7

1.40

1.55

g/l

4.26

1027

1095

Oral corticosteroids

4344

11415

2.39

307.65

1.9

1.6

1.61

1.49

g/l

9.94

3741

9686

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8349

8135

8.43

307.65

2.0

1.4

1.49

1.56

g/l

4.95

7127

6936

Atrial fibrillation and flutter with reimbursement

1115

1507

5.06

307.65

1.8

1.6

1.57

1.53

g/l

0.54

980

1254

4035

9399

2.82

307.65

1.9

1.7

1.64

1.45

g/l

23.81

3497

8019

Acute tubulo-interstitial nephritis

2662

8295

3.00

307.65

1.9

1.6

1.69

1.47

g/l

21.29

2308

6925

Hypertension

2962

5852

2.98

307.65

2.0

1.7

1.54

1.48

g/l

2.34

2572

4911

Autoimmune diseases excluding thyroid diseases, strict definition

4361

9968

2.54

307.65

2.1

1.6

1.50

1.51

g/l

0.27

3770

8485

Pneumonia, organism unspecified

4044

10904

2.82

307.65

1.9

1.6

1.66

1.47

g/l

22.65

3486

9255

Cardiovascular diseases

1827

3146

3.26

307.65

2.1

1.8

1.46

1.29

g/l

7.96

1593

2705

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3562

10266

2.19

307.65

1.8

1.7

1.64

1.48

g/l

18.11

3097

8667

Condition for Implicit Sepsis (Organ dysfunction codes)

4199

9867

3.29

307.65

1.9

1.6

1.59

1.51

g/l

5.42

3615

8354

Autoimmune diseases excluding thyroid diseases

4500

10211

2.55

307.65

2.1

1.6

1.50

1.51

g/l

0.25

3893

8699

Insulin, combination of fast acting with intermediate-acting or long-acting

2708

10987

2.39

307.65

1.9

1.6

1.64

1.52

g/l

9.12

2387

9293

All-cause Heart Failure

3482

7648

3.61

307.65

1.8

1.6

1.57

1.58

g/l

0.09

2992

6467

Heart failure,strict

3346

5900

4.56

307.65

1.8

1.5

1.58

1.57

g/l

0.20

2880

4941

Valvular heart disease excluding rheumatic fever

2491

5124

3.84

307.65

1.8

1.6

1.41

1.60

g/l

14.32

2012

4356

Certain infectious and parasitic diseases

3794

7841

2.50

307.65

1.9

1.6

1.57

1.42

g/l

13.89

3290

6629

Benign neoplasm of colon, rectum, anus and anal canal

2434

6180

2.98

307.65

1.7

1.6

1.58

1.55

g/l

0.71

2115

5253

Other heart diseases, wide

3451

8198

2.71

307.65

1.9

1.7

1.52

g/l

0.12

2932

7046

Bleeding

3566

11249

2.42

307.65

1.8

1.6

1.49

1.58

g/l

5.68

3068

9522

Viral Sepsis

1113

2783

4.45

307.65

2.2

1.6

1.58

1.49

g/l

1.90

978

2346

Heart failure and antihypertensive medication

1781

1498

8.94

307.65

1.9

1.7

1.60

1.51

g/l

1.96

1549

1260

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4289

11691

2.70

307.65

1.9

1.7

1.65

1.47

g/l

24.49

3707

9950

Explicit Sepsis

2665

6724

4.20

307.65

2.2

1.6

1.63

1.51

g/l

6.65

2318

5655

Other septicaemia

2347

5839

4.39

307.65

2.2

1.5

1.63

1.48

g/l

8.48

2038

4914

Tramadol

3214

8325

2.59

307.65

1.7

1.63

1.48

g/l

12.56

2777

7071

Acquired haemolytic anaemia

432

298

28.86

307.65

8.4

1.6

0.89

1.47

g/l

15.45

312

262

Anaemias

2542

683

29.85

307.65

2.4

1.7

1.43

1.15

g/l

11.79

2200

584

Fever of other and unknown origin

2826

7597

3.69

307.65

2.1

1.6

1.63

1.50

g/l

8.11

2447

6438

Oedema, not elsewhere classified

1380

4531

3.23

307.65

1.9

1.6

1.57

1.53

g/l

0.57

1209

3845

Other anaemias

5025

6026

10.43

307.65

2.0

1.5

1.52

1.58

g/l

2.49

4307

5056

Non-ischemic cardiomyopathy

1682

3945

3.86

307.65

1.9

1.6

1.55

1.58

g/l

0.60

1446

3313

Benign neoplasm of colon, rectum, anus and anal canal

2650

10730

2.35

307.65

1.7

1.6

1.57

1.58

g/l

0.09

2292

9072

Bacterial Sepsis

3001

6790

4.39

307.65

2.0

1.5

1.65

1.53

g/l

8.58

2583

5709

Transplanted organ and tissue status

1155

1135

14.09

307.65

2.6

1.7

1.41

1.54

g/l

3.59

1082

970

Renal failure

4675

6691

7.97

307.65

2.1

1.5

1.60

1.53

g/l

4.06

4186

5551

Malaise and fatigue

2324

6396

3.22

307.65

1.8

1.6

1.60

1.52

g/l

3.37

2000

5403

Influenza and pneumonia

4515

11556

2.69

307.65

1.9

1.7

1.63

1.45

g/l

23.11

3914

9837

Polyarthropathies

3273

7748

2.97

307.65

1.7

1.60

1.50

g/l

7.07

2844

6577

Dental caries

1510

3574

4.61

307.65

2.4

1.7

1.49

1.51

g/l

0.33

1333

3042

Implicit Sepsis

4045

9396

3.61

307.65

1.9

1.6

1.62

1.51

g/l

8.08

3484

7936

Renal tubulo-interstitial diseases

5811

9936

4.95

307.65

2.0

1.6

1.62

1.46

g/l

23.44

5125

8335

Dyspnoea

3588

12481

2.29

307.65

1.8

1.7

1.57

1.52

g/l

1.92

3051

10635

Infections, IBD-co-morbidities

1006

1104

7.33

307.65

2.2

1.7

1.54

1.44

g/l

1.76

891

925

Coagulation defects, purpura and other haemorrhagic conditions

1098

2880

4.24

307.65

2.3

1.7

1.32

1.54

g/l

10.54

937

2465

Cardiac arrhythmias

1949

4698

2.84

307.65

1.9

1.7

1.48

1.43

g/l

1.39

1661

4012

Anaemia in chronic diseases classified elsewhere

360

253

24.19

307.65

2.5

2.0

1.54

1.51

g/l

0.15

324

225

Septicaemia

2613

6401

4.36

307.65

2.2

1.5

1.63

1.48

g/l

10.33

2272

5394

Diabetic nephropathy

1113

3237

3.97

307.65

2.2

1.7

1.64

1.62

g/l

0.37

1037

2750

ILD medications

5013

10463

2.75

307.65

2.0

1.6

1.53

1.48

g/l

2.99

4358

8858

Implicit viral Sepsis

1113

2782

4.45

307.65

2.2

1.6

1.58

1.49

g/l

1.89

978

2345

Acute renal failure

1949

3075

7.89

307.65

2.3

1.6

1.66

1.53

g/l

5.64

1732

2540

GASTRO-related operations

2982

4922

3.15

307.65

1.9

1.6

1.49

1.41

g/l

3.78

2560

4210

ILD medications: prednisolone, methylprednisolone, prednisone

4894

10344

2.80

307.65

2.0

1.6

1.56

1.48

g/l

4.61

4259

8754

Diabetes mellitus

3740

10722

2.15

307.65

1.9

1.7

1.63

1.46

g/l

19.20

3263

9060

Inflammatory bowel disease treatment related agents

4709

11682

2.38

307.65

2.0

1.7

1.56

1.48

g/l

6.05

4089

9922

Thrombocytopenia, unspecified

559

1017

6.69

305.45

2.5

1.8

1.18

1.53

g/l

11.52

471

881

Abnormalities of breathing

3199

9063

2.16

305.06

1.9

1.7

1.55

1.49

g/l

2.48

2747

7764

Other autoimmune haemolytic anaemias

243

161

36.36

304.59

9.1

1.5

0.87

1.56

g/l

11.50

189

142

Diseases of liver

1542

5633

2.93

303.82

1.8

1.7

1.28

1.57

g/l

25.88

1300

4820

Diseases of the digestive system

2052

8625

2.51

300.12

1.8

1.6

1.47

1.55

g/l

3.67

1774

7290

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1298

2517

3.38

299.82

2.0

1.6

1.47

1.42

g/l

0.76

1138

2125

Medical observation and evaluation for suspected diseases and conditions

2569

5719

2.37

292.68

1.8

1.6

1.51

1.52

g/l

0.13

2199

4826

Lymphoid leukaemia

508

889

7.28

291.97

3.0

1.8

1.23

1.52

g/l

8.26

442

769

Glomerulonephritis

668

1476

5.22

289.19

2.5

1.7

1.54

1.52

g/l

0.21

604

1262

Type 1 diabetes

1108

3445

3.41

287.52

2.1

1.7

1.52

1.42

g/l

2.86

998

2894

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

344

404

12.35

287.35

2.4

1.6

1.13

1.51

g/l

8.28

292

341

Gout, idiopatic and unspecified

1351

4793

3.10

285.66

1.8

1.6

1.65

1.54

g/l

4.23

1197

4060

Calcific aortic valvular stenosis

1583

5967

2.82

283.31

1.8

1.6

1.43

1.58

g/l

7.51

1260

5074

Calcific aortic valvular stenosis, operated

1583

5967

2.82

283.31

1.8

1.6

1.43

1.58

g/l

7.51

1260

5074

Operations 2 for CAVS

1581

5964

2.82

282.51

1.8

1.6

1.43

1.58

g/l

7.52

1259

5071

Calcific aortic valvular stenosis, diagnosis (helper)

1581

5964

2.82

282.51

1.8

1.6

1.43

1.58

g/l

7.52

1259

5071

Calcific aortic valvular stenosis, including rheumatic fever

1586

5988

2.81

282.36

1.8

1.6

1.43

1.58

g/l

7.88

1263

5092

Diseases of pulp and periapical tissues

1447

5310

2.88

280.47

2.0

1.6

1.55

1.53

g/l

0.33

1265

4538

Intestinal infectious diseases

3382

13546

2.00

279.62

2.0

1.7

1.54

1.50

g/l

1.33

2912

11534

Insulin, fast-acting or short human

1651

6497

2.69

279.33

1.9

1.7

1.60

1.51

g/l

3.14

1464

5496

Azathioprine

733

1771

4.51

278.10

2.3

1.6

1.48

g/l

0.04

660

1517

Endocrine, nutritional and metabolic diseases

2639

6029

2.28

277.51

1.9

1.7

1.51

1.40

g/l

6.60

2294

5075

Chronic periapical parodontitis

992

2967

3.62

276.78

2.2

1.6

1.56

1.55

g/l

0.05

881

2527

Gout, unspecified

1148

3790

3.37

276.61

1.8

1.6

1.64

1.54

g/l

2.84

1020

3209

Complications of procedures, not elsewhere classified

2923

12512

2.09

275.39

1.9

1.7

1.57

1.52

g/l

1.90

2510

10660

Other diseases of the digestive system

1567

6101

2.75

273.26

1.8

1.6

1.47

1.55

g/l

2.89

1357

5145

Other disorders of skin and subcutaneous tissue

2652

11728

2.16

272.30

1.9

1.6

1.59

1.54

g/l

1.89

2293

9949

COPD/asthma related infections

3653

9408

2.00

271.75

1.8

1.7

1.59

1.45

g/l

12.57

3162

8027

COPD/asthma/ILD related infections

3653

9408

2.00

271.75

1.8

1.7

1.59

1.45

g/l

12.57

3162

8027

Codeine

3272

8983

2.06

270.37

1.7

1.8

1.56

1.44

g/l

8.95

2809

7664

Benign neoplasm: Colon

2242

10043

2.31

270.04

1.7

1.6

1.57

1.58

g/l

0.22

1942

8502

GI-bleeding

1565

6151

2.72

267.53

1.8

1.6

1.47

1.56

g/l

3.10

1354

5184

Atherosclerosis, excluding cerebral and coronary sclerosis

2013

6967

2.46

266.53

1.8

1.6

1.70

1.55

g/l

9.69

1750

5859

Other CVD (FINNGEN)

549

788

6.03

266.36

1.8

1.5

1.57

1.52

g/l

0.43

472

655

Gout, strict definition

1049

3366

3.49

266.20

1.8

1.6

1.66

1.55

g/l

3.45

927

2845

Autoimmune diseases related-to ILD

3034

13617

2.02

263.36

1.9

1.7

1.56

1.51

g/l

2.11

2614

11615

Chronic lymphocytic leukaemia, helper endpoint

320

386

11.88

261.45

3.4

1.6

1.23

1.53

g/l

5.08

282

329

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

320

386

11.88

261.45

3.4

1.6

1.23

1.53

g/l

5.08

282

329

Covid-19 confirmed case

1293

4686

2.95

258.65

2.2

1.7

1.60

1.49

g/l

3.26

1152

3982

Type 1 diabetes, wide definition, subgroup 1

901

2636

3.64

257.96

2.0

1.7

1.54

1.42

g/l

2.92

808

2240

Opioids

3376

9090

2.00

256.15

1.8

1.55

1.44

g/l

8.01

2894

7751

Oxycodone

1525

5857

2.66

251.69

1.9

1.6

1.76

1.52

g/l

13.78

1288

4964

Other disorders of kidney and ureter

763

2067

4.17

251.42

2.2

1.7

1.58

1.56

g/l

0.20

687

1773

Pain in limb

2836

10293

2.06

248.40

1.8

1.7

1.55

1.50

g/l

1.93

2439

8751

Parasetamol

2663

6440

2.16

246.62

1.9

1.8

1.55

1.40

g/l

11.15

2294

5510

Asthma, unspecified (mode), excluding more controls

1652

5249

2.55

246.46

1.7

1.60

1.45

g/l

8.07

1414

4472

Codes for special purposes

1701

7187

2.48

245.55

2.1

1.7

1.58

1.47

g/l

4.48

1512

6130

Conduction disorders

1220

3571

3.01

245.32

1.6

1.51

1.59

g/l

2.01

1020

3028

Heart failure and coronary heart disease

1708

5297

2.59

244.96

1.7

1.62

1.54

g/l

2.73

1463

4467

Provisional assignment of new diseases of uncertain etiology

1697

7179

2.47

244.29

2.1

1.7

1.58

1.47

g/l

4.53

1508

6123

Hypothyroidism (congenital or acquired)

662

781

5.01

243.10

2.1

1.7

1.39

1.12

g/l

7.96

567

673

STROKE

1935

5822

2.39

241.97

1.8

1.7

1.57

1.53

g/l

1.05

1649

4894

Diarrhoea and gastroenteritis of presumed infectious origin

2501

11221

2.09

239.56

2.0

1.7

1.54

1.50

g/l

1.38

2156

9553

Non-invasive ventilation

768

1977

3.84

237.62

1.9

1.7

1.59

1.44

g/l

3.63

673

1693

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2297

11098

2.15

236.41

2.0

1.6

1.57

1.53

g/l

1.05

1964

9440

Hypertensive Heart Disease

1049

2834

3.24

235.77

1.8

1.6

1.60

1.50

g/l

2.35

887

2355

Disorders of lens

2508

7670

2.14

234.72

1.8

1.7

1.57

1.58

g/l

0.23

2178

6528

Osteopathies and chondropathies

2065

9145

2.23

232.70

1.9

1.7

1.60

1.55

g/l

1.53

1792

7743

Hernia of abdominal wall, postoperative

667

1708

4.16

232.15

1.7

1.4

1.60

1.49

g/l

1.96

573

1460

Type 1 diabetes, wide definition

922

2926

3.34

231.37

2.0

1.7

1.53

1.42

g/l

2.97

827

2473

Finngen Rheumatological endpoints

3235

9734

1.94

230.96

1.8

1.7

1.57

1.47

g/l

6.56

2766

8302

Hypothyroidism and >3 levothyroxin purchases

642

779

4.87

229.21

2.1

1.7

1.37

1.12

g/l

6.99

548

672

Hypothyroidism, levothyroxine purchases

642

779

4.87

229.21

2.1

1.7

1.37

1.12

g/l

6.99

548

672

Hypertensive Renal Disease

321

447

9.00

227.78

2.3

1.6

1.60

1.51

g/l

0.77

305

368

Chronic lymphocytic leukaemia

320

461

9.87

225.78

3.4

1.9

1.23

1.57

g/l

6.77

282

406

Hypo-osmolality and hyponatraemia

842

2587

3.54

224.96

1.6

1.60

1.55

g/l

0.72

738

2183

Persons encountering health services in other circumstances, wide

4173

12438

1.78

222.74

1.9

1.7

1.52

g/l

0.03

3646

10526

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

794

2395

3.69

221.77

1.9

1.7

1.12

1.57

g/l

33.66

666

2060

Symptoms and signs involving the urinary system

2820

11481

1.96

218.79

1.8

1.7

1.58

1.55

g/l

0.86

2383

9797

Codeine or tramadol medication

3939

12453

1.79

218.41

1.7

1.8

1.59

1.49

g/l

7.98

3398

10617

Chronic gastritis

1247

4841

2.74

218.11

1.7

1.6

1.48

1.60

g/l

3.89

1069

4079

Pain in throat and chest

2766

8704

1.99

215.92

1.7

1.50

1.51

g/l

0.19

2350

7442

Gastrointestinal diseases

1823

3889

2.40

214.48

1.9

1.7

1.48

g/l

0.10

1584

3298

Hyperkalaemia

405

758

6.40

214.13

2.1

1.7

1.58

1.49

g/l

0.93

356

642

Hard cardiovascular diseases

2785

9325

1.98

213.69

1.7

1.63

1.55

g/l

3.26

2402

7921

Other bacterial intestinal infections

870

2823

3.34

213.16

2.0

1.6

1.61

1.54

g/l

1.25

757

2387

Other soft tissue disorders, not elsewhere classified

3171

10626

1.89

212.95

1.8

1.54

1.49

g/l

1.92

2720

9048

Endocarditis

296

410

8.99

210.80

2.2

1.6

1.44

1.50

g/l

0.36

237

351

Other (not insulin) diabetes medications

3222

10615

1.88

210.33

1.7

1.69

1.49

g/l

24.58

2778

8966

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

382

695

6.81

209.88

2.1

1.6

1.41

1.49

g/l

0.76

319

593

Coronary atherosclerosis

2531

8320

2.04

208.53

1.7

1.63

1.58

g/l

1.76

2178

7060

Disorders of choroid and retina

2951

11646

1.91

207.44

1.8

1.7

1.55

1.56

g/l

0.32

2542

9867

AV-block

816

2325

3.43

205.80

1.7

1.5

1.52

1.61

g/l

1.56

685

1954

Diaphragmatic hernia

1502

6522

2.43

205.72

1.6

1.62

1.59

g/l

0.68

1292

5553

Reimbursement for rheumatic diseases

2057

10068

2.11

204.90

1.7

1.58

1.53

g/l

1.21

1754

8576

Ischaemic heart disease, wide definition

2719

8922

1.97

204.47

1.7

1.61

1.57

g/l

1.17

2341

7570

Syncope and collapse

1622

6374

2.34

204.04

1.7

1.6

1.55

1.52

g/l

0.63

1360

5378

Type 2 diabetes, definitions combined

3088

10024

1.89

203.89

1.8

1.7

1.67

1.48

g/l

19.53

2652

8460

Failure and rejection of transplanted organs and tissues

172

119

22.41

203.05

2.7

1.7

1.33

1.49

g/l

0.81

159

106

Cardiomyopathy

766

2366

3.48

202.75

1.8

1.5

1.53

1.59

g/l

0.77

663

2017

Genitourinary diseases

1979

4504

2.26

202.37

2.0

1.6

1.48

1.47

g/l

0.28

1721

3760

Abnormal findings on examination of blood, without diagnosis

1924

8659

2.18

201.95

1.8

1.7

1.64

1.53

g/l

4.55

1664

7363

Bacterial intestinal infections, IBD co-morbidities

885

2995

3.20

201.89

2.0

1.6

1.61

1.55

g/l

0.90

770

2534

Paroxysmal tachycardia

692

1641

3.72

200.25

2.0

1.6

1.48

1.47

g/l

0.18

581

1375

Type 2 diabetes, strict (exclude DM1)

3096

10122

1.87

200.19

1.8

1.7

1.67

1.48

g/l

19.59

2658

8549

Ischemic heart diseases

2728

9034

1.95

199.96

1.7

1.61

1.57

g/l

1.30

2348

7672

Asthma, unspecified (mode)

1714

6152

2.28

199.28

1.7

1.6

1.60

1.46

g/l

8.04

1463

5225

Direct fill therapy

639

1783

3.91

198.93

2.3

1.8

1.46

1.52

g/l

0.64

570

1543

Adjustment and management of implanted device

927

3267

3.08

197.25

1.8

1.6

1.43

1.54

g/l

2.58

808

2767

Cystic kidney disease

279

395

8.93

195.54

1.9

2.0

1.48

g/l

0.01

261

346

Nausea and vomiting

1102

4164

2.75

194.92

2.1

1.7

1.53

g/l

0.02

956

3524

Systemic connective tissue disorders

1398

6023

2.44

194.43

2.2

1.6

1.69

1.55

g/l

5.09

1216

5119

Fall on same level

3785

12355

1.75

193.57

1.7

1.8

1.53

1.50

g/l

0.96

3256

10562

Nephrotic syndrome

273

383

9.02

192.91

2.4

1.9

1.51

1.49

g/l

0.14

248

338

Explicit bacterial Sepsis

541

1377

4.35

192.84

2.3

1.6

1.62

1.50

g/l

1.69

464

1158

Depression medications

673

823

4.21

192.70

1.8

1.7

1.47

1.12

g/l

12.94

580

709

Haemorrhage from respiratory passages

1405

5614

2.44

192.37

1.7

1.6

1.46

1.57

g/l

4.31

1196

4752

Gastroduodenal ulcer

1183

4762

2.63

190.85

1.8

1.6

1.54

1.58

g/l

0.65

1019

3995

Other retinal disorders

2418

10217

1.97

190.81

1.8

1.7

1.55

1.57

g/l

0.32

2092

8652

Other disorders involving the immune mechanism, not elsewhere classified

269

376

9.06

190.74

2.7

2.1

1.41

1.43

g/l

0.16

240

327

Infections of the skin and subcutaneous tissue

1962

9716

2.08

187.77

1.9

1.7

1.59

1.49

g/l

4.14

1702

8321

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

257

348

9.44

187.61

2.7

2.1

1.39

1.43

g/l

0.21

229

303

Streptococcal septicaemia

474

1124

4.74

186.70

2.3

1.6

1.64

1.44

g/l

3.45

411

941

Type 2 diabetes, definitions combined, including avohilmo

3047

10044

1.84

186.32

1.8

1.7

1.67

1.48

g/l

20.21

2620

8486

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2351

11544

1.96

185.86

1.8

1.6

1.62

1.55

g/l

2.84

1978

9822

Chronic periodontitis, complicated

540

1425

4.28

184.82

2.1

1.7

1.62

1.56

g/l

0.62

480

1222

Enterocolitis due to Clostridium difficile

608

1736

3.90

184.80

2.1

1.7

1.63

1.53

g/l

1.53

534

1470

Asthma, excluding more controls

2178

5734

2.07

183.49

1.7

1.57

1.43

g/l

8.92

1879

4902

Diseases of the skin and subcutaneous tissue

3409

9778

1.79

182.70

1.9

1.7

1.51

1.50

g/l

0.23

2908

8317

Care involving use of rehabilitation procedures

2046

9892

2.02

181.14

1.7

1.6

1.58

1.51

g/l

2.21

1793

8330

Multiple myeloma, excluding all cancers (controls excluding all cancers)

348

665

6.36

180.69

2.4

1.6

1.38

1.50

g/l

1.25

312

565

Senile cataract

2253

7164

2.02

180.62

1.8

1.6

1.58

g/l

0.01

1946

6083

Gastric ulcer

862

3062

3.03

180.04

1.8

1.6

1.55

1.57

g/l

0.26

736

2578

Deposits [accretions] on teeth

384

763

5.44

177.42

2.8

1.7

1.40

1.47

g/l

0.60

346

642

Bacterial pneumoniae

1539

6281

2.26

176.95

1.9

1.6

1.68

1.48

g/l

11.48

1343

5294

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3638

12317

1.72

176.57

1.9

1.7

1.52

g/l

0.00

3171

10439

Other pulmonary diagnosis

2556

6753

1.94

176.54

1.8

1.7

1.56

1.44

g/l

7.32

2212

5747

Pacemaker

1495

6721

2.30

176.41

1.8

1.6

1.46

1.58

g/l

5.39

1249

5691

Multiple myeloma and malignant plasma cell neoplasms

343

662

6.28

176.13

2.4

1.6

1.39

1.50

g/l

1.20

308

563

Chronic nephritic syndrome

301

512

7.11

176.13

2.3

1.9

1.55

1.52

g/l

0.18

272

446

Excluding asthma or asthma-COPD overlap

2553

6753

1.94

175.73

1.8

1.7

1.55

1.44

g/l

6.80

2212

5747

Symptoms and signs involving the circulatory and respiratory systems

3195

9086

1.80

175.72

1.9

1.7

1.49

g/l

0.16

2753

7783

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2050

10634

2.00

174.52

2.0

1.6

1.56

1.53

g/l

0.64

1742

9062

Other gastritis (incl. Duodenitis)

970

3716

2.78

174.22

1.8

1.6

1.48

1.57

g/l

2.21

841

3146

Rheumatoid arthritis

1223

4692

2.48

173.99

1.5

1.7

1.63

1.53

g/l

2.57

1042

3969

Cytomegalovirus infection, IBD co-morbidity

203

226

11.81

173.94

3.1

2.0

1.42

1.51

g/l

0.52

184

196

Amputation

591

1729

3.84

173.75

2.1

1.7

1.78

1.52

g/l

7.23

521

1452

Other and unspecified acquired haemolytic anaemias

151

114

24.25

172.92

6.9

1.9

0.72

1.51

g/l

10.14

Diabetic retinopathy, excluding more controls

1148

2531

2.74

172.31

1.9

1.7

1.65

1.63

g/l

0.29

1027

2140

Congenital malformations of the urinary system

349

689

5.80

172.09

1.9

1.50

1.49

g/l

0.11

318

606

Other arrhythmias

1836

6922

2.08

170.78

1.8

1.6

1.48

1.54

g/l

2.16

1563

5914

Other special examinations and investigations of persons without complaint or reported diagnosis

2222

5722

2.01

170.63

1.9

1.6

1.50

1.52

g/l

0.33

1902

4828

Sub-endpoint used in defining T1D endpoints

1177

4881

2.48

170.59

2.0

1.7

1.56

1.49

g/l

1.43

1062

4109

Bacterial pneumonia, not elsewhere classified

1466

5964

2.27

169.85

1.8

1.6

1.67

1.49

g/l

10.58

1282

5028

Vascular disorders of the intestines

422

990

4.89

169.60

2.1

1.6

1.51

1.53

g/l

0.20

365

844

IgA nephropathy (IgA glomerulonephritis)

221

283

10.15

169.54

2.9

2.1

1.38

1.50

g/l

0.88

200

242

COPD differential diagnosis

2522

6751

1.91

167.53

1.8

1.7

1.55

1.44

g/l

6.24

2182

5758

ILD differential diagnosis

2522

6751

1.91

167.51

1.8

1.7

1.55

1.44

g/l

6.24

2182

5758

Hyperlipidaemia, other/unspecified

1471

6507

2.24

166.27

1.7

1.6

1.60

1.55

g/l

0.92

1257

5484

Other/unspecified cytomegaloviral diseases

186

197

12.83

166.13

3.2

2.0

1.42

1.51

g/l

0.44

168

170

Cardiomyopathies, Primary/intrinsic

559

1617

3.75

164.70

1.8

1.6

1.53

1.59

g/l

0.70

486

1377

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1075

2015

2.74

163.72

1.9

1.7

1.53

1.40

g/l

3.39

949

1704

Biguanides

3097

11131

1.76

163.62

1.6

1.7

1.70

1.48

g/l

25.59

2665

9436

Myocardial infarction

1931

7072

2.04

163.32

1.6

1.7

1.69

1.58

g/l

5.49

1684

5997

Statin medication

2022

5738

2.02

161.98

1.9

1.7

1.56

1.45

g/l

4.45

1758

4817

Cardiomyopathy (excluding other)

566

1673

3.66

161.19

1.8

1.6

1.53

1.59

g/l

0.77

493

1423

Cytomegaloviral disease

203

249

10.53

161.02

3.1

2.0

1.42

1.54

g/l

0.75

184

216

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

482

1302

4.20

159.98

1.8

1.7

2.00

1.53

g/l

13.53

406

1113

Major coronary heart disease event

2575

9637

1.84

159.83

1.6

1.7

1.63

1.57

g/l

2.34

2226

8180

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

466

829

4.43

159.63

2.0

1.7

1.63

1.50

g/l

1.58

395

695

Other cataract

1596

5959

2.16

159.47

1.8

1.6

1.51

1.58

g/l

1.80

1399

5031

Peripheral artery operations in Hilmo

683

2291

3.26

159.16

2.0

1.7

1.78

1.53

g/l

8.14

610

1930

Fibrosis and cirrhosis of liver

431

1080

4.55

158.85

2.0

1.8

1.09

1.56

g/l

19.09

364

939

Myocardial infarction, without ST-elevation

1698

7886

2.09

157.85

1.6

1.68

1.54

g/l

7.23

1468

6642

Asthma (only as main-diagnosis), excluding more controls

1913

5734

2.03

157.82

1.6

1.7

1.58

1.43

g/l

8.77

1641

4902

L01XX Other antineoplastic agents

390

919

5.03

157.74

2.3

1.8

1.06

1.55

g/l

20.27

341

796

Other arthritis (FG)

1073

4509

2.48

156.92

1.7

1.67

1.49

g/l

6.00

910

3861

Disorders of gallbladder, biliary tract and pancreas

3235

12495

1.71

156.26

1.8

1.7

1.52

1.54

g/l

0.57

2786

10633

Other nutritional deficiencies

1973

10221

1.94

155.91

1.8

1.63

1.48

g/l

10.06

1690

8804

Major coronary heart disease event excluding revascularizations

2403

9205

1.87

155.86

1.6

1.7

1.64

1.57

g/l

3.10

2066

7809

Malignant neoplasm, wide definition for exclusion

2718

9149

1.80

154.25

1.8

1.7

1.58

1.51

g/l

2.90

2331

7817

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2718

9149

1.80

154.23

1.8

1.7

1.58

1.51

g/l

2.90

2331

7817

Gastro-oesophageal reflux disease

2138

10283

1.89

154.22

1.7

1.58

1.55

g/l

0.76

1813

8740

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

2718

9150

1.80

154.21

1.8

1.7

1.58

1.51

g/l

2.88

2330

7818

Unspecified haematuria

1652

7073

2.09

153.64

1.8

1.6

1.56

1.55

g/l

0.08

1408

6038

Pre-eclampsia

621

1987

3.28

153.49

3.2

1.7

1.15

1.52

g/l

17.94

560

1704

Neoplasms

2199

6256

1.92

151.49

1.9

1.8

1.45

1.44

g/l

0.06

1894

5386

Enlarged lymph nodes

611

1960

3.31

151.28

2.0

1.6

1.62

1.50

g/l

1.67

520

1688

Benign neoplasms

2249

6847

1.90

150.96

1.8

1.50

1.44

g/l

1.73

1922

5890

Fungal Sepsis

265

468

6.81

149.19

1.9

1.8

1.65

1.50

g/l

1.24

225

400

Other disorders of teeth and supporting structures

820

3117

2.78

149.05

1.9

1.6

1.55

1.54

g/l

0.17

713

2638

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

625

2068

3.29

148.85

2.0

1.6

1.61

1.53

g/l

0.84

512

1760

Asthma

2297

6688

1.88

148.17

1.7

1.57

1.44

g/l

8.97

1975

5698

Pregnancy hypertension

1087

4199

2.41

147.74

2.6

1.7

1.21

1.51

g/l

20.95

967

3611

Pre-eclampsia or eclampsia

657

2227

3.09

146.97

3.1

1.6

1.17

1.53

g/l

17.71

592

1912

Exposure to unspecified factor

3049

14325

1.69

146.46

1.8

1.7

1.52

1.51

g/l

0.13

2614

12229

Benign neoplasms

3138

10508

1.70

145.92

1.8

1.7

1.50

g/l

0.18

2678

8993

Cirrhosis of liver, NAS

333

735

5.36

145.86

2.1

1.8

1.00

1.58

g/l

20.03

280

642

Benign neoplasm: Colon, unspecified

951

3918

2.56

145.29

1.8

1.6

1.54

g/l

0.02

795

3328

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

646

2116

3.15

145.15

2.0

1.8

1.40

1.48

g/l

1.44

546

1837

Myeloproliferative diseases

470

1336

3.95

144.52

1.8

1.10

1.54

g/l

19.40

404

1146

Hypothyroidism, drug reimbursement

326

439

5.47

144.43

2.1

1.5

1.44

1.18

g/l

4.09

280

371

Peripheral arterial reconstruction

858

3421

2.72

144.31

1.7

1.6

1.73

1.54

g/l

6.77

750

2897

Other specified/unspecified arthritis

947

3919

2.53

143.46

1.7

1.67

1.51

g/l

4.59

805

3344

Amputation of toe

438

1200

4.19

143.21

1.9

1.7

1.75

1.52

g/l

4.93

388

1021

Multiple myeloma and malignant plasma cell neoplasms

343

793

5.20

142.73

2.4

1.7

1.39

1.57

g/l

2.38

308

683

Other diseases of urinary system

3310

11410

1.67

142.50

1.7

1.55

1.50

g/l

2.00

2827

9754

All influenza

904

3679

2.58

142.22

2.0

1.6

1.54

1.46

g/l

1.60

775

3107

Malignant neoplasm

2743

9534

1.74

141.21

1.8

1.6

1.58

1.52

g/l

2.47

2351

8152

Factors influencing health status and contact with health services

1014

2001

2.61

140.79

1.9

1.5

1.54

1.56

g/l

0.23

875

1693

Persons encountering health services for examination and investigation

2125

5722

1.90

139.20

1.8

1.6

1.50

1.52

g/l

0.35

1828

4828

Sulfasalazine

972

4123

2.45

139.08

1.5

1.6

1.55

1.50

g/l

0.79

832

3500

Symptoms and signs involving the digestive system and abdomen

3297

10112

1.66

138.36

1.8

1.7

1.50

1.53

g/l

0.88

2812

8608

Bacterial pneumonia (organism specified)

1665

7915

1.99

137.60

1.9

1.6

1.67

1.52

g/l

8.12

1450

6685

Disorders of mineral metabolism

386

983

4.33

137.57

2.0

1.7

1.57

1.50

g/l

0.69

333

845

Alcohol use disorder, Swedish definition

1886

9511

1.90

137.57

1.6

1.7

1.52

1.53

g/l

0.22

1609

8116

Cerebrovascular diseases

2564

10808

1.75

136.63

1.8

1.6

1.61

1.56

g/l

1.27

2174

9194

Insulin, fast-acting (human)

570

1868

3.23

136.17

2.0

1.7

1.45

1.46

g/l

0.14

518

1590

Polyneuropathies and other disorders of the peripheral nervous system

926

3917

2.52

135.77

2.1

1.6

1.57

1.56

g/l

0.19

803

3336

Certain disorders involving the immune mechanism

746

2840

2.79

135.70

2.2

1.7

1.45

1.55

g/l

2.22

641

2449

COPD (mode)

1143

4098

2.31

135.46

1.6

1.5

1.71

1.51

g/l

9.80

987

3434

Symptoms and signs involving cognition, perception, emotional state and behaviour

3038

13084

1.66

135.37

1.7

1.51

1.54

g/l

0.95

2591

11178

Volume depletion

461

1346

3.76

134.77

1.8

1.7

1.64

1.50

g/l

2.20

395

1135

Constipation

2832

12292

1.69

134.17

1.7

1.54

1.55

g/l

0.18

2360

10511

Viral pneumonia

530

1685

3.38

134.12

2.2

1.6

1.61

1.46

g/l

2.95

466

1423

Implicit fungal Sepsis

238

423

6.75

133.10

2.0

1.8

1.64

1.52

g/l

0.84

203

363

Other disorders of urethra and urinary system

2214

9445

1.80

132.57

1.7

1.58

1.50

g/l

2.97

1880

8056

Other medical care

1410

6908

2.07

132.16

1.7

1.6

1.70

1.53

g/l

6.78

1197

5833

Hernia

2936

12190

1.67

132.04

1.7

1.54

1.55

g/l

0.21

2514

10383

Seropositive rheumatoid arthritis

913

3852

2.47

132.03

1.5

1.7

1.61

1.53

g/l

1.48

787

3265

Asthma (mode)

2206

6751

1.83

131.78

1.7

1.57

1.44

g/l

8.05

1888

5758

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1165

4716

2.22

131.10

2.6

1.7

1.22

1.52

g/l

22.01

1036

4050

Disorders of other endocrine glands

1431

7120

2.04

130.82

2.0

1.7

1.54

1.52

g/l

0.32

1241

6066

Abnormal findings on diagnostic imaging of lung

1761

9313

1.91

130.76

1.8

1.6

1.66

1.56

g/l

3.65

1487

7929

Other necrotizing vasculopathies

400

1097

4.11

129.82

3.1

1.7

1.83

1.54

g/l

5.03

347

943

Pre-eclampsia or poor fetal growth

786

3113

2.60

128.97

3.0

1.7

1.17

1.45

g/l

13.88

703

2680

Substance abuse, excluding more controls

1827

8743

1.88

128.78

1.6

1.7

1.58

1.50

g/l

2.63

1568

7481

Hypokalaemia

493

1540

3.45

128.75

1.5

1.6

1.73

1.51

g/l

4.88

423

1305

Use of hypnotics and sedatives

3341

12194

1.61

128.35

1.7

1.57

1.52

g/l

1.95

2867

10401

Myocardial infarction, strict

1738

6786

1.94

128.23

1.6

1.7

1.68

1.57

g/l

4.89

1519

5756

Other and unspecified aplastic anaemias

123

104

16.72

128.20

2.6

1.7

1.22

1.56

g/l

2.17

102

Myeloid leukaemia

201

315

7.88

128.04

1.9

1.8

1.42

1.51

g/l

0.56

177

271

1938

9960

1.84

127.92

1.6

1.7

1.53

g/l

0.02

1653

8501

Ascites

381

1021

4.16

127.24

2.0

1.7

1.23

1.51

g/l

5.54

314

874

Other and unspecified polyneuropathies, also in other diseases

830

3449

2.58

126.92

2.1

1.6

1.57

1.56

g/l

0.10

719

2948

2008

10197

1.81

126.26

1.6

1.7

1.53

1.52

g/l

0.05

1710

8715

Other diseases of pleura

1734

8364

1.91

126.15

1.8

1.6

1.67

1.55

g/l

4.98

1464

7090

3598

12204

1.58

125.63

1.8

1.7

1.53

1.51

g/l

0.50

3073

10422

Other diseases of pericardium

250

486

5.88

125.48

1.8

1.6

1.65

1.52

g/l

0.91

204

416

Obesity

1805

9876

1.86

125.47

1.8

1.67

1.48

g/l

14.46

1549

8509

Obesity due to excess calories

1394

7092

2.03

125.40

1.8

1.66

1.47

g/l

11.26

1203

6131

Obesity and other hyperalimentation

1811

9919

1.85

125.15

1.8

1.67

1.48

g/l

14.59

1553

8546

Any event in cancer register

2752

9889

1.68

125.09

1.8

1.7

1.56

1.51

g/l

1.77

2372

8459

SLE (Finngen)

198

308

7.36

124.85

2.4

1.5

1.55

1.53

g/l

0.08

180

267

Diseases of oral cavity, salivary glands and jaws

2974

9370

1.66

124.10

1.8

1.6

1.49

1.54

g/l

1.80

2546

7965

Agranulocytosis

485

1538

3.42

123.97

1.9

1.7

1.51

1.55

g/l

0.41

417

1324

Cellulitis

797

3269

2.57

123.84

1.9

1.7

1.58

1.51

g/l

1.14

691

2803

Headache

1712

7756

1.88

122.12

1.8

1.7

1.50

1.47

g/l

0.57

1469

6608

Other necrotizing vasculopathies (FG)

328

814

4.53

122.00

2.2

1.7

1.89

1.47

g/l

7.85

288

690

Other systemic involvement of connective tissue (FG)

881

3771

2.42

121.87

2.0

1.7

1.68

1.52

g/l

4.22

761

3189

Asthma (only as main-diagnosis)

1986

6688

1.83

120.65

1.6

1.7

1.59

1.44

g/l

9.80

1695

5698

Osteomyelitis

352

935

4.23

119.43

2.1

1.8

1.80

1.49

g/l

6.29

321

811

Falls/tendency to fall

3375

10791

1.59

119.18

1.7

1.8

1.50

g/l

0.01

2883

9244

Cardiomyopathy, other and unspecified

360

966

4.07

119.03

1.9

1.6

1.60

g/l

0.04

317

834

Disorders of parathyroid gland

838

3544

2.47

118.75

2.2

1.6

1.57

1.59

g/l

0.25

732

2985

Noninfective enteritis and colitis

1476

7804

1.95

118.05

1.8

1.7

1.53

1.50

g/l

0.40

1281

6661

Myeloproliferative diseases (CML excluded)

411

1227

3.74

117.26

1.8

1.08

1.53

g/l

18.96

352

1057

Parodontitis or operation codes

2795

12884

1.63

117.06

1.9

1.7

1.57

1.54

g/l

0.64

2409

10977

Chronic periodontitis, including avohilmo

2781

12874

1.63

116.73

1.9

1.7

1.56

1.55

g/l

0.46

2396

10971

Parodontitis

2790

12883

1.63

116.43

1.9

1.7

1.57

1.54

g/l

0.63

2404

10976

Alcoholic liver disease

474

1551

3.34

115.59

1.7

1.14

1.58

g/l

20.70

383

1331

Bronchitis

3272

13906

1.57

114.99

1.9

1.7

1.51

g/l

0.03

2804

11870

Myeloid leukaemia

201

353

7.00

114.54

1.9

2.0

1.42

1.56

g/l

0.95

177

311

483

1591

3.21

114.48

2.4

1.8

1.50

1.49

g/l

0.05

423

1354

Osteoporosis

963

4226

2.29

114.17

2.1

1.6

1.58

1.59

g/l

0.24

814

3564

Cutaneous abscess, furuncle and carbuncle

846

3690

2.39

113.98

2.0

1.7

1.62

1.50

g/l

2.88

732

3152

Rheumatoid arthritis, including avohilmo

1304

6722

2.01

113.74

1.5

1.7

1.62

1.56

g/l

1.26

1118

5729

Symptoms and signs concerning food and fluid intake

417

1273

3.51

112.51

1.5

1.6

1.46

1.52

g/l

0.48

366

1084

Convulsions, not elsewhere classified

729

2948

2.53

112.22

1.9

1.7

1.47

1.46

g/l

0.09

618

2519

Asthma-related pneumonia or sepsis

1293

6682

2.01

111.61

1.8

1.7

1.68

1.52

g/l

7.10

1104

5636

Asthma, hospital admissions 3, pneumonia

1293

6682

2.01

111.61

1.8

1.7

1.68

1.52

g/l

7.10

1104

5636

Asthma-related pneumonia

1291

6669

2.01

111.59

1.8

1.7

1.68

1.52

g/l

7.02

1102

5623

Other diseases of liver

645

2520

2.71

111.32

1.8

1.7

1.32

1.57

g/l

9.25

552

2183

Disorders of calcium metabolism

303

758

4.44

111.06

2.1

1.8

1.70

1.51

g/l

2.36

263

645

Angina pectoris

1998

7825

1.78

110.98

1.6

1.7

1.57

1.58

g/l

0.11

1699

6637

Other diseases of intestine

504

1740

3.11

110.89

1.8

1.7

1.59

1.54

g/l

0.45

438

1482

Mental and behavioural disorders due to psychoactive substance use

1886

10325

1.77

110.29

1.6

1.7

1.58

1.52

g/l

2.07

1617

8826

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

184

301

6.80

109.79

2.0

1.7

1.44

1.54

g/l

0.59

171

256

Abdominal and pelvic pain

3140

10110

1.59

109.65

1.8

1.7

1.50

1.53

g/l

0.75

2679

8607

Oesophageal varices

256

576

5.18

109.21

2.0

1.7

1.00

1.61

g/l

20.16

218

491

Other disorders of white blood cells

302

768

4.43

108.93

2.3

1.8

1.35

1.53

g/l

2.56

257

661

Other diseases of anus and rectum

1014

4844

2.17

108.87

1.7

1.6

1.53

1.55

g/l

0.24

857

4098

Pulmonary heart disease, diseases of pulmonary circulation

1182

6006

2.05

108.09

2.1

1.6

1.66

1.56

g/l

2.70

1022

5085

Venous thromboembolism

1843

10425

1.77

107.35

2.0

1.6

1.66

1.55

g/l

4.90

1603

8813

Acute myeloid leukaemia and myelodysplastic syndromes

169

270

8.13

106.95

2.0

1.8

1.28

1.59

g/l

2.82

144

236

Benign neoplasm of other and ill-defined parts of digestive system

642

2555

2.66

106.87

1.8

1.6

1.55

g/l

0.05

544

2183

Neurological diseases, wide definition

813

1650

2.52

106.73

1.8

1.47

1.31

g/l

4.23

708

1404

Substance abuse

1827

10145

1.76

106.52

1.6

1.7

1.58

1.52

g/l

1.93

1568

8670

Presence of other functional implants

1856

7568

1.79

106.50

1.8

1.6

1.56

1.61

g/l

1.34

1570

6405

Benign neoplasm: Sigmoid colon

678

2777

2.59

106.40

1.6

1.63

1.54

g/l

1.50

591

2362

Acute peritonitis

341

959

3.97

106.38

2.2

1.8

1.53

1.52

g/l

0.06

318

834

Non-follicular lymphoma, hilmo, excluding all cancers

433

1420

3.33

105.15

2.1

1.6

1.57

1.52

g/l

0.41

361

1219

Other and unspecified disorders of white blood cells

243

539

5.19

105.11

2.4

1.8

1.29

1.55

g/l

3.84

208

465

Chronic tubulo-interstitial nephritis

206

394

5.88

104.85

2.2

1.7

1.45

1.47

g/l

0.09

188

339

Pain, not elsewhere classified

788

3451

2.36

104.57

1.7

1.6

1.57

1.49

g/l

1.49

676

2943

Injuries to the head

3281

14148

1.54

104.45

1.7

1.8

1.50

1.52

g/l

0.32

2785

12097

Disorders of thyroid, IBD co-morbidities

503

1236

3.06

104.23

1.8

1.7

1.52

1.38

g/l

2.29

427

1042

Parodontitis and operation codes

2584

12761

1.61

102.68

1.9

1.7

1.56

1.55

g/l

0.30

2224

10890

Other antidepressants

3275

11273

1.54

101.35

1.6

1.8

1.56

1.50

g/l

2.58

2792

9652

Acute posthaemorrhagic anaemia

199

382

5.94

101.34

2.0

1.9

1.42

1.52

g/l

0.60

163

325

Other functional intestinal disorders

1356

6978

1.90

100.88

1.7

1.6

1.53

g/l

0.02

1150

5880

Hepatic failure, not elsewhere classified

228

499

5.33

100.64

2.0

1.9

1.08

1.58

g/l

9.67

170

433

Spondylopathies

2516

9608

1.62

99.64

1.6

1.7

1.59

1.55

g/l

1.49

2159

8175

Asthma, hospital admission 2, infections

1803

10479

1.73

99.34

1.8

1.7

1.65

1.50

g/l

8.81

1548

8913

Asthma-related infections

1803

10479

1.73

99.34

1.8

1.7

1.65

1.50

g/l

8.81

1548

8913

Diseases of the eye and adnexa

2315

7055

1.67

99.17

1.9

1.8

1.45

1.49

g/l

1.04

2005

6043

SLE, strict definition

196

380

5.91

98.86

2.4

1.9

1.55

1.53

g/l

0.08

178

329

SLE, ICD10

196

380

5.91

98.86

2.4

1.9

1.55

1.53

g/l

0.08

178

329

Left ventricular outflow tract obstruction (LVOTO), broad definition

405

1320

3.30

98.63

2.1

1.8

1.27

1.51

g/l

4.13

274

1157

Benign neoplasm: Colon, unspecified

951

4635

2.16

98.44

1.8

1.7

1.54

1.58

g/l

0.69

795

3937

Diabetic retinopathy

1390

4754

1.94

97.80

1.9

1.7

1.65

g/l

0.00

1232

4087

Charcot foot

137

190

9.00

97.69

2.2

2.0

1.65

1.41

g/l

1.65

126

164

Hyperparathyroidism

719

3111

2.41

96.97

2.1

1.6

1.58

g/l

0.01

629

2620

Retention of urine

1278

5792

1.94

96.87

1.6

1.64

1.54

g/l

3.26

1069

4940

Coronary revascularization (ANGIO or CABG)

1636

6536

1.80

96.11

1.6

1.7

1.63

1.57

g/l

1.47

1400

5549

Systemic lupus erythematosus

198

397

5.67

96.01

2.4

1.9

1.55

1.51

g/l

0.16

180

343

Essential (haemorrhagic) thrombocythaemia

211

452

5.36

95.08

1.8

1.6

1.09

1.53

g/l

8.05

178

391

General examination and investigation of persons without complaint and reported diagnosis

1843

5704

1.75

94.83

1.8

1.6

1.51

1.52

g/l

0.11

1558

4815

Viral infections characterized by skin and mucous membrane lesions

1270

6879

1.90

94.63

1.9

1.7

1.52

1.51

g/l

0.05

1115

5852

Gingivitis and periodontal diseases

2779

9265

1.58

94.49

1.8

1.6

1.50

1.54

g/l

1.44

2367

7888

Other diseases of blood and blood-forming organs

323

954

3.73

93.20

2.3

1.8

1.20

1.54

g/l

7.66

278

825

Paralytic ileus and intestinal obstruction

874

4207

2.16

92.37

1.8

1.6

1.66

1.56

g/l

2.32

765

3543

Benign neoplasm: Ascending colon

508

1944

2.80

92.35

1.8

1.6

1.60

1.53

g/l

0.83

450

1657

Gestational [pregnancy-induced] hypertension

603

2471

2.51

92.20

2.6

1.7

1.22

1.47

g/l

9.23

541

2117

Dermatitis

1832

11098

1.69

92.12

1.7

1.56

1.52

g/l

0.91

1574

9501

Persons encountering health services for specific procedures, not carried out

298

837

3.82

91.75

1.7

1.8

1.66

1.43

g/l

3.11

256

732

Malignant immunoproliferative diseases

105

117

12.89

91.24

2.9

1.7

1.46

1.45

g/l

0.01

102

Viral hepatitis, IBD co-morbidity

175

323

5.73

91.03

1.7

1.8

1.44

1.35

g/l

0.50

141

267

Cystitis

2536

9979

1.58

90.82

1.7

1.54

1.49

g/l

1.64

2179

8521

Benzodiazepine use

2969

14162

1.52

90.71

1.6

1.8

1.61

1.50

g/l

7.01

2480

12141

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2900

12567

1.53

90.40

1.8

1.7

1.51

1.56

g/l

1.65

2485

10706

Other and unspecified dermatitis

1532

8896

1.77

90.39

1.7

1.56

1.52

g/l

0.67

1318

7607

Pain in joint

1706

6610

1.74

90.37

1.7

1.57

1.51

g/l

1.71

1473

5630

Follow-up examination after treatment for conditions other than malignant neoplasms

1271

4454

1.91

90.36

1.7

1.6

1.54

1.51

g/l

0.48

1122

3784

Aortic valve malfunction, age under 60 years

376

1237

3.27

90.26

2.1

1.8

1.26

1.52

g/l

4.24

252

1079

Other external causes of accidental injury

2532

8090

1.59

89.94

1.7

1.51

1.50

g/l

0.31

2151

6940

Diabetic retinopathy, strict definition

778

3184

2.30

89.66

2.1

1.7

1.57

1.62

g/l

0.61

697

2738

DVT of lower extremities and pulmonary embolism

1428

8148

1.80

89.34

2.0

1.6

1.68

1.55

g/l

5.05

1238

6898

Dizziness and giddiness

2268

11753

1.60

88.94

1.7

1.50

1.55

g/l

1.63

1936

10024

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1414

8069

1.80

88.55

1.6

1.7

1.56

1.53

g/l

0.68

1221

6890

Chronic myeloproliferative disease

134

207

8.83

88.42

2.4

1.9

0.84

1.48

g/l

12.77

118

186

Disorder of lipoprotein metabolism, unspecified

534

2137

2.66

88.26

1.7

1.60

1.53

g/l

0.94

466

1808

Abnormalities of heart beat

1050

5424

1.97

87.97

1.8

1.7

1.52

1.53

g/l

0.18

891

4589

Idiopathic gout

428

1548

3.02

87.74

1.8

1.7

1.74

1.54

g/l

3.99

384

1332

Pulmonary embolism

1036

5412

1.99

87.42

2.1

1.6

1.71

1.56

g/l

4.76

891

4595

Other noninfective gastroenteritis and colitis

799

3796

2.18

87.19

1.9

1.7

1.54

1.52

g/l

0.27

702

3233

Pain (limb, back, neck, head abdominally)

2287

7187

1.62

87.19

1.8

1.7

1.49

1.51

g/l

0.35

1959

6084

Other CVD

777

3680

2.23

86.97

1.7

1.6

1.55

1.56

g/l

0.06

659

3110

Other and unspecified diseases of blood and blood-forming organs

166

314

6.27

86.88

3.0

1.8

1.24

1.55

g/l

3.23

149

275

Vocal cord dysfunction

339

975

3.34

86.57

1.8

1.6

1.67

1.41

g/l

4.10

290

817

Idiopathic thrombocytopenic purpura

183

378

5.61

86.31

2.8

1.9

1.14

1.53

g/l

6.29

156

335

Pulmonary heart disease

1036

5442

1.98

86.00

2.1

1.6

1.71

1.56

g/l

4.90

891

4623

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

180

368

5.65

85.81

2.1

1.7

1.43

1.48

g/l

0.25

148

324

Accidents

2509

8090

1.58

85.72

1.7

1.51

1.50

g/l

0.18

2124

6940

Persons encountering health services in other circumstances

1101

5877

1.92

85.65

1.9

1.7

1.53

1.49

g/l

0.73

956

4993

Stroke, including SAH

2092

9780

1.62

85.26

1.7

1.59

1.58

g/l

0.29

1778

8311

Soft tissue disorders

3077

10788

1.50

85.23

1.8

1.50

1.49

g/l

0.13

2630

9179

Mental and behavioural disorders due to alcohol

1579

9141

1.72

84.93

1.6

1.7

1.56

1.52

g/l

0.91

1362

7815

Diseases of the respiratory system

1931

5854

1.68

84.84

1.8

1.7

1.55

1.45

g/l

3.97

1671

4991

Injuries to the abdomen, lower back, lumbar spine and pelvis

1258

6992

1.84

84.68

1.8

1.7

1.51

1.53

g/l

0.22

1041

5963

Other disorders of skin and subcutaneous tissue, not elsewhere classified

540

2216

2.58

84.43

1.9

1.6

1.70

1.55

g/l

2.69

471

1894

Need for immunization against other single viral diseases

138

225

7.37

84.28

3.0

1.9

1.41

1.52

g/l

0.68

130

197

Later onset COPD, excluding more controls

807

3008

2.20

83.76

1.5

1.71

1.51

g/l

7.56

695

2525

Sequelae of external causes of morbidity and mortality

858

4262

2.10

83.74

1.9

1.7

1.61

1.54

g/l

1.20

738

3644

Coronary artery bypass grafting

1097

4448

1.96

83.67

1.7

1.6

1.60

1.55

g/l

1.00

927

3754

Intracranial trauma

1596

7052

1.72

83.27

1.7

1.8

1.51

1.49

g/l

0.38

1342

6062

Systemic lupus erythematosus, unspecified

166

324

5.85

83.13

2.5

2.0

1.52

1.53

g/l

0.02

148

284

Mycoses

860

4287

2.09

82.89

1.9

1.7

1.56

1.54

g/l

0.20

737

3666

Seropositive rheumatoid arthritis, wide

911

4642

2.04

82.61

1.5

1.7

1.61

1.57

g/l

0.66

786

3949

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

14.62

82.60

2.7

1.8

1.38

1.45

g/l

0.28

Other acute lower respiratory infections

1642

9478

1.69

82.57

1.9

1.7

1.54

1.51

g/l

0.57

1430

8021

Gout due to impairment of renal function

113

157

10.28

82.53

2.2

1.9

1.62

1.46

g/l

0.90

105

137

Coxarthrosis [arthrosis of hip](FG)

1648

7137

1.71

82.28

1.5

1.6

1.62

1.54

g/l

2.71

1397

6038

Other specific joint derangements/joint disorders

1961

8182

1.63

82.28

1.7

1.8

1.55

1.45

g/l

4.34

1690

7004

Other systemic involvement of connective tissue

903

4597

2.04

81.97

2.0

1.6

1.67

1.54

g/l

3.26

781

3910

Zoster [herpes zoster]

656

2978

2.32

81.38

1.9

1.7

1.50

1.54

g/l

0.43

573

2523

Stroke, excluding SAH

2006

9432

1.62

81.35

1.7

1.6

1.60

1.58

g/l

0.42

1698

8010

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

181

395

5.54

81.16

2.5

1.7

1.44

1.57

g/l

0.83

165

347

Multiple myeloma

181

395

5.54

81.16

2.5

1.7

1.44

1.57

g/l

0.83

165

347

Hydronephrosis

400

1443

2.94

80.93

1.7

1.6

1.87

1.49

g/l

9.46

352

1212

Vitreous haemorrhage

423

1580

2.88

80.88

2.3

1.7

1.51

1.55

g/l

0.26

376

1356

Psychiatric diseases

3262

11257

1.47

80.86

1.7

1.8

1.55

1.50

g/l

1.66

2781

9647

Non-follicular lymphoma

433

1642

2.86

80.84

2.1

1.7

1.57

1.54

g/l

0.20

361

1409

Isolated proteinuria

175

370

5.47

80.37

2.3

2.0

1.49

1.50

g/l

0.06

159

315

Diseases of peritoneum

418

1560

2.87

79.83

2.1

1.7

1.50

1.54

g/l

0.31

386

1335

Vitamin B12 deficiency anaemia

431

1640

2.80

78.99

1.9

1.7

1.48

1.54

g/l

0.64

357

1389

Low back pain

2117

10501

1.58

78.97

1.7

1.8

1.57

1.50

g/l

2.77

1781

8991

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

878

4489

2.03

78.89

1.5

1.7

1.61

1.57

g/l

0.50

757

3819

Other/unspecified seropositive rheumatoid arthritis

889

4572

2.02

78.50

1.5

1.7

1.61

1.57

g/l

0.52

766

3886

Alcohol use disorder, ICD-based

1282

7381

1.78

78.24

1.6

1.7

1.56

1.52

g/l

0.65

1103

6314

In situ neoplasms

1046

5400

1.90

77.97

1.8

1.6

1.51

1.53

g/l

0.34

900

4582

Any mental disorder

3338

11652

1.45

77.92

1.7

1.8

1.55

1.51

g/l

1.51

2846

9969

Intestinal stricture

1047

5704

1.90

77.65

1.8

1.6

1.64

1.56

g/l

1.92

915

4828

Benign neoplasm: Stomach

371

1320

3.01

77.55

1.8

1.5

1.55

1.54

g/l

0.12

310

1126

Missing teeth due to accident, extraction or parodontitis

426

1625

2.78

77.55

1.9

1.6

1.48

1.59

g/l

1.45

373

1387

Osteonecrosis

263

767

3.77

77.46

1.8

1.74

1.55

g/l

2.07

241

666

Dorsalgia

2927

10826

1.49

77.29

1.7

1.8

1.55

1.49

g/l

2.71

2494

9263

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1640

6797

1.69

77.20

1.7

1.6

1.49

1.56

g/l

2.40

1419

5776

Coxarthrosis

1543

6244

1.72

77.17

1.6

1.7

1.63

1.55

g/l

2.38

1306

5279

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1368

6214

1.77

77.14

1.4

1.6

1.68

1.56

g/l

4.34

1178

5272

Benign neoplasm of other and ill-defined parts of digestive system

642

2954

2.29

77.12

1.8

1.7

1.55

1.57

g/l

0.25

544

2533

Benign neoplasm: Rectum, anus and anal canal

671

3138

2.24

77.10

1.6

1.55

g/l

0.07

579

2666

Arthropathies

2555

8617

1.53

76.84

1.8

1.54

1.45

g/l

4.12

2202

7351

Benign neoplasm: Rectum

608

2739

2.34

76.82

1.6

1.5

1.55

1.54

g/l

0.10

530

2328

Hypotension

671

3169

2.24

75.90

1.7

1.56

1.54

g/l

0.23

573

2679

Cardiodefibrillation

1314

7703

1.77

75.85

1.7

1.6

1.43

1.58

g/l

7.60

1098

6562

Malignant immunoproliferative diseases

105

148

10.08

75.71

2.9

2.3

1.46

1.54

g/l

0.33

128

Other diseases of arteries and capillaries

367

1316

2.99

75.63

2.0

1.7

1.54

1.50

g/l

0.31

327

1116

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

697

3313

2.16

75.35

1.8

1.9

1.54

1.40

g/l

3.29

590

2851

External causes of morbidity and mortality

1952

6116

1.62

75.33

1.7

1.8

1.52

1.47

g/l

1.29

1658

5232

Seronegative rheumatoid arthritis

413

1571

2.77

75.33

1.6

1.64

1.52

g/l

1.54

348

1333

Diseases of the musculoskeletal system and connective tissue

1528

4495

1.73

75.22

1.9

1.7

1.47

1.42

g/l

1.27

1326

3821

Methotrexate

477

1943

2.57

75.21

1.5

1.6

1.51

1.53

g/l

0.14

417

1661

Other (seronegative) rheumatoid arthritis, wide

666

3137

2.22

75.10

1.6

1.7

1.65

1.56

g/l

1.25

565

2671

Ischaemic Stroke, excluding all haemorrhages

1889

9102

1.61

74.63

1.7

1.6

1.61

1.58

g/l

0.62

1600

7720

Chronic pancreatitis

475

1950

2.59

74.55

1.8

1.7

1.52

1.54

g/l

0.20

422

1671

Chronic ulcer of skin, not elsewhere classified

312

1035

3.29

74.53

2.0

1.8

1.80

1.50

g/l

5.09

274

884

Arthropathies in other diseases classified elsewhere

186

437

4.77

74.40

2.1

1.9

1.70

1.50

g/l

1.74

170

372

Acute bronchitis

1293

7429

1.75

73.68

1.8

1.7

1.53

g/l

0.07

1125

6257

Pleural effusion

628

2927

2.27

73.49

1.7

1.6

1.67

1.55

g/l

2.07

523

2487

Budesonide

417

1622

2.69

72.36

1.9

1.6

1.40

1.48

g/l

0.97

377

1383

Benign neoplasm: Sigmoid colon

678

3273

2.18

72.23

1.6

1.7

1.63

1.57

g/l

0.88

591

2793

Other reaction to severe stress, and adjustment disorders

908

4813

1.93

72.16

2.2

1.8

1.42

1.43

g/l

0.17

791

4148

Colectomy operation

638

3015

2.23

71.85

1.5

1.7

1.71

1.54

g/l

4.45

558

2574

Fracture of lumbar spine and pelvis

772

3902

2.06

71.81

1.9

1.6

1.52

1.57

g/l

0.80

640

3302

Emergency coronary revascularization (for ACS)

1913

8859

1.59

71.63

1.6

1.61

1.56

g/l

1.30

1628

7503

ILD, hospital admission 2, with pulmonary infections

385

1459

2.83

71.49

1.9

1.6

1.67

1.48

g/l

2.85

324

1234

Cholelithiasis, broad definition with cholecystitis

2523

11768

1.49

71.32

1.8

1.7

1.52

1.55

g/l

0.74

2156

10000

Gonarthrosis [arthrosis of knee](FG)

2111

8102

1.56

70.96

1.5

1.7

1.59

1.53

g/l

2.09

1783

6874

Benign neoplasm: Transverse colon

388

1490

2.79

70.30

1.8

1.6

1.58

1.52

g/l

0.48

350

1277

Dermatitis and eczema

3091

14339

1.43

70.24

1.8

1.7

1.54

1.51

g/l

0.81

2624

12266

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1232

6320

1.76

70.19

1.5

1.6

1.88

1.56

g/l

15.85

1024

5377

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1503

6275

1.68

70.10

1.7

1.6

1.50

1.57

g/l

2.18

1285

5320

Pneumocystosis

123

218

7.06

69.91

2.6

2.1

1.57

1.55

g/l

0.07

101

191

Cough

1129

6193

1.79

69.86

1.8

1.7

1.54

g/l

0.03

956

5264

Mood disorders, excluding more controls

2652

11092

1.48

69.48

1.7

1.8

1.52

1.51

g/l

0.20

2290

9505

Other or unspecified ileus, impaction or obstruction

617

2913

2.21

68.90

1.7

1.6

1.70

1.54

g/l

3.48

541

2446

Spinal stenosis

1646

8118

1.63

68.90

1.6

1.64

1.58

g/l

1.69

1414

6880

Cardiac arrest

221

514

3.92

68.86

1.9

1.6

1.58

1.51

g/l

0.39

190

411

Symptoms and signs involving the skin and subcutaneous tissue

1935

12653

1.55

68.84

1.8

1.7

1.47

1.53

g/l

2.35

1650

10812

Decubitus ulcer and pressure area

278

908

3.36

68.46

2.0

1.7

1.82

1.52

g/l

4.49

246

764

Myocarditis

147

305

5.10

67.15

1.9

1.6

1.49

1.42

g/l

0.35

126

249

Amiodarone users

437

1822

2.58

67.11

1.9

1.7

1.44

1.55

g/l

1.66

370

1560

Other dorsopathies, not elsewhere classified

2930

10854

1.44

66.56

1.7

1.8

1.52

1.49

g/l

0.91

2493

9286

Inflammatory bowel disease

897

4872

1.89

66.53

1.7

1.8

1.51

1.50

g/l

0.04

777

4171

Abnormal findings on examination of urine, without diagnosis

217

618

3.89

66.53

2.3

2.0

1.49

1.50

g/l

0.03

193

538

Other viral diseases

762

3913

1.99

66.30

2.4

1.8

1.42

1.45

g/l

0.47

674

3359

Asthma (diagnoses ohter than nonallergic)

2435

14372

1.47

66.27

1.7

1.8

1.60

1.50

g/l

6.41

2092

12262

Unspecified fall

1443

8883

1.65

66.19

1.7

1.57

1.52

g/l

1.24

1213

7572

Osteoporosis with pathological fracture (FG)

271

886

3.31

66.13

2.0

1.6

1.62

1.52

g/l

0.77

238

753

Episodal and paroxysmal disorders

3208

11734

1.42

66.06

1.7

1.8

1.52

1.50

g/l

0.52

2717

10045

Rare circulating lymphoid malignancy

180

456

4.52

65.86

2.1

2.0

1.43

1.49

g/l

0.34

148

402

Benign neoplasm: Ascending colon

508

2276

2.37

65.76

1.8

1.7

1.60

1.57

g/l

0.24

450

1944

Obesity, other/unspecified

874

4723

1.90

65.74

1.7

1.71

1.46

g/l

10.69

753

4070

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1450

6140

1.67

65.65

1.8

1.6

1.48

1.57

g/l

3.09

1233

5202

Candidiasis

447

1887

2.49

65.58

1.9

1.8

1.54

1.51

g/l

0.24

383

1632

Myelodysplastic syndrome

134

9.64

65.56

2.4

1.7

0.96

1.64

g/l

8.05

119

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1462

6196

1.66

65.24

1.7

1.6

1.48

1.57

g/l

3.38

1242

5249

Pericarditis

165

390

4.66

65.20

1.8

1.7

1.74

1.52

g/l

1.52

144

343

Haemorrhage, not elsewhere classified

187

488

4.27

65.11

2.0

1.5

1.29

1.52

g/l

2.54

151

413

Folate deficiency anaemia

105

10.66

64.86

1.9

2.0

1.58

1.52

g/l

0.16

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

598

1778

2.23

64.60

2.7

2.0

1.10

1.26

g/l

5.03

531

1547

Other obstetric conditions, not elsewhere classified

606

1819

2.21

64.09

2.6

2.0

1.09

1.26

g/l

5.43

539

1581

Hypothyroidism, strict autoimmune

1941

8456

1.54

63.96

1.8

1.6

1.52

1.51

g/l

0.13

1645

7193

Crohn disease

408

1673

2.55

63.53

1.7

1.8

1.55

1.51

g/l

0.40

357

1459

Other neurological diseases

2171

11877

1.50

63.52

1.6

1.7

1.55

1.56

g/l

0.26

1854

10071

Renal tubulo-interstitial disorders in diseases classified elsewhere

10.95

63.38

3.0

1.8

1.58

1.49

g/l

0.33

Other disorders of glucose regulation and pancreatic internal secretion

322

1185

2.89

63.09

2.0

1.8

1.44

1.50

g/l

0.53

284

1020

Sleep disorders (combined)

2752

12751

1.43

63.02

1.7

1.58

1.52

g/l

2.26

2359

10904

Cholelithiasis

2398

11624

1.47

62.93

1.8

1.7

1.51

1.55

g/l

1.15

2045

9876

Congenital malformations, deformations and chromosomal abnormalities

1471

8865

1.62

62.86

1.9

1.8

1.42

1.47

g/l

1.44

1244

7629

Any operation in hilmo

11.90

62.61

2.5

1.4

1.42

1.07

g/l

1.70

Acute upper respiratory infections of multiple and unspecified sites

2018

10128

1.52

62.53

2.0

1.7

1.49

g/l

0.08

1723

8679

Dental caries, including avohilmo

2444

8591

1.48

61.96

1.7

1.53

1.54

g/l

0.26

2085

7288

Dental pulpitis 2

2242

7762

1.50

61.90

1.7

1.54

g/l

0.12

1907

6563

Lower back pain or/and sciatica

2880

14304

1.42

61.89

1.6

1.8

1.57

1.51

g/l

2.29

2454

12234

COPD

1506

7878

1.62

61.87

1.6

1.70

1.55

g/l

8.04

1296

6685

Dental caries 1

2445

8600

1.48

61.73

1.7

1.53

1.54

g/l

0.25

2086

7297

Poisoning by drugs, medicaments and biological substances

617

3031

2.09

61.46

1.6

1.8

1.61

1.44

g/l

3.80

520

2615

Acute pancreatitis

651

3276

2.07

61.42

1.8

1.7

1.63

1.55

g/l

1.07

565

2770

Noninfectious colitis NAS

447

1943

2.41

61.29

1.9

1.7

1.56

1.52

g/l

0.49

395

1682

Amputation of foot

161

400

4.73

61.07

2.1

2.0

1.82

1.51

g/l

2.90

144

341

Protozoal diseases

153

364

4.82

60.82

2.6

2.1

1.52

1.49

g/l

0.13

129

318

Pneumonia due to other infectious organisms, not elsewhere classified

155

371

4.65

60.55

2.6

1.7

1.56

1.52

g/l

0.17

129

318

Chronic lower respiratory diseases

3383

13403

1.38

60.44

1.7

1.8

1.58

1.49

g/l

5.94

2911

11442

Dental caries 3

2557

9108

1.46

60.43

1.7

1.54

g/l

0.05

2179

7742

Dental caries 1 and operation codes

2653

9552

1.45

60.36

1.7

1.51

1.54

g/l

1.19

2247

8121

Need for other prophylactic measures

232

731

3.45

60.33

1.9

1.65

1.53

g/l

1.12

203

644

Sequelae with surgical and medical care as external cause

662

3381

2.04

60.08

2.0

1.7

1.62

1.55

g/l

1.04

569

2881

Elevated blood glucose level

310

1153

2.87

59.63

2.1

1.7

1.57

1.49

g/l

0.67

272

1000

Immunodeficiency with predominantly antibody defects

126

258

5.47

59.59

2.7

2.0

1.39

1.50

g/l

0.52

107

230

Dental caries 3 and operation codes

2742

9968

1.43

59.19

1.7

1.51

1.54

g/l

0.73

2327

8499

Benign neoplasm: Caecum

373

1528

2.60

59.12

1.6

1.60

1.52

g/l

0.76

336

1306

1187

7157

1.68

58.97

1.8

1.7

1.62

1.48

g/l

5.25

1029

6092

Substance use, excluding alcohol

524

2461

2.20

58.96

1.6

1.8

1.66

1.48

g/l

3.70

440

2127

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

366

1490

2.61

58.71

2.0

1.8

1.58

1.51

g/l

0.68

322

1285

Dental operations

2083

7204

1.51

58.54

1.6

1.53

1.56

g/l

0.96

1769

6110

Hepatomegaly and splenomegaly, not elsewhere classified

9.88

58.17

2.3

2.4

1.27

1.39

g/l

0.37

ILD, hospital admissions 3, with pneumonia sepsis

334

1310

2.73

58.15

1.9

1.5

1.72

1.50

g/l

3.38

285

1100

Sulfonylureas

1266

6235

1.67

58.14

1.6

1.76

1.51

g/l

16.40

1110

5234

Open wound of head

1531

9797

1.57

57.58

1.7

1.53

1.54

g/l

0.13

1303

8343

Pyogenic arthritis

262

910

3.07

57.26

1.8

1.73

1.49

g/l

2.85

224

773

Personality disorders, excluding more controls

592

2936

2.06

57.23

1.7

1.9

1.57

1.40

g/l

3.64

511

2528

Diseases of the myoneural junction and muscle

435

1934

2.37

57.05

1.7

1.67

1.54

g/l

1.96

359

1647

Other respiratory diseases principally affecting the interstitium

653

3391

2.02

56.83

1.9

1.6

1.63

1.56

g/l

1.04

552

2877

Acquired pure red cell aplasia [erythroblastopenia]

18.04

56.81

2.8

2.0

1.30

1.56

g/l

0.86

Benign neoplasm: Stomach

371

1546

2.56

56.69

1.8

1.7

1.55

g/l

0.01

310

1326

Other chronic obstructive pulmonary disease

1443

7698

1.60

56.53

1.6

1.71

1.55

g/l

8.09

1239

6526

Secondary and unspecified malignant neoplasm of lymph nodes

334

1330

2.69

56.34

1.8

1.69

1.51

g/l

2.02

273

1145

Polycythaemia vera

170

461

4.12

56.21

1.8

1.6

0.98

1.54

g/l

13.84

149

403

Neurological diseases

2432

8558

1.45

56.10

1.8

1.48

1.49

g/l

0.25

2090

7343

All influenza (not pneumonia)

438

1955

2.32

56.09

2.1

1.6

1.51

1.47

g/l

0.47

379

1660

Dental pulpitis 2, only avohilmo

2266

8020

1.47

55.88

1.7

1.54

g/l

0.04

1931

6792

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

300

1137

2.79

55.40

1.8

1.7

1.64

1.52

g/l

1.16

260

995

Misadventures to patients during surgical and medical care

453

2068

2.29

55.39

1.8

1.7

1.47

1.54

g/l

0.94

390

1780

Invasive ventilation

289

1082

2.86

55.17

1.9

1.8

1.64

1.51

g/l

1.45

251

922

Arthrosis

1964

7297

1.50

55.08

1.6

1.7

1.58

1.52

g/l

1.48

1656

6177

Acute pancreatitis (for exclusion)

651

3405

1.99

55.00

1.8

1.6

1.63

1.55

g/l

1.14

565

2894

Secondary thrombocytopenia

128

7.97

54.90

1.8

1.6

1.56

1.52

g/l

0.09

113

Injuries to the hip and thigh

1433

8477

1.58

54.84

1.7

1.56

1.55

g/l

0.16

1194

7214

Diseases of spleen

110

219

5.92

54.52

2.5

1.8

1.29

1.52

g/l

1.28

193

Acute sinusitis

1301

7675

1.61

54.16

1.9

1.8

1.52

1.48

g/l

0.77

1100

6598

Other diseases of hard tissues of teeth

1647

8128

1.53

54.11

2.0

1.6

1.45

1.53

g/l

3.11

1415

6965

Injuries to the thorax

1333

8529

1.60

54.00

1.8

1.7

1.52

1.54

g/l

0.18

1157

7260

Mood [affective] disorders

2755

13163

1.39

53.85

1.7

1.8

1.51

1.52

g/l

0.09

2381

11254

Viral pneumonia (unknown virus, not influenza)

244

843

3.08

53.83

2.6

1.8

1.59

1.51

g/l

0.59

215

732

Unspecified privation

373

1590

2.47

53.80

2.2

1.7

1.61

1.52

g/l

1.04

323

1375

Visual disturbances and blindness

1425

9261

1.57

53.76

1.7

1.52

1.54

g/l

0.22

1216

7890

Diseases of pulp and periapical tissues, including avohilmo

3128

11965

1.37

53.76

1.7

1.54

1.50

g/l

1.17

2675

10207

Anxiety disorders, excluding more controls

2111

9711

1.46

53.59

1.8

1.49

1.50

g/l

0.02

1821

8353

Other hereditary haemolytic anaemias

12.91

53.51

3.9

1.5

0.75

1.48

g/l

4.68

Mood disorders

2760

13190

1.39

53.41

1.7

1.8

1.51

1.52

g/l

0.09

2385

11273

Colorectal cancer, excluding all cancers (controls excluding all cancers)

843

4655

1.81

53.26

1.5

1.6

1.76

1.54

g/l

8.36

729

3955

Unspecified nephritic syndrome

124

277

5.10

53.25

2.4

2.0

1.60

1.58

g/l

0.08

110

243

Dysphagia

744

4103

1.87

53.04

1.7

1.6

1.52

1.56

g/l

0.68

628

3494

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

614

3191

2.00

52.94

1.4

1.5

1.77

1.54

g/l

7.38

526

2711

Poisoning by medicine

545

2704

2.07

52.93

1.6

1.8

1.59

1.44

g/l

2.84

459

2352

Dental pulpitis 4

3125

11983

1.37

52.86

1.7

1.54

1.50

g/l

1.25

2672

10225

Dental pulpitis 1

3125

11989

1.37

52.76

1.7

1.54

1.50

g/l

1.24

2672

10231

Depression

2490

12309

1.41

52.59

1.8

1.50

1.51

g/l

0.30

2147

10537

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

697

3769

1.89

52.33

1.8

1.9

1.54

1.42

g/l

2.77

590

3267

Weight loss

352

1486

2.51

52.17

1.6

1.8

1.43

1.52

g/l

0.99

310

1284

Early onset COPD, excluding more controls

576

2941

2.02

51.70

1.6

1.5

1.71

1.49

g/l

6.24

496

2492

Parodontitis or/and operation codes

1748

6984

1.51

51.58

1.9

1.7

1.53

1.50

g/l

0.82

1519

5965

Immunodeficiencies

191

588

3.51

51.54

2.3

1.8

1.40

1.51

g/l

0.77

160

514

Acute myeloid leukaemia, helper endpoint

119

8.14

51.19

1.7

1.65

1.54

g/l

0.30

101

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

119

8.14

51.19

1.7

1.65

1.54

g/l

0.30

101

Exposure to other specified factors

1911

12447

1.46

51.09

1.9

1.7

1.59

1.50

g/l

3.60

1644

10678

Diabetic neuropathy

495

2426

2.17

50.96

1.9

1.7

1.62

1.63

g/l

0.17

443

2082

Gonarthrosis

1786

6919

1.50

50.87

1.5

1.7

1.58

1.54

g/l

1.07

1490

5860

Thoracic aortic aneurysm

484

2353

2.16

50.84

1.8

1.7

1.46

1.53

g/l

0.84

373

2008

Amputation of ankle bones

131

319

4.74

50.76

2.4

1.9

1.89

1.50

g/l

3.03

117

277

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

470

2257

2.17

50.62

1.7

1.6

1.75

1.54

g/l

3.66

394

1926

Benign neoplasm: Rectum

608

3211

1.98

50.33

1.6

1.7

1.55

1.57

g/l

0.14

530

2744

Drug-induced cataract

120

273

4.97

50.31

2.1

2.0

1.46

1.53

g/l

0.26

107

240

Fracture of rib(s), sternum and thoracic spine

906

5371

1.74

50.30

1.8

1.7

1.55

g/l

0.02

781

4575

Complications of internal orthopaedic prosthetic devices, implants and grafts

718

3995

1.86

50.04

1.6

1.68

1.56

g/l

2.32

582

3387

Benign neoplasm: Transverse colon

388

1745

2.37

50.01

1.8

1.7

1.58

1.56

g/l

0.08

350

1493

Nerve, nerve root and plexus disorders

2940

13706

1.36

49.97

1.7

1.57

1.53

g/l

1.38

2553

11638

Other pleural conditions

411

1894

2.30

49.80

1.9

1.7

1.68

1.54

g/l

1.79

356

1601

Aortic aneurysm

790

4449

1.81

49.72

1.8

1.6

1.51

1.52

g/l

0.04

634

3748

Abnormal weight loss

326

1361

2.55

49.64

1.6

1.8

1.44

1.52

g/l

0.84

286

1169

Benign neoplasm: Rectum, anus and anal canal

671

3671

1.90

49.63

1.6

1.7

1.55

1.57

g/l

0.13

579

3119

Other joint disorders

2280

8604

1.43

49.44

1.8

1.50

1.45

g/l

1.51

1926

7342

Other chronic obstructive pulmonary disease, including avohilmo

1673

9479

1.50

49.42

1.5

1.6

1.71

1.55

g/l

9.29

1427

8065

Open wound of lower leg

457

2190

2.17

49.36

1.8

1.7

1.59

1.51

g/l

1.06

392

1881

Other and unspecified coagulation defects

174

518

3.60

49.34

2.9

1.8

1.34

1.53

g/l

1.86

156

456

Sleep apnoea

2479

12219

1.39

48.84

1.7

1.60

1.54

g/l

2.12

2119

10435

Depression or dysthymia

2023

7888

1.45

48.82

1.7

1.8

1.52

1.51

g/l

0.09

1721

6768

Other nutritional anaemias

118

7.83

48.79

3.0

2.1

1.30

1.56

g/l

1.51

104

Concussion

1248

6921

1.58

48.66

1.6

1.8

1.51

1.49

g/l

0.27

1041

5950

Other symptoms and signs involving cognitive functions and awareness

1337

8209

1.56

48.62

1.7

1.53

1.57

g/l

0.65

1109

6973

Obesity related asthma

903

5395

1.72

48.42

1.8

1.7

1.70

1.53

g/l

5.74

776

4621

Other and unspecified myopathies

325

1373

2.52

48.27

1.6

1.7

1.65

1.53

g/l

1.33

264

1165

Other arthrosis

1395

6530

1.55

48.26

1.6

1.7

1.56

1.54

g/l

0.39

1201

5550

Other infectious diseases

302

1233

2.60

48.25

1.9

1.7

1.77

1.50

g/l

3.70

266

1054

Unspecified jaundice

215

739

3.14

48.25

2.0

1.8

1.17

1.49

g/l

5.05

186

631

Other diseases of stomach and duodenum

240

874

2.93

48.24

1.8

1.53

1.59

g/l

0.47

212

751

Wegener granulomatosis

181

6.04

48.20

3.1

2.1

1.62

1.45

g/l

0.68

162

Explicit fungal Sepsis

10.72

48.20

1.8

1.9

1.69

1.43

g/l

0.83

Hypoglycaemia, other or unspecified

248

919

2.87

48.09

2.1

1.8

1.40

1.51

g/l

1.05

215

796

Acidosis

111

247

5.17

48.08

2.1

2.2

1.62

1.54

g/l

0.33

104

216

COPD related to multimorbidity

1310

7199

1.57

47.94

1.6

1.70

1.55

g/l

7.36

1122

6088

Polyarthrosis

565

2819

1.98

47.90

1.6

1.7

1.56

1.58

g/l

0.24

492

2356

Sequelae of cerebrovascular disease

1154

6432

1.62

47.89

1.9

1.7

1.59

1.56

g/l

0.50

971

5450

Acute myeloid leukaemia

131

7.37

46.75

1.7

2.3

1.65

1.56

g/l

0.22

115

COPD, hospital admission 2, with asthma infections

1073

5754

1.64

46.39

1.5

1.6

1.75

1.54

g/l

10.44

920

4848

Other/unspecified dorsalgia

1023

6338

1.64

46.36

1.9

1.7

1.56

1.52

g/l

0.58

873

5408

Injury, poisoning and certain other consequences of external causes

1510

4998

1.53

46.28

1.8

1.7

1.50

1.46

g/l

0.73

1316

4245

Crohn's disease NAS

218

769

3.00

46.22

1.7

1.9

1.50

1.48

g/l

0.09

187

683

Vascular diseases of the intestine

175

549

3.50

46.20

2.3

1.8

1.56

1.47

g/l

0.59

151

468

Anxiety (asthma-related co-morbidities)

1326

6852

1.55

45.98

1.8

1.9

1.46

1.45

g/l

0.24

1161

5883

Malignant neoplasm of skin

1904

10119

1.44

45.78

1.8

1.6

1.50

1.60

g/l

5.27

1624

8547

Type 1 diabetes, definitions combined

243

905

2.77

45.63

2.5

1.9

1.29

1.36

g/l

0.63

219

780

5-aminosalicylic acid

521

2683

1.99

45.55

1.8

1.6

1.41

1.46

g/l

0.61

450

2297

Erosion of teeth

118

7.01

45.52

2.2

1.9

1.33

1.52

g/l

1.02

102

Other complications of surgical and medical care, not elsewhere classified

299

1243

2.52

45.51

1.9

1.7

1.55

1.52

g/l

0.22

250

1081

Cholangitis (primary sclerosing, PSC), with reimbursement 202

178

5.76

45.48

2.0

2.3

1.28

1.48

g/l

1.10

157

Isolated proteinuria with specified morphological lesion

141

6.86

45.46

2.5

2.3

1.57

1.60

g/l

0.08

125

Coronary angioplasty

1196

5922

1.59

45.38

1.6

1.7

1.60

1.56

g/l

0.60

1025

5019

Unstable angina pectoris

1248

6756

1.57

45.37

1.5

1.7

1.57

1.56

g/l

0.19

1039

5700

Disorders of eyelid, lacrimal system and orbit

2309

13225

1.39

45.28

1.7

1.51

1.54

g/l

0.88

1978

11266

Cholangitis (primary sclerosing, PSC)

235

876

2.87

45.27

1.7

1.8

1.47

1.49

g/l

0.11

196

754

Viral pneumonia (known virus, not influenza)

122

306

4.51

45.21

2.0

1.53

1.48

g/l

0.19

112

270

Spondyloarthritis

520

2688

1.99

45.21

1.7

1.57

1.52

g/l

0.52

442

2297

Other coagulation defects

238

891

2.82

45.15

2.5

1.8

1.41

1.52

g/l

1.05

210

782

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

165

498

3.44

45.12

2.8

1.7

1.25

1.45

g/l

2.12

144

422

Drug-induced osteoporosis with pathological fracture

197

5.71

45.11

1.9

2.0

1.70

1.68

g/l

0.07

171

Transient ischemic attack

1591

9064

1.48

44.86

1.6

1.56

1.58

g/l

0.26

1343

7667

Complications of cardiac and vascular prosthetic devices, implants and grafts

118

292

4.64

44.77

2.8

1.8

1.57

1.51

g/l

0.24

102

255

Degeneration of macula and posterior pole

1470

8214

1.51

44.74

1.6

1.53

1.59

g/l

1.43

1239

6919

Biological medication for rheuma

393

1842

2.20

44.65

1.6

1.8

1.59

1.48

g/l

1.20

330

1598

Other inflammatory liver diseases

229

848

2.87

44.50

1.7

1.9

1.40

1.56

g/l

1.56

197

745

Type 1 diabetes, strict (exclude DM2)

240

901

2.74

44.38

2.5

1.9

1.28

1.36

g/l

0.70

216

777

Injuries to the knee and lower leg

3212

14030

1.32

44.32

1.7

1.8

1.57

1.50

g/l

3.22

2773

11967

Other and unspecified drugs and medicaments

278

1136

2.58

44.17

1.9

1.8

1.61

1.53

g/l

0.65

242

985

Collagenous colitis

290

1210

2.52

44.01

1.8

1.61

1.54

g/l

0.52

255

1057

Dorsopathies

2853

10898

1.35

44.00

1.8

1.51

1.49

g/l

0.47

2441

9323

Suppurative and necrotic conditions of lower respiratory tract

226

841

2.90

43.96

1.6

1.9

1.80

1.52

g/l

3.12

189

724

Other/unspecified rheumatoid arthritis

424

2073

2.14

43.74

1.4

1.7

1.66

1.55

g/l

1.37

357

1756

Duodenal ulcer

394

1874

2.20

43.73

1.7

1.6

1.52

1.58

g/l

0.63

345

1581

Ulcerative colitis

654

3673

1.83

43.73

1.8

1.7

1.51

1.50

g/l

0.06

564

3152

Thrombotic microangiopathy

10.77

43.61

9.4

1.9

1.36

1.43

g/l

0.16

In situ neoplasms

1046

6665

1.61

43.47

1.8

1.6

1.51

1.56

g/l

1.15

900

5653

Secondary right heart disease

189

646

3.20

43.25

2.1

1.8

1.29

1.55

g/l

3.07

165

554

Problems related to lifestyle

294

1239

2.46

43.21

1.7

1.9

1.57

1.46

g/l

1.11

250

1066

COPD, hospital admissions

1446

8330

1.50

43.21

1.6

1.71

1.55

g/l

9.06

1237

7044

Other Crohn's disease

212

763

2.92

43.20

1.7

2.0

1.54

1.46

g/l

0.61

186

673

COPD, early/later onset

1453

8374

1.50

42.76

1.6

1.71

1.55

g/l

8.57

1247

7082

Benign neoplasm: Caecum

373

1762

2.24

42.58

1.6

1.7

1.60

1.56

g/l

0.27

336

1508

Basal cell carcinoma

1723

9672

1.45

42.39

1.8

1.6

1.49

1.60

g/l

5.64

1460

8166

ILD, hospital admissions

519

2758

1.97

42.36

1.9

1.7

1.62

1.57

g/l

0.55

435

2356

Abnormalities of gait and mobility

417

2056

2.13

42.29

1.5

1.7

1.64

1.53

g/l

1.53

375

1762

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

168

542

3.37

42.23

2.2

1.6

1.56

1.51

g/l

0.19

136

460

Basal cell carcinoma, including avohilmo

1757

9790

1.44

42.11

1.8

1.6

1.49

1.60

g/l

6.01

1489

8269

Other specified/unspecified systemic involvement of connective tissue

199

705

3.00

42.04

2.3

1.8

1.42

1.53

g/l

0.79

182

614

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

17.29

41.68

2.6

1.9

1.56

1.60

g/l

0.07

Other and unspecified local infections of skin and subcutaneous tissue

305

1333

2.40

41.64

1.8

1.7

1.74

1.52

g/l

2.93

268

1147

Amyloidosis

110

272

4.59

41.62

1.9

2.0

1.50

1.53

g/l

0.12

234

Other local infections of skin and subcutaneous tissue

319

1421

2.35

41.60

1.7

1.73

1.52

g/l

2.89

278

1222

Other metabolic disorders

320

1421

2.33

41.58

2.0

1.7

1.47

1.49

g/l

0.15

282

1214

Leukaemia of unspecified cell type

8.33

41.52

1.7

1.8

1.70

1.43

g/l

0.84

Intestinal adhesions without obstruction

272

1133

2.53

41.43

1.8

1.7

1.62

1.55

g/l

0.53

231

968

Neurotic, stress-related and somatoform disorders

2163

11243

1.38

41.26

1.8

1.49

1.50

g/l

0.18

1869

9655

Amyloidosis, other/unspecified

224

5.06

41.22

1.9

1.49

1.56

g/l

0.25

194

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

390

1893

2.16

41.09

1.7

1.5

1.85

1.54

g/l

6.19

328

1623

Other interstitial pulmonary diseases

523

2814

1.94

41.08

1.9

1.7

1.63

1.57

g/l

0.74

439

2393

Acute upper respiratory infections

2844

13544

1.33

41.07

1.9

1.7

1.52

g/l

0.13

2424

11567

Artificial opening status

201

728

2.96

41.05

1.7

1.8

1.84

1.56

g/l

3.06

178

623

IBD patients in KELA-register

577

3180

1.86

41.04

1.8

1.44

1.47

g/l

0.39

507

2755

Non-Hodgkin lymphoma, all

188

661

3.12

41.04

1.9

1.8

1.71

1.53

g/l

1.23

142

576

Fracture of shoulder and upper arm

982

6241

1.61

41.01

1.8

1.7

1.52

1.54

g/l

0.29

830

5318

Crohn's disease of small intestine

213

791

2.83

40.97

1.8

1.9

1.57

1.48

g/l

0.68

189

697

Benign neoplasm: Small intestine

163

528

3.37

40.81

1.7

1.6

1.60

1.54

g/l

0.38

138

455

Alcohol dependence

769

4613

1.71

40.79

1.5

1.7

1.61

1.53

g/l

1.41

652

3962

Interstitial lung disease

523

2822

1.94

40.73

1.9

1.7

1.63

1.57

g/l

0.68

439

2404

Interstitial lung disease endpoints

523

2822

1.94

40.73

1.9

1.7

1.63

1.57

g/l

0.68

439

2404

Other diseases of lip and oral mucosa

446

2273

2.03

40.61

1.8

1.6

1.48

1.57

g/l

1.34

390

1923

Other anxiety disorders

988

5560

1.60

40.42

1.8

1.45

1.42

g/l

0.38

867

4783

Mixed connective tissue disease

216

816

2.80

40.40

2.4

1.8

1.47

1.55

g/l

0.50

196

707

Functional dyspepsia

657

3785

1.78

40.24

1.8

1.7

1.53

1.56

g/l

0.22

565

3214

COPD, hospital admissions 3, with asthma pneumonia sepsis

921

4928

1.64

39.85

1.6

1.7

1.77

1.54

g/l

11.44

783

4152

Other disorders of gingiva or/and edentulous alveolar ridge

174

590

3.14

39.82

2.5

1.8

1.60

1.45

g/l

1.17

156

507

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

601

3388

1.82

39.80

1.6

1.7

1.78

1.49

g/l

11.63

526

2900

Gingival hyperplasia

128

362

3.83

39.52

2.6

1.8

1.55

1.50

g/l

0.22

117

311

Nonischemic cardiomyopathy

207

776

2.84

39.48

1.7

1.8

1.58

1.48

g/l

0.71

180

673

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1677

9403

1.44

39.41

1.8

1.6

1.50

1.60

g/l

4.34

1423

7932

Diabetes mellitus in pregnancy

545

1883

1.90

39.35

2.6

1.9

1.19

1.31

g/l

2.44

486

1636

Anxiety disorders

2182

11415

1.37

39.22

1.8

1.49

1.50

g/l

0.20

1883

9798

Pruritus

320

1463

2.28

39.08

1.9

1.8

1.56

1.52

g/l

0.27

266

1266

Polyuria

679

3997

1.75

38.96

1.7

1.6

1.51

1.54

g/l

0.30

574

3429

Visual disturbances

1241

8398

1.50

38.80

1.7

1.51

1.54

g/l

0.54

1065

7168

Carcinoma in situ of skin of other and unspecified parts of face

293

1306

2.39

38.74

1.8

1.5

1.40

1.52

g/l

1.68

264

1104

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

11.57

38.71

2.3

2.4

1.48

1.69

g/l

0.71

Diffuse large B-cell lymphoma, helper endpoint

175

609

3.11

38.67

1.5

1.6

1.81

1.51

g/l

2.57

140

520

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

175

609

3.11

38.67

1.5

1.6

1.81

1.51

g/l

2.57

140

520

Crohn disease (strict definition, require KELA, min 2 HDR)

190

687

2.91

38.47

1.6

2.0

1.45

1.44

g/l

0.08

165

608

Familial hypercholesterolemia

494

2659

1.93

38.47

1.7

1.6

1.69

1.54

g/l

2.71

409

2244

Sleep apnoea, including avohilmo

2541

12470

1.34

38.42

1.7

1.59

1.53

g/l

2.46

2171

10669

Superficial injury of head

624

3600

1.78

38.19

1.6

1.8

1.49

1.52

g/l

0.31

528

3076

Nonalcoholic fatty liver disease

269

1159

2.43

37.91

1.8

1.45

1.56

g/l

0.98

237

1005

L01XE Protein kinase inhibitors

224

896

2.69

37.81

2.0

1.8

1.61

1.53

g/l

0.36

197

775

Recurrent or chronic depression

923

4198

1.61

37.80

1.8

1.9

1.46

g/l

0.00

797

3610

Nonhereditary hypogammaglobulinemia

101

7.16

37.79

2.5

2.3

1.35

1.48

g/l

0.41

Visual impairment including blindness (binocular or monocular)

242

1000

2.56

37.74

1.7

1.8

1.60

1.51

g/l

0.62

198

863

Fracture of femur

849

4865

1.64

37.40

1.7

1.6

1.57

1.56

g/l

0.12

698

4109

Suicide or other Intentional self-harm

574

3248

1.81

37.38

1.7

1.8

1.64

1.46

g/l

4.22

479

2802

Hernia of abdominal wall

1258

8611

1.49

37.26

1.7

1.60

1.54

g/l

1.69

1095

7350

Polymyalgia rheumatica

454

2410

1.97

37.25

1.7

1.6

1.84

1.54

g/l

7.08

380

2029

Inflammatory bowel disease, strict (require KELA)

577

3276

1.80

37.23

1.8

1.44

1.48

g/l

0.43

507

2834

Other pulmonary heart/vessel disease

197

746

2.86

37.22

2.1

1.8

1.28

1.53

g/l

3.30

173

639

All anxiety disorders

1342

7422

1.47

37.21

1.8

1.46

g/l

0.08

1176

6382

1267

8180

1.49

37.06

1.8

1.6

1.48

1.59

g/l

3.89

1092

6893

Seropositive rheumatoid arthritis, strict definition

436

2285

1.98

36.78

1.4

1.7

1.62

1.56

g/l

0.66

371

1955

Delirium, not induced by alcohol and other psychoactive substances

407

2090

2.04

36.76

1.6

1.7

1.64

1.51

g/l

1.98

331

1784

Non-selective monoamine reuptake inhibitors

1039

6645

1.54

36.69

1.5

1.7

1.66

1.55

g/l

3.22

880

5632

Crohn disease (strict definition, require KELA)

190

706

2.82

36.54

1.6

2.0

1.45

1.44

g/l

0.08

165

624

Special screening examination for other diseases and disorders

232

948

2.53

36.47

1.9

1.6

1.54

1.52

g/l

0.13

210

820

Viral and other specified intestinal infections

473

2478

1.90

36.41

2.2

1.9

1.41

1.37

g/l

0.41

402

2152

Fracture of lower leg, including ankle

1406

9816

1.45

36.39

1.6

1.7

1.65

1.53

g/l

4.55

1210

8355

Injuries to the ankle and foot

1603

10443

1.41

36.37

1.8

1.54

1.48

g/l

1.84

1381

8978

Skin changes due to chronic exposure to nonionizing radiation

1212

7837

1.50

36.31

1.8

1.6

1.47

1.59

g/l

4.64

1053

6611

Dental caries 3, only avohilmo

2490

9624

1.34

36.26

1.6

1.7

1.53

1.54

g/l

0.09

2114

8205

Other viral hepatitis

170

597

2.98

36.25

1.7

1.9

1.42

1.45

g/l

0.15

140

523

Dental caries 1, only avohilmo

2386

9167

1.35

36.23

1.6

1.7

1.54

g/l

0.08

2026

7801

Alcohol-induced chronic pancreatitis

229

941

2.58

36.21

1.8

1.58

1.54

g/l

0.30

199

810

Injuries to the shoulder and upper arm

2205

13899

1.35

36.18

1.8

1.7

1.54

g/l

0.01

1884

11834

Undetermined asthma, excluding more controls

298

1360

2.25

36.15

1.7

1.6

1.66

1.48

g/l

2.29

249

1147

Personality disorders

592

3411

1.77

36.14

1.7

1.9

1.57

1.43

g/l

2.65

511

2956

Speech therapy

758

4681

1.66

36.06

1.7

1.56

1.55

g/l

0.04

692

3978

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

100

7.16

35.98

1.8

2.0

1.25

1.44

g/l

0.68

Intestinal malabsorption

156

528

3.15

35.90

1.8

1.9

1.36

1.52

g/l

1.36

137

463

Ulcerative colitis, NAS

374

1872

2.06

35.87

1.8

1.7

1.54

1.51

g/l

0.27

327

1614

Chronic hepatitis, not elsewhere classified

130

396

3.55

35.85

2.0

1.19

1.54

g/l

3.71

117

349

Other intervertebral disc disorders

2209

10107

1.35

35.84

1.6

1.7

1.58

1.52

g/l

2.02

1905

8634

Special screening examination for infectious and parasitic diseases

479

1907

1.90

35.73

2.1

1.9

1.22

1.41

g/l

4.56

416

1635

Other skin changes

511

2848

1.86

35.63

1.8

1.7

1.40

1.56

g/l

4.00

441

2441

Shoulder lesions

2056

9319

1.37

35.61

1.7

1.60

1.55

g/l

1.51

1763

7901

Benign neoplasm: Duodenum

114

323

3.92

35.52

1.8

1.7

1.60

1.54

g/l

0.21

281

Other diseases of pancreas

261

1147

2.41

35.52

1.7

1.54

g/l

0.01

237

997

Actinic keratosis

1185

7694

1.50

35.46

1.8

1.6

1.47

1.59

g/l

5.26

1029

6485

Ventral hernia

672

4058

1.70

34.95

1.7

1.6

1.62

1.57

g/l

0.71

580

3445

Psoriatic and enteropathic arthropathies

301

1402

2.22

34.95

1.5

1.7

1.64

1.49

g/l

1.61

252

1196

Disorders of oesophagus in diseases classified elsewhere

103

276

4.19

34.93

2.0

1.64

1.61

g/l

0.08

238

Bipolar affective disorders

426

2245

1.94

34.91

1.8

1.56

1.43

g/l

1.89

362

1935

Pyothorax

173

634

2.95

34.82

1.6

1.9

1.83

1.55

g/l

2.44

147

548

Sciatica+with lumbago

1260

8275

1.47

34.79

1.6

1.7

1.60

1.52

g/l

2.22

1103

7082

Acquired absence of limb

122

6.41

34.64

1.8

1.7

1.87

1.55

g/l

1.17

108

ILD, hospital admissions 1, main diag only

453

2462

1.92

34.62

1.9

1.7

1.62

1.57

g/l

0.53

383

2108

Tumor necrosis factor alpha inhibitors

334

1626

2.11

34.48

1.5

1.8

1.58

1.49

g/l

0.77

281

1412

Filling of root of tooth

115

333

3.73

34.31

1.6

2.1

1.49

1.50

g/l

0.04

296

Behavioural syndromes associated with physiological disturbances and physical factors

717

4407

1.65

34.28

2.0

1.8

1.43

1.44

g/l

0.12

617

3811

Disorders of magnesium metabolism

8.33

34.24

1.5

2.6

1.45

1.47

g/l

0.04

Postprocedural endocrine and metabolic disorders, not elsewhere classified

282

1290

2.25

34.20

2.1

1.8

1.49

1.50

g/l

0.09

250

1103

Spondylopathies (FG)

336

1647

2.10

34.02

1.7

1.55

1.46

g/l

0.85

280

1414

Hypoparathyroidism

144

484

3.23

33.89

2.5

1.7

1.54

1.53

g/l

0.04

123

418

Dental operations, only avohilmo

2104

8036

1.36

33.71

1.6

1.7

1.51

1.56

g/l

1.31

1771

6856

Failed induction of labour

129

402

3.33

33.69

2.5

2.2

1.03

1.24

g/l

2.42

118

351

Type 1 diabetes, strict definition, subgroup 1

164

584

2.89

33.67

2.4

2.0

1.22

1.27

g/l

0.28

146

506

Dependence on enabling machines and devices, not elsewhere classified

127

5.96

33.66

2.7

1.6

1.37

1.48

g/l

0.37

112

Psoriasis

738

4603

1.64

33.61

1.7

1.61

1.53

g/l

1.21

625

3929

Left bundle-branch block

212

868

2.56

33.54

1.5

1.52

1.60

g/l

0.63

174

738

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

379

1949

1.99

33.49

1.7

1.9

1.64

1.45

g/l

3.11

325

1690

Intracranial injury

1513

10526

1.41

33.49

1.7

1.50

1.52

g/l

0.38

1261

9003

Hodgkin lymphoma

105

291

3.89

33.40

1.9

1.51

1.40

g/l

0.42

253

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

196

774

2.65

33.39

1.6

2.0

1.45

1.44

g/l

0.04

170

683

Secondary uncertain malignant neoplasm

417

2231

1.95

33.35

1.8

1.7

1.72

1.55

g/l

2.10

339

1922

Benign neoplasm: Descending colon

220

923

2.53

33.31

1.6

1.53

1.51

g/l

0.06

195

789

Leukaemia of unspecified cell type

112

6.57

33.30

1.7

2.2

1.70

1.53

g/l

0.43

Moderate visual impairment, binocular

134

437

3.34

33.29

1.8

1.6

1.59

1.60

g/l

0.02

117

383

Abnormal results of function studies

250

1105

2.36

33.28

1.7

1.8

1.43

1.53

g/l

0.85

200

960

Congenital malformations of heart and great arteries

340

1634

2.08

33.28

1.9

1.8

1.29

1.48

g/l

2.86

256

1422

Heart failure and hypertrophic cardiomyopathy

250

4.35

33.27

2.0

1.9

1.56

1.55

g/l

0.03

224

Acute gastritis

249

1101

2.37

33.21

1.5

1.7

1.51

1.56

g/l

0.34

214

938

Other obstructive and reflux uropathy

133

429

3.27

33.07

2.2

1.8

1.78

1.39

g/l

4.13

112

373

Sequelae of other external causes

182

700

2.75

32.99

1.6

2.0

1.66

1.53

g/l

0.88

161

607

Deforming dorsopathies

706

4377

1.65

32.86

1.9

1.7

1.56

1.53

g/l

0.36

619

3756

Late syphilis

166

5.20

32.84

2.0

1.9

1.56

1.52

g/l

0.15

143

Other disorders of veins

968

6445

1.53

32.75

1.7

1.6

1.48

1.57

g/l

2.31

813

5471

COPD-related respiratory insufficiency

420

2270

1.93

32.73

1.6

1.7

1.73

1.54

g/l

3.52

366

1922

Dipeptidyl peptidase 4 (DPP-4) inhibitors

368

1901

2.02

32.70

1.5

1.7

1.82

1.50

g/l

8.76

327

1625

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

329

1634

2.10

32.70

1.6

1.85

1.53

g/l

5.38

279

1399

Acute nephritic syndrome

260

4.11

32.66

2.5

1.9

1.55

1.46

g/l

0.38

228

Spondylosis

1417

8673

1.42

32.62

1.6

1.7

1.61

1.56

g/l

1.06

1215

7385

Infection of intervertebral disc (pyogenic)

185

5.00

32.47

1.9

2.1

1.60

1.56

g/l

0.16

166

Type 1 diabetes, strict definition

171

635

2.76

32.41

2.4

1.9

1.22

1.29

g/l

0.47

153

548

Soft tissue disorders related to use, overuse and pressure

685

4244

1.65

32.06

1.7

1.57

g/l

0.05

595

3620

Barrett oesophagus

183

720

2.72

31.97

1.5

1.8

1.62

1.56

g/l

0.35

163

613

Asthma, hospital admissions , main diagnosis only

2091

14245

1.33

31.87

1.6

1.8

1.59

1.50

g/l

4.31

1781

12170

Other disorders of lacrimal gland

849

5539

1.56

31.80

1.7

1.52

1.56

g/l

0.68

728

4712

Melanocytic naevi

646

3953

1.67

31.65

2.1

1.7

1.37

1.48

g/l

2.56

568

3380

Disorders of continuity of bone

252

1140

2.29

31.64

1.7

1.8

1.54

1.51

g/l

0.17

217

999

Benign neoplasm of other and unspecified endocrine glands

330

1657

2.06

31.55

1.6

1.66

1.55

g/l

1.16

285

1420

Viral hepatitis

194

783

2.58

31.53

1.7

1.9

1.41

1.47

g/l

0.36

157

683

Laparoscopic right hemicolectomy

215

922

2.50

31.38

1.3

1.8

1.77

1.55

g/l

3.27

185

802

Ulcer of oesophagus

251

1144

2.31

31.38

1.5

1.7

1.58

1.56

g/l

0.15

215

982

Open wound of ankle and foot

293

1413

2.15

31.35

1.8

1.63

1.49

g/l

1.41

254

1222

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

397

2133

1.94

31.35

1.9

1.5

1.48

1.52

g/l

0.27

343

1801

Chronic viral hepatitis

140

480

3.05

31.24

1.7

1.9

1.39

1.42

g/l

0.14

114

416

Disorders of adult personality and behaviour

602

3627

1.69

31.24

1.7

1.9

1.54

1.43

g/l

2.11

519

3145

Lung transplantation

7.28

31.24

2.1

2.3

1.61

1.48

g/l

0.29

Other disorders of ear

2439

12589

1.30

31.22

1.6

1.7

1.52

1.55

g/l

0.99

2035

10774

Other viral diseases, not elsewhere classified

444

2457

1.85

31.08

2.2

1.7

1.42

1.46

g/l

0.36

387

2112

Asthma, including avohilmo

3096

14313

1.27

31.08

1.7

1.8

1.57

1.50

g/l

3.47

2648

12215

Other and unspecified types of non-Hodgkin lymphoma, hilmo

168

645

2.81

30.95

2.2

1.8

1.56

1.54

g/l

0.06

136

561

Tubulo-interstitial nephritis, not specified as acute or chronic

202

841

2.50

30.79

1.8

1.6

1.64

1.47

g/l

1.76

171

704

Unspecified acute lower respiratory infection

408

2219

1.89

30.68

2.0

1.7

1.63

1.50

g/l

1.76

364

1891

Epilepsy

813

5278

1.56

30.68

1.8

1.7

1.51

g/l

0.02

676

4507

Nonorganic sleeping disorders, excluding more controls

403

2179

1.89

30.60

1.9

1.8

1.49

1.44

g/l

0.51

348

1873

Superficial injury of lower leg

598

3623

1.69

30.57

1.7

1.47

1.50

g/l

0.26

509

3085

Mucosal proctocolitis

325

1640

2.04

30.53

1.8

1.41

1.49

g/l

0.79

284

1427

Other benign neoplasms of skin

889

5792

1.53

30.50

1.7

1.6

1.51

1.54

g/l

0.47

731

4917

Neuromuscular dysfunction of bladder

280

1344

2.17

30.48

1.5

1.7

1.55

1.53

g/l

0.13

248

1157

Other blood glucose lowering drugs, excl. Insulins

494

2855

1.78

30.45

1.5

1.6

1.72

1.51

g/l

5.13

424

2419

Non-allergic asthma (mode), excluding more controls

434

2383

1.84

30.32

1.6

1.63

1.47

g/l

2.94

369

2005

Opening and dilatation of root channel of tooth

178

704

2.64

30.29

1.8

2.0

1.53

1.46

g/l

0.43

155

615

Other symptoms and signs involving the digestive system and abdomen

412

2257

1.87

30.15

2.0

1.7

1.55

1.54

g/l

0.10

346

1930

Use of pramipexole

622

3834

1.67

30.06

1.8

1.7

1.53

1.58

g/l

0.85

533

3255

Human immunodeficiency virus [HIV] disease resulting in other conditions

168

4.77

30.05

1.4

1.8

1.16

1.47

g/l

2.10

154

Crohn's disease of large intestine

153

567

2.83

29.69

1.8

2.0

1.52

1.44

g/l

0.48

138

501

Other specified/unspecified necrotizing vasculopathies

167

4.88

29.66

2.0

1.6

1.71

1.49

g/l

0.82

150

Pneumonia derived septicemia

132

456

3.11

29.56

2.1

2.0

1.61

1.51

g/l

0.48

114

400

Chronic myeloid leukaemia [CML], BCR/ABL-positive

117

5.97

29.56

1.8

1.27

1.52

g/l

1.02

101

Benign neoplasm: Small intestine

163

632

2.79

29.55

1.7

1.9

1.60

1.56

g/l

0.21

138

551

Congenital malformations of the circulatory system

359

1834

1.95

29.52

2.0

1.8

1.24

1.49

g/l

5.28

279

1591

Drug-induced neutropenia

223

992

2.36

29.50

1.9

1.8

1.64

1.55

g/l

0.51

194

864

Selective serotonin reuptake inhibitors

2730

11312

1.28

29.49

1.6

1.8

1.54

1.50

g/l

1.41

2290

9687

Papulosquamous disorders

993

6802

1.49

29.38

1.6

1.7

1.56

1.55

g/l

0.15

836

5824

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

240

1102

2.28

29.34

1.7

1.8

1.51

1.53

g/l

0.10

217

950

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

162

620

2.70

29.28

1.6

2.0

1.63

1.43

g/l

1.55

129

540

Discitis, unspecified

228

4.21

28.91

1.4

2.0

1.77

1.59

g/l

0.71

200

Irritable bowel syndrome

602

3704

1.65

28.86

1.7

1.47

1.50

g/l

0.36

520

3166

Other and unspecified immunodeficiencies with predominantly antibody defects

118

5.62

28.86

2.7

2.6

1.33

1.45

g/l

0.33

103

Persistent mood disorders

485

2826

1.76

28.77

1.7

1.54

1.51

g/l

0.25

418

2401

Disorders of sclera, cornea, iris and ciliary body

1336

9687

1.40

28.62

1.9

1.7

1.53

1.52

g/l

0.13

1142

8276

Benign neoplasm: Adrenal gland

212

935

2.38

28.56

1.6

1.5

1.72

1.51

g/l

2.61

184

809

Stomatitis and related lesions

218

969

2.33

28.56

2.1

1.7

1.38

1.49

g/l

0.82

182

820

Maternal care for other known or suspected fetal problems

393

1343

1.91

28.54

2.7

2.0

1.17

1.30

g/l

2.00

347

1169

Covid-19 suspected case

461

2661

1.77

28.18

2.0

1.8

1.54

1.43

g/l

1.52

409

2273

Persons with potential health hazards related to communicable diseases

774

5029

1.55

28.18

2.2

1.9

1.42

1.40

g/l

0.40

670

4371

Disorders of skin appendages

1087

7620

1.45

28.17

1.8

1.56

1.47

g/l

2.52

968

6541

Human immunodeficiency virus [HIV] disease

190

4.36

28.07

1.4

1.8

1.17

1.52

g/l

2.75

173

Cardiomyopathy, Hypertrophic obstructive

209

4.20

27.93

1.9

1.7

1.58

1.52

g/l

0.20

180

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

154

4.92

27.93

1.8

1.6

1.65

1.47

g/l

0.63

133

Infections with a predominantly sexual mode of transmission

602

3729

1.64

27.91

1.9

1.40

1.41

g/l

0.11

524

3230

Postpartum care and examination

242

691

2.28

27.90

3.2

1.9

1.06

1.42

g/l

8.91

218

595

Other interventions on the root canals of the tooth

174

4.52

27.83

2.6

2.1

1.48

1.47

g/l

0.04

154

Diagnoses used for exclusion with ILD

718

4660

1.58

27.77

1.8

1.7

1.59

1.54

g/l

0.64

591

3950

Postprocedural disorders of digestive system, not elsewhere classified

122

418

3.14

27.76

1.4

2.0

1.51

1.52

g/l

0.02

105

369

Mixed hyperlipidaemia

144

539

2.84

27.71

1.5

1.9

1.75

1.48

g/l

2.41

126

466

Disorders of the thyroid gland

2502

12910

1.28

27.51

1.8

1.7

1.50

1.51

g/l

0.27

2110

11043

Carcinoma in situ of skin of other and unspecified parts of face

293

1499

2.07

27.29

1.8

1.7

1.40

1.53

g/l

1.89

264

1267

Subjective visual disturbances

612

3852

1.62

27.01

1.7

1.50

1.54

g/l

0.63

530

3313

Retinal vascular occlusion

390

2187

1.85

26.99

1.7

1.57

g/l

0.01

328

1856

Mental and behavioural disorders due to opioids

101

313

3.38

26.85

1.7

2.1

1.63

1.39

g/l

1.45

279

Disorders of lacrimal system

1019

7138

1.45

26.80

1.7

1.50

1.56

g/l

1.17

867

6062

Allergic purpura

100

310

3.43

26.76

1.5

2.1

1.62

1.47

g/l

0.63

274

Injuries to unspecified part of trunk, limb or body region

280

1411

2.06

26.70

1.9

1.8

1.56

1.49

g/l

0.51

248

1212

Diffuse large B-cell lymphoma

175

737

2.55

26.68

1.5

1.8

1.81

1.54

g/l

2.19

140

640

Eosinophilic disease (BM)

146

4.81

26.67

1.6

2.0

1.59

1.53

g/l

0.16

124

Fracture of foot, except ankle

547

3356

1.66

26.67

1.8

1.7

1.58

1.49

g/l

1.45

475

2887

Syphilis

102

323

3.42

26.61

1.9

2.1

1.41

1.53

g/l

0.66

285

Total colectomy operation

138

516

2.83

26.57

1.7

2.0

1.58

1.47

g/l

0.68

127

457

Total colectomy

138

516

2.83

26.57

1.7

2.0

1.58

1.47

g/l

0.68

127

457

Benign neoplasm: Duodenum

114

389

3.23

26.49

1.8

2.0

1.60

1.53

g/l

0.30

340

Respiratory disorders in diseases classified elsewhere

165

4.64

26.46

2.1

1.69

1.49

g/l

0.76

147

Gonarthrosis,primary

2405

11942

1.28

26.43

1.5

1.7

1.61

1.56

g/l

1.47

2049

10171

Specific personality disorders

489

2919

1.70

26.42

1.7

1.9

1.56

1.43

g/l

2.26

428

2533

Carcinoma in situ of skin

250

1219

2.15

26.38

1.7

1.5

1.50

1.52

g/l

0.13

214

1047

Retinal vascular disorders

393

2225

1.83

26.32

1.7

1.56

1.57

g/l

0.04

329

1891

Other and unspecified disorders of skin and subcutaneous tissue

199

887

2.35

26.20

1.8

1.59

1.53

g/l

0.34

173

766

Primary biliary cholangitis (PBC)

209

4.03

26.15

1.7

1.5

1.25

1.53

g/l

1.68

179

Reactive arthropathies

232

1097

2.19

26.13

1.9

1.8

1.66

1.48

g/l

1.52

189

934

Abnormal serum enzyme levels

902

6142

1.48

26.08

1.6

1.53

g/l

0.03

788

5236

Left ventricular outflow tract obstruction, narrow definition

147

572

2.70

26.06

2.0

1.26

1.48

g/l

1.52

497

Hodgkin lymphoma, hilmo

105

342

3.30

26.05

1.9

2.1

1.51

1.43

g/l

0.30

303

Combinations of oral blood glucose lowering drugs

748

4970

1.54

26.00

1.5

1.6

1.74

1.49

g/l

10.92

641

4242

Undetermined asthma

298

1542

1.98

25.98

1.7

1.6

1.66

1.48

g/l

2.40

249

1300

Procreative management

618

3292

1.61

25.90

2.2

1.8

1.31

1.52

g/l

6.26

526

2844

Melanocytic naevi of trunk

284

1453

2.01

25.79

1.9

1.7

1.43

1.48

g/l

0.36

249

1251

Sicca syndrome [Sjögren]

232

1105

2.18

25.77

2.0

1.7

1.64

1.57

g/l

0.43

198

948

Urticaria and erythema

818

5536

1.50

25.69

1.9

1.7

1.46

1.49

g/l

0.50

700

4750

Other diseases of the respiratory system

619

3963

1.60

25.67

1.8

1.6

1.72

1.54

g/l

4.26

516

3350

Other respiratory disorders and diseases

619

3963

1.60

25.67

1.8

1.6

1.72

1.54

g/l

4.26

516

3350

Complications following infusion, transfusion and therapeutic injection

169

4.46

25.51

2.7

2.0

1.70

1.51

g/l

0.57

150

Kela reimbursement Agammaglobulinemia (D80-84)

6.80

25.44

2.0

2.5

1.30

1.42

g/l

0.29

Abnormal findings on diagnostic imaging of other body structures

334

1814

1.90

25.43

1.8

1.7

1.63

1.56

g/l

0.52

291

1573

Other diseases of biliary tract

267

1351

2.06

25.34

1.8

1.7

1.46

1.54

g/l

0.64

226

1148

Oesophagitis

179

775

2.43

25.31

1.9

1.8

1.58

1.53

g/l

0.33

159

659

Other diseases of oesophagus

289

1501

2.00

25.31

1.8

1.7

1.47

1.56

g/l

1.02

250

1285

Arterial embolism and thrombosis

203

927

2.30

25.29

1.9

1.7

1.78

1.48

g/l

4.11

177

777

Exclusions for E4_PCOS_BROAD

405

2329

1.78

25.24

1.8

1.54

1.50

g/l

0.29

351

2002

Alcohol abuse, main dg, excluding more controls

356

1972

1.85

25.22

1.6

1.8

1.57

1.47

g/l

1.27

307

1686

Hypothyroidism, other/unspecified

2306

12032

1.28

25.21

1.8

1.7

1.51

1.50

g/l

0.16

1957

10288

Phlebitis and thrombophlebitis (not including DVT)

576

3638

1.62

25.12

2.0

1.6

1.63

1.58

g/l

0.55

515

3098

6-mercaptopurine

237

3.68

25.11

1.6

1.8

1.42

1.35

g/l

0.23

209

Haemorrhoids and perianal venous thrombosis

745

4973

1.52

25.11

1.7

1.6

1.53

1.56

g/l

0.38

648

4192

Shock, not elsewhere classified

102

5.69

25.08

2.4

1.5

1.62

1.44

g/l

0.50

Other embolism and thrombosis

363

2033

1.84

25.03

2.5

1.7

1.57

1.56

g/l

0.06

314

1724

Psoriatic arthropathies

251

1243

2.08

24.98

1.5

1.7

1.64

1.51

g/l

1.16

210

1058

Myalgia

518

3190

1.65

24.91

1.6

1.7

1.53

1.51

g/l

0.21

443

2721

Hypothyreosis and Thyroxine purchase for inclusion criteria

2374

12451

1.27

24.82

1.8

1.7

1.52

1.51

g/l

0.19

2021

10641

Injuries to the elbow and forearm

1652

11401

1.32

24.73

1.8

1.7

1.53

1.52

g/l

0.17

1415

9747

Disorders of synovium and tendon

1240

8177

1.38

24.67

1.7

1.48

1.52

g/l

0.76

1073

6992

Acquired absence of organs, not elsewhere classified

140

4.82

24.54

2.0

2.2

1.61

1.49

g/l

0.38

122

Hypersplenism

8.89

24.51

2.5

1.8

0.80

1.49

g/l

4.02

Symptoms and signs involving the nervous and musculoskeletal systems

1456

10965

1.34

24.44

1.5

1.7

1.57

1.53

g/l

1.12

1260

9354

Other and unspecified effects of external causes

604

3876

1.58

24.41

1.8

1.55

1.47

g/l

1.33

519

3319

Other abnormal findings of blood chemistry

141

558

2.67

24.30

2.0

1.9

1.48

1.49

g/l

0.02

123

486

Vitamin deficiency

155

641

2.55

24.28

1.8

1.9

1.39

1.48

g/l

0.59

129

563

Vitamin deficiency, wide

155

641

2.55

24.28

1.8

1.9

1.39

1.48

g/l

0.59

129

563

Familial hypercholesterolemia, with ischemic heart disease

313

1698

1.92

24.23

1.7

1.68

1.57

g/l

1.31

257

1440

Retinal detachments and breaks

954

6738

1.44

24.20

1.8

1.6

1.52

1.58

g/l

1.22

818

5731

Disorders of porphyrin and bilirubin metabolism

113

5.22

24.09

1.8

2.2

0.86

1.44

g/l

5.12

Dental pulpitis 4, only avohilmo

2965

12605

1.24

23.89

1.7

1.8

1.53

1.51

g/l

0.50

2534

10769

Polyarthritis, unspecified

121

447

2.86

23.87

1.6

1.8

1.74

1.52

g/l

1.31

107

383

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

343

1920

1.85

23.83

1.4

1.5

1.74

1.52

g/l

4.24

295

1627

Other or ill-defined heart diseases

142

566

2.61

23.82

2.0

1.6

1.55

g/l

0.02

117

485

Coeliac disease

303

1629

1.91

23.75

1.7

1.8

1.44

1.51

g/l

0.59

255

1413

Operations for atrial fibrillation

242

3.80

23.71

2.2

1.7

1.24

1.55

g/l

1.77

209

Other renal tubulo-interstitial diseases

201

3.86

23.43

3.2

1.8

1.61

1.34

g/l

1.56

173

Pneumococcal septicemia

121

453

2.86

23.43

2.1

2.0

1.62

1.50

g/l

0.61

103

394

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

530

3344

1.63

23.37

1.5

1.73

1.54

g/l

4.64

455

2841

Erosion of teeth, including avohilmo

413

2352

1.73

23.35

1.9

1.7

1.33

1.46

g/l

2.52

367

2028

Adrenocortical insufficiency

114

414

2.92

23.27

1.8

2.0

1.61

1.49

g/l

0.60

364

Colitis, primary sclerosing

112

5.06

23.21

1.8

2.2

1.25

1.52

g/l

1.15

101

Adalimumab

204

962

2.19

23.15

1.5

1.9

1.60

1.52

g/l

0.48

178

834

Fentanyl

288

1542

1.93

22.94

1.7

1.6

1.89

1.51

g/l

5.84

234

1308

Aspergillosis

108

5.45

22.78

1.7

2.5

1.86

1.47

g/l

1.37

Iron deficiency

155

4.25

22.76

1.8

2.3

1.30

1.26

g/l

0.14

140

Adverse effects, not elsewhere classified

435

2626

1.69

22.73

1.8

1.54

1.48

g/l

0.64

379

2249

Carcinoma in situ of other and unspecified digestive organs

318

3.24

22.71

1.8

1.7

1.60

1.52

g/l

0.38

275

Other specified congenital malformation syndromes affecting multiple systems

130

4.63

22.71

1.7

2.2

1.17

1.25

g/l

0.26

119

Osteonecrosis due to drugs

177

4.26

22.66

2.1

2.0

1.82

1.53

g/l

1.09

156

Carcinoma in situ of skin of ear and external auricular canal

205

3.99

22.65

2.0

1.7

1.48

1.46

g/l

0.05

170

Traumatic subdural haemorrhage

392

2272

1.75

22.64

1.9

1.6

1.51

1.56

g/l

0.56

326

1927

Poor fetal growth

213

1027

2.12

22.63

3.3

2.0

1.12

1.27

g/l

1.90

190

893

DVT of lower extremities

521

3300

1.62

22.61

1.8

1.6

1.59

1.58

g/l

0.08

462

2794

Gangrene, not elsewhere classified

5.89

22.57

2.1

1.8

1.89

1.62

g/l

0.87

Fitting and adjustment of other devices

919

6061

1.43

22.56

1.8

1.6

1.62

1.55

g/l

1.52

767

5095

Maternal care for known or suspected fetal abnormality and damage

253

1147

2.00

22.54

2.2

1.9

1.16

1.32

g/l

1.94

222

990

Type1 diabetes, definitions combined, early onset

139

559

2.55

22.54

2.4

2.0

1.21

1.29

g/l

0.53

125

494

Small fibre neuropathy

108

391

2.99

22.48

2.9

2.0

1.50

1.54

g/l

0.15

341

Other specified/unspecified bacterial intestinal infections

193

907

2.22

22.39

1.8

1.9

1.56

1.53

g/l

0.15

161

794

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

147

620

2.51

22.24

1.6

1.5

1.80

1.48

g/l

2.35

124

532

Other disorders of adrenal gland

129

510

2.66

22.21

1.9

2.0

1.62

1.49

g/l

0.66

113

447

Other and unspecified vasculitis limited to skin

301

3.27

22.18

1.5

2.0

1.48

1.54

g/l

0.20

264

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

188

4.00

22.09

4.2

1.7

1.44

1.50

g/l

0.16

166

Vasculitis limited to skin, not elsewhere classified

328

3.15

22.08

1.5

2.0

1.47

1.54

g/l

0.25

287

Amenorrhoea

151

640

2.43

22.08

2.4

2.0

1.22

1.35

g/l

0.96

124

570

Alcohol withdrawal state with delirium

215

1061

2.12

21.98

1.5

1.7

1.55

1.54

g/l

0.09

183

917

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

758

5219

1.48

21.98

1.8

1.7

1.51

1.54

g/l

0.39

659

4454

Colitis, primary sclerosing, strict definition

5.52

21.97

1.7

2.3

1.15

1.51

g/l

1.80

Allergic asthma (mode), excluding more controls

433

2579

1.67

21.88

1.6

1.8

1.55

1.36

g/l

4.17

385

2199

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

103

5.32

21.85

2.0

1.8

1.41

1.52

g/l

0.25

Carcinoma in situ of skin of upper limb, including shoulder

305

3.27

21.84

2.0

1.6

1.57

1.54

g/l

0.11

260

Rotator cuff syndrome

1543

8795

1.32

21.83

1.7

1.59

1.56

g/l

0.54

1321

7479

Conductive and sensorineural hearing loss

2095

11557

1.27

21.81

1.6

1.7

1.53

1.57

g/l

1.40

1736

9893

Psoriasis vulgaris

466

2898

1.64

21.78

1.7

1.8

1.62

1.54

g/l

0.98

395

2504

Scoliosis

215

1060

2.09

21.75

1.8

1.9

1.54

1.46

g/l

0.60

187

923

Asthma/COPD (KELA code 203)

2350

13363

1.25

21.74

1.6

1.8

1.61

1.49

g/l

8.24

2019

11412

Giant cell arteritis

150

647

2.47

21.71

1.5

1.8

2.09

1.55

g/l

5.31

122

552

Viral warts

245

1268

1.99

21.63

2.1

1.9

1.52

1.47

g/l

0.34

220

1106

Congenital malformations of aortic and mitral valves

122

476

2.70

21.62

2.0

1.24

1.49

g/l

1.70

415

Thyroiditis, ILD-related definition

258

1358

1.95

21.58

2.0

1.8

1.43

1.52

g/l

0.89

215

1169

Dentofacial anomalies [including malocclusion]

525

3318

1.59

21.55

1.8

1.7

1.41

1.48

g/l

0.85

462

2846

Herpesviral [herpes simplex] infections

285

1553

1.89

21.50

1.7

1.8

1.50

1.52

g/l

0.12

247

1336

Reactive arthropathies, FINNGEN

180

836

2.23

21.34

1.9

1.8

1.71

1.45

g/l

2.21

149

716

Dental pulpitis 1, only avohilmo

2947

12678

1.22

21.25

1.7

1.8

1.53

1.51

g/l

0.48

2519

10833

Inflammatory diseases of the central nervous system

222

1122

2.05

21.09

1.9

1.8

1.71

1.52

g/l

1.98

192

974

Injury of unspecified body region

214

1069

2.08

21.09

1.9

1.8

1.58

1.50

g/l

0.51

190

929

Maternal care for other conditions predominantly related to pregnancy

324

1812

1.79

21.07

2.2

1.8

1.25

1.37

g/l

1.71

281

1574

Coxarthrosis, primary

1625

10996

1.30

21.06

1.5

1.6

1.63

1.58

g/l

1.56

1387

9308

Malnutrition

248

3.46

21.05

1.5

1.8

1.37

1.45

g/l

0.29

219

888

5622

1.43

20.98

1.6

1.55

1.58

g/l

0.40

737

4745

Cholecystitis

405

2460

1.69

20.95

1.8

1.6

1.56

1.55

g/l

0.08

339

2085

Hypothyroidism, strict autoimmune, 3 medication purchases required

2108

11507

1.26

20.94

1.8

1.7

1.52

1.51

g/l

0.23

1785

9840

Umbilical hernia

663

4495

1.50

20.93

1.6

1.7

1.57

1.53

g/l

0.48

581

3885

Supplementary factors related to causes of morbidity and mortality classified elsewhere

711

4885

1.48

20.89

1.7

1.53

1.51

g/l

0.18

615

4160

Paralytic ileus

126

509

2.62

20.87

1.7

1.8

1.72

1.47

g/l

2.24

115

443

Crohn disease (strict definition, all UC cases excluded)

133

549

2.52

20.83

1.6

2.0

1.47

1.45

g/l

0.11

119

484

Polycystic ovarian syndrome, consortium definition

1452

6675

1.32

20.79

1.8

1.50

1.49

g/l

0.15

1239

5730

Donors of organs and tissues

5.07

20.76

1.5

2.2

1.73

1.31

g/l

1.19

Hypertrophic cardiomyopathy

144

622

2.46

20.75

1.8

1.9

1.54

1.56

g/l

0.07

126

548

Iridocyclitis

550

3596

1.56

20.67

1.9

1.7

1.52

g/l

0.04

475

3083

Mature T/NK-cell lymphomas, hilmo

193

3.90

20.66

1.8

1.9

1.65

1.55

g/l

0.28

170

Non-allergic asthma (mode)

434

2657

1.65

20.63

1.6

1.63

1.47

g/l

3.16

369

2238

Benign neoplasm: Descending colon

220

1124

2.06

20.60

1.6

1.7

1.53

1.54

g/l

0.06

195

964

L04AC Interleukin inhibitors

122

486

2.61

20.60

1.7

2.0

1.71

1.51

g/l

1.21

102

428

Pyoderma gangrenosum

5.86

20.57

2.6

2.1

1.25

1.45

g/l

0.67

Abscess of anal and rectal regions

202

995

2.09

20.51

1.6

1.8

1.64

1.48

g/l

1.17

174

870

Other ulcerative colitis

153

677

2.35

20.50

1.6

2.0

1.53

1.49

g/l

0.21

137

598

Exclusions for E4_PCOS_CONSORTIUM

1534

7405

1.31

20.48

1.7

1.8

1.52

1.49

g/l

0.58

1297

6361

Etanercept

153

677

2.34

20.46

1.3

1.9

1.54

1.51

g/l

0.12

121

591

Localized swelling, mass and lump of skin and subcutaneous tissue

756

5278

1.46

20.45

1.8

1.7

1.52

1.55

g/l

0.29

648

4506

Drug-induced osteoporosis

134

4.50

20.43

2.2

2.4

1.66

1.59

g/l

0.17

117

IBD (strict) with PSC

5.46

20.25

1.7

2.5

1.23

1.42

g/l

0.64

Dermatitis due to substances taken internally

152

675

2.34

20.23

2.1

1.8

1.68

1.50

g/l

1.25

136

588

Other and unspecified psoriasis

192

938

2.13

20.17

1.8

1.9

1.76

1.55

g/l

1.66

156

813

Other abnormalities of plasma proteins

201

3.75

20.09

2.1

1.8

1.78

1.47

g/l

1.61

175

Other hammer toe(s) (acquired)

421

2439

1.65

20.04

1.4

1.7

1.55

1.60

g/l

0.48

357

2033

ILD-related respiratory insufficiency

127

529

2.59

20.02

2.2

1.9

1.64

1.55

g/l

0.47

113

459

Postmenopausal osteoporosis with pathological fracture

188

917

2.16

20.01

2.0

1.6

1.57

1.59

g/l

0.08

167

782

Fall on and from stairs and steps

618

4172

1.51

19.97

1.8

1.7

1.52

1.53

g/l

0.15

520

3560

Cholecystectomy

1755

12287

1.28

19.93

1.9

1.7

1.50

1.55

g/l

1.32

1497

10444

Parodontitis, under 40 years, or operation codes

173

810

2.18

19.92

2.9

2.2

1.33

1.18

g/l

1.34

156

713

Other and unspecified haemorrhagic conditions

182

3.83

19.87

1.8

1.54

1.48

g/l

0.16

164

Pneumonia due to Streptococcus pneumoniae

122

496

2.57

19.83

2.1

1.7

1.74

1.48

g/l

1.92

102

430

Parodontitis, under 40 years

172

808

2.17

19.64

2.9

2.2

1.32

1.18

g/l

1.28

155

711

Benign neoplasm of other and unspecified endocrine glands

330

1933

1.76

19.60

1.6

1.7

1.66

1.55

g/l

1.14

285

1665

Disorders of vitreous body and globe

1255

9329

1.33

19.59

1.9

1.6

1.51

1.59

g/l

2.31

1089

7930

Unspecified human immunodeficiency virus [HIV] disease

104

4.92

19.55

1.5

1.6

1.23

1.62

g/l

1.80

Benign neoplasm: Rectosigmoid junction

128

538

2.52

19.55

1.5

1.6

1.69

1.54

g/l

0.87

109

461

Disorders of tooth development and eruption

110

414

2.67

19.52

2.3

2.0

1.31

g/l

0.01

353

Personal history of other diseases and conditions

208

1048

2.02

19.45

2.1

1.8

1.34

1.38

g/l

0.27

178

903

Malignant neoplasm of colon

437

2761

1.63

19.42

1.4

1.7

1.75

1.54

g/l

4.56

377

2346

therapeutic use

107

416

2.75

19.37

1.5

1.8

1.77

1.54

g/l

1.45

368

Emotionally unstable personality disorder

233

1231

1.93

19.22

1.6

2.0

1.48

1.36

g/l

1.08

203

1068

Sensorineural hearing loss

1995

11231

1.26

19.22

1.6

1.7

1.52

1.58

g/l

1.85

1650

9608

Juvenile arthritis (FINNGEN)

367

2.78

19.21

1.8

2.2

1.53

1.29

g/l

1.54

327

Abnormal findings in nipple discharge synovial fluid wound secretions

172

3.86

19.20

2.0

2.4

1.50

1.45

g/l

0.13

152

Artificial joint operation, meniscal resection

2350

12786

1.23

19.18

1.6

1.7

1.60

1.56

g/l

1.29

1990

10910

Exclusion endpoint for clefts

166

3.84

19.18

1.7

2.2

1.22

1.31

g/l

0.30

149

Disease of hard tissues of teeth, NOS

5.16

19.17

1.5

2.0

1.35

1.43

g/l

0.19

Mental and behavioural disorders due to tobacco

215

1113

2.00

19.12

1.7

1.8

1.73

1.52

g/l

2.24

192

959

Disorders of vitreous body

1211

9032

1.33

18.98

1.9

1.6

1.50

1.59

g/l

2.68

1049

7673

Sleep disorders

460

2949

1.59

18.86

1.9

1.8

1.50

1.47

g/l

0.23

393

2547

Superficial injury of hip and thigh

394

2442

1.65

18.79

1.7

1.49

1.52

g/l

0.24

331

2068

Carcinoma in situ of skin of scalp and neck

373

2.88

18.77

1.9

1.6

1.34

1.50

g/l

1.04

315

Other crystal arthropathies

256

3.28

18.76

1.8

1.9

1.63

1.58

g/l

0.16

218

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

6.11

18.73

2.1

1.70

1.55

g/l

0.29

Right hemicolectomy

198

1009

2.06

18.71

1.7

1.70

1.52

g/l

1.79

173

873

Heartburn

245

1331

1.89

18.70

1.6

1.7

1.45

1.51

g/l

0.47

217

1145

Cerebral palsy and other paralytic syndromes

287

1637

1.80

18.69

1.7

1.8

1.54

1.52

g/l

0.17

246

1405

Nonorganic sleeping disorders

403

2511

1.63

18.66

1.9

1.8

1.49

1.45

g/l

0.34

348

2173

Acute generalized exanthematous pustulosis

131

567

2.42

18.64

2.1

1.9

1.60

1.50

g/l

0.54

118

490

Carcinoma in situ of skin of trunk

110

443

2.67

18.62

1.9

1.6

1.38

1.51

g/l

0.92

375

Smoking dependency

215

1125

1.97

18.54

1.7

1.8

1.73

1.53

g/l

2.21

192

968

Early onset COPD

576

3900

1.51

18.46

1.6

1.7

1.71

1.54

g/l

4.24

496

3330

Mixed and other personality disorders

170

817

2.14

18.45

1.7

1.9

1.61

1.46

g/l

1.06

141

709

Polyarteritis nodosa and related conditions

158

3.93

18.40

1.7

2.2

1.62

1.44

g/l

0.60

142

Crystal arthropathies, rheuma endpoint

259

3.24

18.40

1.8

1.6

1.63

1.51

g/l

0.41

222

Schizophrenia or delusion, excluding more controls

610

4134

1.48

18.39

1.5

1.8

1.70

1.47

g/l

6.61

513

3539

Neovascular glaucoma

134

591

2.39

18.34

2.1

1.8

1.59

1.53

g/l

0.26

115

512

Parodontitis, operation under 40 years and operation codes

163

771

2.16

18.33

2.6

2.1

1.29

1.18

g/l

0.93

146

679

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

119

4.58

18.32

2.0

2.2

1.41

1.52

g/l

0.24

103

Other disorders of bone

425

2695

1.60

18.29

1.6

1.8

1.47

1.49

g/l

0.20

361

2316

Portal vein thrombosis

183

3.70

18.28

2.4

2.1

1.25

1.62

g/l

1.74

161

Supervision of high-risk pregnancy

307

1053

1.78

18.24

2.2

1.8

1.17

1.50

g/l

7.99

265

912

Benign neoplasm: Adrenal gland

212

1114

1.98

18.22

1.6

1.8

1.72

1.56

g/l

1.72

184

963

Malignant neoplasm of urinary organs

301

1760

1.77

18.22

1.7

1.86

1.55

g/l

4.57

251

1503

Mental and behavioural disorders due to sedatives or hypnotics

158

743

2.19

18.22

1.4

2.0

1.70

1.49

g/l

1.84

125

648

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

346

2091

1.70

18.20

1.7

1.5

1.75

1.52

g/l

4.30

303

1774

Other diseases of jaws

170

823

2.13

18.19

1.6

1.7

1.50

g/l

0.01

151

708

Insomnia

341

2052

1.70

18.18

2.0

1.8

1.50

1.47

g/l

0.23

290

1777

Alcohol-induced acute pancreatitis

118

495

2.52

18.13

1.7

1.8

1.71

1.55

g/l

1.03

101

423

Generalized skin eruption due to drugs and medicaments

118

494

2.51

18.13

2.2

1.9

1.61

1.48

g/l

0.67

106

431

Carcinoma in situ of skin of lower limb, including hip

256

3.24

18.12

1.6

1.7

1.40

1.59

g/l

1.16

226

Somatoform disorder

357

2177

1.67

18.08

1.6

1.8

1.55

1.51

g/l

0.38

299

1867

Meniscus derangement

1300

6835

1.31

18.07

1.6

1.7

1.53

g/l

0.11

1098

5802

Parodontitis, under 40 years and operation codes

162

769

2.15

18.06

2.6

2.1

1.28

1.18

g/l

0.88

145

677

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

180

3.73

18.05

1.9

1.6

1.52

1.48

g/l

0.11

154

Squamous cell neoplasms and carcinomas of the skin

397

2500

1.64

18.04

1.9

1.6

1.48

1.55

g/l

0.79

343

2102

Paracetamol of NSAID medication

469

1492

1.60

17.95

1.9

1.47

1.31

g/l

2.71

412

1262

Gilbert syndrome

5.55

17.93

1.9

2.0

0.86

1.39

g/l

3.12

Carcinoma in situ of skin of ear and external auricular canal

239

3.39

17.89

2.0

1.7

1.48

1.59

g/l

0.41

207

Common variable immunodeficiency

6.40

17.84

1.4

2.5

1.35

1.44

g/l

0.18

Ankylosing spondylitis

224

1202

1.92

17.83

1.6

1.8

1.60

1.51

g/l

0.72

183

1041

Hypertension, Pulmonary Arterial

5.23

17.82

2.3

2.1

1.15

1.49

g/l

1.23

Ulcerative colitis (strict) with PSC

5.71

17.69

1.8

2.1

1.28

1.42

g/l

0.38

Infarction of spleen

5.72

17.69

2.0

1.8

1.34

1.59

g/l

0.79

Other retinal artery occlusion

372

2.79

17.65

1.7

1.9

1.61

1.56

g/l

0.16

329

Glaucoma secondary to other eye disorders

134

601

2.34

17.65

2.1

1.9

1.59

1.52

g/l

0.27

115

525

Chronic hepatitis NAS

144

4.02

17.63

1.7

1.9

1.35

1.50

g/l

0.51

127

Melanocytic naevi

646

4506

1.46

17.61

2.1

1.7

1.37

1.52

g/l

4.60

568

3871

Corns and callosities

183

924

2.05

17.57

1.7

1.8

1.68

1.53

g/l

1.14

157

793

Diseases of the ear and mastoid process

2960

12569

1.20

17.56

1.8

1.7

1.49

1.52

g/l

0.96

2515

10787

Eosinophilia

203

3.49

17.54

1.6

2.1

1.57

1.51

g/l

0.20

175

Olecranon bursitis

178

893

2.07

17.46

1.7

1.62

1.52

g/l

0.72

156

755

Excessive, frequent and irregular menstruation

841

3365

1.40

17.41

1.7

1.9

1.48

1.47

g/l

0.14

722

2866

Artrosis, including avohilmo

2129

9519

1.24

17.40

1.6

1.7

1.57

1.53

g/l

1.19

1802

8110

Carcinoma in situ of colon

170

3.78

17.40

1.9

1.7

1.68

1.48

g/l

0.97

144

Arterial embolism and thrombosis of lower extremity artery

120

517

2.45

17.38

2.1

1.9

1.72

1.46

g/l

2.01

104

443

Thyrotoxicosis, other and/or unspecified

438

2839

1.57

17.20

1.8

1.6

1.51

1.53

g/l

0.21

376

2418

Single delivery by caesarean section

327

1113

1.72

17.05

2.9

2.0

1.16

1.38

g/l

4.03

296

965

Other symptoms and signs involving the circulatory and respiratory systems

159

770

2.13

17.03

1.8

1.6

1.58

1.56

g/l

0.09

139

659

Unspecified urinary incontinence

225

1230

1.89

17.00

1.8

1.7

1.76

1.54

g/l

2.43

184

1061

Disturbances of skin sensation

567

3886

1.48

16.96

1.8

1.44

1.51

g/l

1.05

474

3346

Intracranial and intraspinal abscess and granuloma

149

3.96

16.95

1.8

2.1

2.04

1.49

g/l

2.68

128

Assault

255

1446

1.80

16.84

1.7

1.9

1.47

1.45

g/l

0.14

215

1253

Benign neoplasm of mouth and pharynx

257

1465

1.80

16.84

1.5

1.6

1.55

1.54

g/l

0.12

209

1259

Melanocytic naevi of trunk

284

1667

1.75

16.78

1.9

1.8

1.43

1.51

g/l

0.79

249

1445

Dissection of aorta

115

496

2.46

16.71

1.5

1.9

1.57

1.44

g/l

0.70

424

Amputation of thigh

110

466

2.52

16.69

2.4

1.7

1.92

1.54

g/l

3.19

405

Diseases of external ear

800

5848

1.39

16.68

1.8

1.7

1.56

1.53

g/l

0.41

680

4969

Rheumatism, unspecified

314

1894

1.69

16.67

1.8

1.7

1.59

1.61

g/l

0.13

274

1612

Fall on same level involving ice and snow

1318

10332

1.29

16.65

1.6

1.7

1.52

1.54

g/l

0.26

1114

8818

Other overlap syndromes

220

3.27

16.59

2.5

2.0

1.64

1.48

g/l

0.50

192

Colorectal cancer

652

4619

1.44

16.58

1.5

1.6

1.75

1.56

g/l

5.62

561

3915

COPD, hospital admissions 1, only main diagnosis

1008

6493

1.34

16.58

1.5

1.6

1.70

1.55

g/l

5.62

861

5478

Carcinoma in situ of other and unspecified digestive organs

378

2.71

16.57

1.8

1.9

1.60

1.58

g/l

0.06

328

Arthropathic psoriasis

271

1576

1.76

16.56

1.5

1.7

1.60

1.56

g/l

0.23

227

1362

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

388

2.65

16.56

1.4

1.6

1.63

1.50

g/l

0.60

335

Chronic rhinitis, nasopharyngitis and pharyngitis

696

4974

1.42

16.55

1.6

1.7

1.53

1.51

g/l

0.12

595

4269

Pregnancy examination and test

232

779

1.88

16.52

2.1

1.9

1.13

1.42

g/l

5.22

209

670

Other disorders of bladder

336

2074

1.67

16.50

1.7

1.54

1.57

g/l

0.25

283

1782

Temporal arteritis

128

582

2.34

16.49

1.5

1.7

2.13

1.56

g/l

5.39

109

502

Other juvenile arthritis

333

2.73

16.49

1.9

2.3

1.49

1.29

g/l

1.07

298

Urticaria

606

4228

1.45

16.48

1.9

1.7

1.47

1.50

g/l

0.32

519

3636

Ulcerative colitis (strict definition, require KELA)

364

2285

1.62

16.44

1.9

1.8

1.43

1.48

g/l

0.47

320

1974

Bacterial, viral and other infectious agents

199

1056

1.94

16.43

1.8

1.9

1.54

1.50

g/l

0.23

169

917

Bullous disorders

175

895

2.04

16.38

1.8

1.46

1.50

g/l

0.23

148

771

KRA_PSY_EATING, excluding more controls

141

657

2.18

16.37

2.2

2.1

1.16

g/l

0.02

121

581

Dermatophytosis

340

2108

1.66

16.36

1.9

1.7

1.54

g/l

0.00

290

1816

Other disorders of the musculoskeletal system and connective tissue

362

2278

1.63

16.34

1.7

1.57

1.56

g/l

0.12

309

1950

Sarcoidosis

323

1976

1.67

16.33

1.9

1.7

1.50

1.56

g/l

0.47

271

1706

Transport accidents

973

6494

1.34

16.28

1.8

1.50

1.48

g/l

0.21

829

5599

Congenital malformations of cardiac septa

156

737

2.11

16.26

2.1

2.0

1.21

1.45

g/l

2.50

129

645

Symptoms and signs involving speech and voice

775

5662

1.39

16.25

1.8

1.7

1.52

1.55

g/l

0.55

660

4823

Thyrotoxicosis

556

3832

1.47

16.24

1.8

1.7

1.55

1.54

g/l

0.13

477

3250

Systemic sclerosis (FG)

254

3.04

16.24

2.0

1.7

1.50

1.46

g/l

0.13

217

Malignant neoplasm of digestive organs

1059

7983

1.33

16.21

1.4

1.6

1.67

1.56

g/l

3.53

908

6731

Other problems related to primary support group, including family circumstances

212

1120

1.88

16.19

2.2

1.9

1.33

1.38

g/l

0.26

185

985

Diseases of male genital organs

1387

5483

1.29

16.15

1.8

1.7

1.52

1.55

g/l

0.54

1193

4683

Other encephalitis

318

2.79

15.98

2.5

2.1

1.68

1.45

g/l

1.32

278

Giant cell arteritis with polymyalgia rheumatica

128

590

2.30

15.97

1.5

1.8

2.13

1.57

g/l

5.28

109

514

Bicuspidal aortic valve syndrome

103

430

2.51

15.97

2.0

1.33

1.51

g/l

0.92

373

Carcinoma in situ of skin

250

1445

1.80

15.95

1.7

1.50

1.54

g/l

0.32

214

1231

Gestational diabetes (for exclusion)

528

2527

1.49

15.90

2.6

2.0

1.25

1.30

g/l

0.71

465

2204

Type of accident

639

4536

1.43

15.88

1.7

1.52

1.51

g/l

0.13

553

3869

Later onset COPD

893

5244

1.36

15.88

1.5

1.6

1.71

1.54

g/l

5.92

762

4412

Alcohol abuse, main dg

356

2244

1.62

15.87

1.6

1.8

1.57

1.50

g/l

0.80

307

1939

Allergic asthma (mode)

433

2790

1.54

15.87

1.6

1.8

1.55

1.37

g/l

3.88

385

2374

Abscess of lung

190

3.43

15.87

1.6

2.0

1.84

1.55

g/l

1.01

164

Embolic stroke with flimmer

349

2.70

15.81

1.5

1.8

1.64

1.62

g/l

0.07

296

Encephalitis

337

2.72

15.80

2.5

2.1

1.66

1.48

g/l

0.90

297

Other congenital malformations

184

963

1.96

15.78

1.6

1.9

1.29

1.45

g/l

1.61

151

849

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

352

2220

1.61

15.63

1.9

1.8

1.43

1.49

g/l

0.51

309

1916

Cardiac murmurs and other cardiac sounds

199

1059

1.90

15.62

1.8

1.54

1.47

g/l

0.45

172

912

Other headache syndromes

882

6610

1.35

15.54

1.6

1.8

1.45

1.50

g/l

0.78

746

5694

Keratitis

782

5761

1.37

15.51

1.9

1.7

1.53

1.51

g/l

0.18

669

4911

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

387

2499

1.58

15.50

1.9

1.8

1.43

1.49

g/l

0.57

342

2165

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

270

2.88

15.48

1.7

2.2

1.33

1.32

g/l

0.02

235

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

505

3405

1.48

15.45

1.9

1.41

1.38

g/l

0.20

427

2956

Drug-induced hypoglycaemia without coma

214

3.23

15.44

1.6

1.9

1.64

1.48

g/l

0.70

189

Unspecified misadventure during surgical and medical care

152

755

2.10

15.43

1.8

1.9

1.34

1.54

g/l

1.89

127

651

Malignant neoplasm of kidney, except renal pelvis

270

1607

1.74

15.41

1.6

1.7

1.85

1.54

g/l

3.80

225

1372

Autoimmune hepatitis

5.30

15.40

1.9

1.3

1.26

1.59

g/l

0.98

Irregular menses

822

4931

1.36

15.32

1.9

1.43

1.44

g/l

0.11

707

4263

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

547

3808

1.46

15.29

1.4

1.5

2.04

1.54

g/l

15.10

458

3236

Lumbar disc prolapse

1474

9368

1.26

15.28

1.6

1.7

1.61

1.53

g/l

2.42

1290

8010

Fissure and fistula of anal and rectal regions

521

3592

1.47

15.19

1.9

1.6

1.57

1.54

g/l

0.28

440

3058

Extreme obesity with alveolar hypoventilation

119

542

2.30

15.16

1.3

1.9

1.78

1.53

g/l

2.03

474

Carcinoma in situ of skin of upper limb, including shoulder

373

2.65

15.05

2.0

1.57

1.59

g/l

0.06

328

Abnormal involuntary movements

324

2027

1.64

15.02

1.6

1.7

1.54

1.53

g/l

0.04

278

1739

Pulmonary oedema

273

2.93

14.99

2.5

1.8

1.54

1.60

g/l

0.18

237

Gonarthrosis, primary, with knee surgery

1485

9749

1.26

14.98

1.5

1.7

1.64

1.57

g/l

1.83

1257

8279

Fracture of forearm

1221

8992

1.28

14.95

1.8

1.7

1.56

1.54

g/l

0.31

1047

7662

Acute and subacute iridocyclitis

441

2955

1.52

14.94

1.9

1.7

1.52

g/l

0.06

381

2540

Ulcerative enterocolitis

346

2.63

14.93

1.6

2.1

1.34

1.45

g/l

0.59

302

Benign neoplasm of urinary organs

122

564

2.25

14.91

2.1

1.7

1.56

1.50

g/l

0.30

103

487

Ankylosing spondylitis, ICD10

212

1185

1.84

14.91

1.6

1.8

1.60

1.53

g/l

0.40

174

1034

Post-traumatic stress disorder

142

692

2.09

14.88

1.6

2.0

1.34

1.30

g/l

0.21

119

615

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

836

3790

1.37

14.79

1.7

1.6

1.63

1.51

g/l

2.82

713

3226

Other bursopathies

323

2028

1.63

14.74

1.8

1.7

1.50

1.58

g/l

0.68

282

1732

Other peripheral vascular diseases

189

1024

1.90

14.73

2.0

1.8

1.43

1.49

g/l

0.35

161

882

Other specified disorders of kidney and ureter

102

441

2.43

14.72

2.8

2.0

1.54

1.57

g/l

0.12

391

Nonalcoholic steatohepatitis

4.98

14.71

2.7

2.2

1.16

1.51

g/l

1.15

Recurring oral aphthae, including avohilmo

317

1983

1.63

14.69

1.9

1.8

1.42

1.52

g/l

1.09

272

1707

Atrial septal defect

394

2.49

14.65

2.5

2.1

1.17

1.43

g/l

1.92

349

Acute alcohol intoxication, ICD10

442

2976

1.51

14.62

1.5

1.8

1.58

1.50

g/l

1.13

376

2577

Other other unspecified disorders of the circulatory system

114

519

2.31

14.58

1.6

1.9

1.45

1.52

g/l

0.27

454

Tobacco use

130

623

2.16

14.47

1.9

1.70

1.49

g/l

1.93

120

539

Special screening examination for neoplasms

125

592

2.19

14.37

1.7

1.6

1.52

1.53

g/l

0.03

103

509

Migraine

904

5830

1.33

14.36

1.9

1.41

1.44

g/l

0.38

782

5066

Psoriatic arthropathies, ICD10

247

1461

1.73

14.28

1.5

1.7

1.65

1.56

g/l

0.70

207

1255

Adult respiratory distress syndrome

177

3.40

14.26

1.9

2.3

1.66

1.51

g/l

0.53

152

Rash and other nonspecific skin eruption

238

1396

1.75

14.21

1.7

1.8

1.58

1.54

g/l

0.21

203

1213

Other postsurgical states

152

776

2.02

14.20

1.5

1.7

1.56

1.54

g/l

0.08

136

664

Anterior Iridocyclitis

466

3192

1.48

14.17

1.9

1.7

1.51

1.53

g/l

0.15

401

2739

Clear cell adenocarcinoma of kidney

147

748

2.07

14.14

1.6

1.8

1.80

1.55

g/l

1.58

124

651

Lichen simplex chronicus and prurigo

165

869

1.96

14.13

1.7

1.8

1.65

1.54

g/l

0.84

137

759

Coxibs

830

3284

1.36

14.12

1.7

2.0

1.51

1.43

g/l

1.77

708

2802

Colon adenocarcinoma

343

2215

1.59

14.07

1.4

1.7

1.74

1.55

g/l

3.26

295

1881

Carcinoma in situ of skin of scalp and neck

430

2.47

14.03

1.9

1.8

1.34

1.52

g/l

1.27

377

Intentional self-harm by unspecified means

4.33

14.01

1.5

2.5

1.55

1.25

g/l

0.90

Excessive attrition of teeth

796

3194

1.37

14.01

1.6

1.7

1.43

1.50

g/l

1.21

679

2747

Memory loss

271

1657

1.69

14.01

1.7

1.8

1.54

1.53

g/l

0.09

222

1430

Other extrapyramidal and movement disorders in other diseases

549

3889

1.44

14.00

1.6

1.7

1.52

1.56

g/l

0.54

461

3323

Campylobacter enteritis

305

2.69

13.94

2.1

1.60

1.47

g/l

0.45

265

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

154

796

1.99

13.86

1.6

1.9

1.57

1.47

g/l

0.56

129

698

Follicular lymphoma

120

570

2.20

13.80

1.5

1.6

1.82

1.49

g/l

1.85

495

Hyperplasia of prostate

1047

4619

1.31

13.79

1.8

1.7

1.53

1.57

g/l

0.62

904

3946

Cyst of kidney

196

1104

1.84

13.68

2.0

1.7

1.67

1.53

g/l

1.25

170

949

Personal history of medical treatment

4.26

13.68

1.8

1.9

1.83

1.47

g/l

0.93

Wet age-related macular degeneration

513

3547

1.45

13.66

1.6

1.58

1.56

g/l

0.18

427

3002

Chronic laryngitis and laryngotracheitis

340

2203

1.58

13.59

1.7

1.66

1.57

g/l

0.81

283

1890

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

140

3.55

13.55

3.1

2.2

1.30

1.36

g/l

0.14

123

Speech and linguistic disorders, excluding more controls

145

693

2.01

13.51

1.9

2.1

1.58

1.28

g/l

2.71

125

601

Other and unspecified urticaria

396

2650

1.52

13.50

2.0

1.7

1.45

1.50

g/l

0.58

337

2267

Open wound of forearm

226

1327

1.75

13.47

1.9

1.7

1.48

1.51

g/l

0.21

187

1133

Presence of other devices

569

4080

1.42

13.46

1.8

1.6

1.55

1.60

g/l

0.68

495

3463

Migraine with aura

428

2908

1.49

13.44

1.7

1.9

1.45

1.42

g/l

0.25

374

2534

Superficial injury of abdomen, lower back and pelvis

335

2168

1.57

13.41

1.7

1.8

1.47

1.49

g/l

0.20

278

1878

Acute alcohol intoxication

599

4336

1.40

13.39

1.6

1.8

1.60

1.51

g/l

1.39

515

3725

Restrictive cardiomyopathy

6.23

13.39

2.3

1.8

1.38

1.53

g/l

0.28

Temporomandibular joint disorders

293

1836

1.62

13.36

1.5

1.8

1.47

1.48

g/l

0.04

249

1567

Carcinoma in situ of colon

201

3.17

13.34

1.9

1.68

1.53

g/l

0.65

175

Systemic sclerosis

283

2.72

13.33

2.0

1.8

1.50

1.53

g/l

0.08

247

Follow-up examination after treatment for malignant neoplasms

247

1489

1.70

13.31

1.6

1.5

1.71

1.57

g/l

1.11

207

1263

Disorders of muscles

230

1362

1.73

13.25

1.8

1.7

1.66

1.53

g/l

1.08

204

1164

Disorders of purine and pyrimidine metabolism

4.91

13.23

2.1

1.7

1.69

1.45

g/l

0.56

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

5.53

13.17

2.0

1.8

1.70

1.43

g/l

0.66

Maternal care for known or suspected abnormality of pelvic organs

366

1650

1.55

13.06

2.6

1.9

1.18

1.40

g/l

5.47

322

1424

Lung diseases due to external agents

384

2582

1.52

13.00

1.7

1.67

1.55

g/l

1.67

311

2181

Other noninfective disorders of lymphatic vessels and lymph nodes

401

2.39

13.00

1.7

1.8

1.77

1.56

g/l

0.87

347

Other epidermal thickening

121

590

2.13

12.98

1.5

1.9

1.51

1.52

g/l

0.06

108

509

Other arterial embolism and thrombosis

390

2.43

12.98

1.7

2.0

1.85

1.45

g/l

3.23

336

Other and unspecified injuries of head

156

831

1.94

12.94

1.4

1.9

1.49

1.55

g/l

0.36

128

715

Diseases of salivary glands

394

2658

1.50

12.94

2.0

1.6

1.55

g/l

0.01

344

2254

Right bundle-branch block

440

2.32

12.93

1.6

1.5

1.62

1.59

g/l

0.15

384

Focal epilepsy

486

3417

1.44

12.88

1.9

1.7

1.44

1.52

g/l

0.94

395

2941

Other disorders of eyelid

1114

8545

1.27

12.86

1.6

1.7

1.54

1.59

g/l

1.02

967

7225

Hallux valgus (acquired)

697

3735

1.36

12.86

1.6

1.7

1.55

g/l

0.01

593

3141

Other disorders of nervous system

172

949

1.87

12.81

1.8

1.64

1.55

g/l

0.64

146

822

Other specified and unspecified personality disorders

185

1040

1.82

12.78

1.6

1.9

1.66

1.48

g/l

1.46

164

901

Attention to artificial openings

110

521

2.20

12.77

1.5

1.6

1.71

1.43

g/l

2.49

460

Hyphaema and other vascular disorders of iris and ciliary body

267

2.76

12.76

1.8

2.0

1.80

1.52

g/l

1.41

234

Carcinoma in situ of skin of trunk

110

525

2.23

12.75

1.9

1.8

1.38

1.54

g/l

1.20

463

Pain associated with micturition

264

1639

1.65

12.70

2.2

1.7

1.45

1.54

g/l

0.84

225

1415

Pneumonitis due to solids and liquids

229

1375

1.72

12.69

1.6

1.7

1.77

1.51

g/l

3.31

189

1158

Cardiomyopathy in other diseases

5.15

12.68

1.4

1.8

1.30

1.79

g/l

1.99

Mental and behavioural disorders due to use of other stimulants, including caffeine

204

2.94

12.59

1.6

2.1

1.48

1.33

g/l

0.51

186

Conotruncal defects

108

3.83

12.57

2.6

2.4

1.01

1.21

g/l

0.83

Prurigo nodularis

316

2.58

12.56

1.6

1.9

1.57

1.52

g/l

0.16

277

Other and unspecified nonorganic psychotic disorders

351

2327

1.53

12.51

1.6

1.8

1.61

1.44

g/l

2.44

296

2018

Acute pharyngitis

264

1629

1.63

12.49

1.8

1.9

1.43

1.39

g/l

0.30

232

1417

Phobic anxiety disorders

220

1305

1.71

12.46

1.9

1.42

1.36

g/l

0.33

197

1138

Carpal tunnel syndrome

1372

10085

1.24

12.41

1.7

1.58

1.55

g/l

0.62

1194

8569

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

162

886

1.89

12.41

1.4

1.5

1.54

1.49

g/l

0.28

145

740

Myositis

342

2.49

12.40

1.4

1.8

1.73

1.54

g/l

1.00

293

Chronic sinusitis

936

7302

1.29

12.40

1.8

1.7

1.55

1.52

g/l

0.43

798

6264

Other psoriatic arthropathies

234

1421

1.69

12.33

1.5

1.7

1.65

1.56

g/l

0.61

195

1224

Primary gonarthrosis, bilateral

1285

9104

1.25

12.32

1.4

1.7

1.65

1.57

g/l

1.96

1077

7723

Other shoulder lesions

197

1141

1.76

12.31

1.7

1.8

1.59

1.55

g/l

0.21

177

974

Oter anti-inflammatory and antirheumatic agents, non-steroids

687

2820

1.37

12.30

1.7

1.8

1.57

1.49

g/l

1.42

585

2391

Open wound of abdomen, lower back and pelvis

324

2.51

12.28

1.9

2.2

1.66

1.42

g/l

1.29

288

Volvulus

319

2.53

12.26

3.0

1.9

1.63

1.47

g/l

0.57

277

severe traumatic brain injury, does not include concussion

580

4246

1.39

12.25

1.8

1.6

1.50

1.54

g/l

0.35

480

3612

Background retinopathy and retinal vascular changes

297

2.62

12.19

2.0

1.57

1.52

g/l

0.15

266

Other/unspecified reactive arthropathies

158

863

1.88

12.12

2.0

1.9

1.72

1.52

g/l

1.31

129

756

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

668

4984

1.35

12.10

1.7

1.8

1.51

1.43

g/l

1.35

572

4306

Enteropathic arthropathies

227

2.81

12.03

1.5

2.3

1.57

1.45

g/l

0.55

201

Other benign neoplasms of skin

889

6931

1.30

12.00

1.7

1.6

1.51

1.57

g/l

1.04

731

5918

Benign neoplasm: Kidney

385

2.36

11.93

2.3

1.7

1.56

1.48

g/l

0.33

328

Fall involving bed

451

2.27

11.93

1.6

1.8

1.61

1.60

g/l

0.01

388

Focal epilepsy, strict definition

449

3159

1.44

11.93

1.9

1.7

1.47

1.52

g/l

0.44

361

2714

Abnormality of red blood cells

5.00

11.93

1.6

2.4

1.53

1.49

g/l

0.06

Fracture of skull and facial bones

454

3199

1.44

11.92

1.7

1.8

1.49

1.52

g/l

0.28

394

2754

Redundant prepuce, phimosis and paraphimosis

449

3143

1.44

11.91

1.6

1.7

1.55

1.52

g/l

0.31

380

2682

Disorders of myoneural junction and muscle in diseases classified elsewhere

4.18

11.88

2.3

1.85

1.69

g/l

0.24

Benign neoplasm: Rectosigmoid junction

128

661

2.03

11.87

1.5

1.8

1.69

1.58

g/l

0.59

109

572

Disorders of conjunctiva

1789

12563

1.20

11.78

1.8

1.49

1.50

g/l

0.22

1556

10729

Panic disorder

257

1611

1.62

11.78

1.8

1.9

1.54

1.39

g/l

1.39

233

1400

Ulcerative ileocolitis

432

2.25

11.69

1.9

2.0

1.40

1.49

g/l

0.38

379

Use of disulfiram, acamprosate or naltrexone

190

1108

1.75

11.65

1.5

1.8

1.73

1.51

g/l

2.43

161

954

Striking against or struck by other objects

654

4903

1.35

11.65

1.8

1.49

1.48

g/l

0.04

561

4224

Recurring oral aphthae

115

573

2.08

11.65

2.1

2.0

1.32

1.52

g/l

1.41

505

Carcinoma in situ of skin of lower limb, including hip

324

2.53

11.63

1.6

1.8

1.40

1.60

g/l

1.32

286

Systemic sclerosis, icd10

297

2.55

11.62

2.0

1.9

1.52

1.56

g/l

0.12

260

Progressive vascular leukoencephalopathy

117

592

2.09

11.60

1.5

1.7

1.62

1.54

g/l

0.44

502

Fibromyalgia

158

873

1.85

11.58

1.6

1.8

1.49

1.53

g/l

0.20

137

757

Toxic liver disease

177

3.08

11.57

1.9

2.0

1.26

1.50

g/l

0.97

157

Rheumatic fever incl heart disease

101

482

2.19

11.56

2.4

1.9

1.35

1.53

g/l

0.86

418

Trigger finger

305

2001

1.55

11.56

1.7

1.44

1.56

g/l

1.57

270

1710

Nail disorders

181

1044

1.78

11.55

2.2

1.8

1.63

1.50

g/l

1.02

161

906

Malignant melanoma, excluding all cancers (controls excluding all cancers)

393

2718

1.47

11.53

1.8

1.6

1.48

1.54

g/l

0.58

336

2316

Other aneurysm

155

858

1.87

11.53

1.9

1.8

1.57

1.47

g/l

0.59

136

729

Spondylolisthesis/Spondylolysis

398

2757

1.47

11.52

1.8

1.7

1.63

1.58

g/l

0.54

355

2364

Other immunodeficiencies

101

3.82

11.46

2.0

2.5

1.20

1.51

g/l

1.07

Menorrhagia

723

3010

1.34

11.46

1.7

1.8

1.47

1.53

g/l

0.73

617

2546

Synovial cyst of popliteal space [Baker]

181

1048

1.77

11.46

1.8

1.7

1.49

1.59

g/l

0.70

155

893

Inflammatory diseases of female pelvic organs

1136

6874

1.25

11.42

1.7

1.8

1.48

1.49

g/l

0.15

958

5918

Internal derangement of knee

782

6014

1.31

11.41

1.6

1.7

1.52

1.50

g/l

0.25

653

5133

Pure hyperglyceridaemia

270

2.61

11.36

1.8

2.2

1.74

1.51

g/l

1.00

237

Varicose veins

1524

9545

1.22

11.36

1.7

1.6

1.59

1.57

g/l

0.27

1283

8078

Respiratory insufficiency

201

1198

1.72

11.35

1.6

1.5

1.70

1.50

g/l

2.06

170

1012

Assault by bodily force

139

743

1.91

11.33

1.8

2.0

1.49

1.43

g/l

0.33

121

645

Seborrhoeic keratosis

530

3877

1.39

11.29

1.8

1.6

1.48

1.58

g/l

1.92

471

3307

Rheumatic valve diseases

345

2.41

11.27

2.5

1.8

1.21

1.58

g/l

2.18

301

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

160

897

1.82

11.21

2.3

1.8

1.37

1.59

g/l

2.37

142

769

Eating disorders

188

1102

1.73

11.19

2.0

2.1

1.26

1.32

g/l

0.51

163

966

Infective dermatitis

266

1708

1.59

11.18

1.5

1.7

1.51

1.54

g/l

0.21

219

1483

Injuries to the neck

460

3288

1.42

11.16

1.7

1.8

1.52

1.47

g/l

0.43

399

2826

Other diseases of upper respiratory tract

2877

13061

1.15

11.08

1.8

1.7

1.54

1.52

g/l

0.53

2450

11146

Colorectal adenocarcinoma

530

3894

1.39

11.07

1.5

1.6

1.73

1.55

g/l

4.18

455

3308

Marfan's syndrome

5.24

11.05

1.6

1.9

1.18

1.41

g/l

0.40

Other follicular disorders

147

808

1.86

11.04

1.7

1.9

1.67

1.47

g/l

1.88

135

705

Speech disturbances, not elsewhere classified

224

1389

1.66

11.00

1.8

1.58

1.54

g/l

0.30

186

1189

Postprocedural musculoskeletal disorders, not elsewhere classified

178

1040

1.77

11.00

1.9

1.7

1.68

1.55

g/l

0.98

146

899

Congenital malformations of pulmonary and tricuspid valves

4.89

10.95

2.8

1.6

1.10

1.28

g/l

0.43

Extrapyramidal and movement disorders

904

7151

1.28

10.94

1.6

1.55

1.56

g/l

0.21

749

6089

Orthopaedic devices associated with adverse incidents

253

2.68

10.93

1.4

2.0

1.71

1.51

g/l

0.91

220

Coxarthrosis, primary, with hip surgery

1210

9369

1.24

10.91

1.5

1.6

1.63

1.58

g/l

1.17

1026

7926

Necrotizing fasciitis

5.26

10.89

1.3

1.4

1.81

1.58

g/l

0.50

Hypopituitarism

146

805

1.86

10.87

2.0

1.9

1.45

1.49

g/l

0.22

130

704

Conjunctivitis (acute, non atopic)

552

4068

1.37

10.86

2.0

1.7

1.52

1.51

g/l

0.09

496

3479

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

799

3704

1.31

10.82

1.5

1.64

1.51

g/l

2.95

679

3153

Benign neoplasm: Skin of eyelid, including canthus

327

2213

1.50

10.75

1.4

1.6

1.52

1.55

g/l

0.24

278

1891

Myocardial infarction, with ST-elevation

501

3669

1.39

10.70

1.6

1.68

1.54

g/l

2.62

428

3098

Other degenerative diseases of the nervous system

668

3848

1.33

10.61

1.5

1.7

1.56

g/l

0.05

521

3279

Septal defects

132

695

1.91

10.60

1.8

2.1

1.27

1.43

g/l

1.23

109

611

Personal history of certain other diseases

126

3.30

10.56

1.5

2.0

1.49

1.26

g/l

0.86

112

Other disorders of iris and ciliary body

362

2.32

10.52

1.7

2.0

1.77

1.54

g/l

1.20

321

Spontaneous rupture of synovium and tendon

194

1173

1.69

10.50

1.7

1.6

1.66

1.59

g/l

0.39

162

999

Early complications of trauma

106

535

2.05

10.42

2.0

1.70

1.53

g/l

0.91

464

!Aliquae complicationes praecoces traumatis

106

535

2.05

10.42

2.0

1.70

1.53

g/l

0.91

464

Diplopia

300

2010

1.52

10.41

1.6

1.7

1.61

1.55

g/l

0.51

251

1733

Acute suppurative otitis media

441

2950

1.41

10.41

2.0

1.9

1.40

1.36

g/l

0.34

385

2573

Other predominantly sexually transmitted diseases, not elsewhere classified

284

1878

1.53

10.34

1.8

1.9

1.40

1.42

g/l

0.11

241

1629

Sequelae of injuries, of poisoning and of other consequences of external causes

483

3528

1.39

10.34

1.6

1.8

1.63

1.54

g/l

1.41

413

3041

Congenital iodine-deficiency syndrome/hypothyroidism

417

2.20

10.30

1.9

1.7

1.56

1.52

g/l

0.12

360

Other disorders of optic [2nd] nerve and visual pathways

148

836

1.82

10.27

2.0

1.9

1.42

1.51

g/l

0.50

128

733

Ankylosing spondylitis, strict definition

449

2.13

10.24

1.3

2.0

1.51

1.48

g/l

0.09

388

Central retinal artery occlusion

368

2.31

10.23

1.7

1.9

1.55

1.52

g/l

0.10

320

Overexertion and strenuous or repetitive movements

213

1326

1.64

10.23

1.5

1.8

1.58

1.53

g/l

0.41

176

1152

Bronchiectasis

216

1354

1.64

10.23

1.6

1.7

1.63

1.53

g/l

0.86

184

1148

Other chondrocalcinosis

180

2.97

10.21

1.8

2.2

1.60

g/l

0.00

160

Malignant neoplasm of small intestine

317

2.41

10.20

1.3

2.0

1.58

g/l

0.01

280

Superficial injury of thorax

334

2295

1.48

10.19

1.8

1.7

1.41

1.51

g/l

1.14

287

1957

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

178

2.87

10.16

1.7

2.4

1.69

1.39

g/l

1.04

155

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

152

3.10

10.13

1.3

1.7

1.49

1.50

g/l

0.04

131

Organic, including symptomatic, mental disorders

1351

8090

1.22

10.11

1.5

1.6

1.61

1.57

g/l

0.84

1080

6910

Deficiency of other B group vitamins

280

2.48

10.09

1.7

1.8

1.40

1.51

g/l

0.40

249

Follow-up care involving plastic surgery

386

2.22

10.09

1.5

1.7

1.75

1.52

g/l

1.10

336

Drug-induced adrenocortical insufficiency

191

2.83

10.08

1.9

2.2

1.64

1.52

g/l

0.31

170

Blindness, monocular

106

3.59

10.05

1.8

2.4

1.69

1.55

g/l

0.24

Unspecified mental disorder

819

6460

1.28

10.05

1.6

1.8

1.62

1.49

g/l

3.76

699

5519

Leiomyoma of uterus

790

3457

1.30

10.04

1.7

1.52

1.53

g/l

0.06

665

2971

Complications of other internal prosthetic devices, implants and grafts

104

530

2.04

10.00

1.6

1.7

1.44

1.52

g/l

0.44

465

Eating disorder

141

789

1.81

9.91

2.2

2.3

1.16

1.21

g/l

0.32

121

689

Postzoster neuralgia

200

2.78

9.84

1.6

1.8

1.36

1.58

g/l

0.85

180

Otitis externa

454

3312

1.39

9.84

1.9

1.7

1.53

1.51

g/l

0.14

402

2844

Lesion of ulnar nerve

303

2058

1.50

9.82

1.6

1.7

1.57

1.54

g/l

0.22

267

1770

Benign neoplasm of mouth and pharynx

257

1691

1.55

9.77

1.5

1.7

1.55

g/l

0.04

209

1451

Congenital malformations of cardiac chambers and connections

5.39

9.76

2.2

2.3

1.04

1.08

g/l

0.06

CR(E)ST syndrome

166

2.94

9.76

2.0

2.1

1.48

1.63

g/l

0.50

143

Generalized anxiety disorder

251

1639

1.55

9.72

1.8

1.9

1.38

1.41

g/l

0.20

220

1426

Orchitis and epididymitis

238

1543

1.58

9.70

1.6

1.65

1.54

g/l

1.14

213

1332

Voice disturbances

567

4292

1.34

9.66

1.8

1.7

1.49

1.56

g/l

1.07

487

3667

Marginal zone B-cell lymphoma

104

3.58

9.65

3.5

2.0

1.62

1.50

g/l

0.22

Fracture of neck

155

906

1.77

9.64

1.8

1.55

1.53

g/l

0.09

133

786

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

239

1553

1.57

9.62

1.6

1.71

1.54

g/l

2.09

199

1335

Selective deficiency of immunoglobulin G [IgG] subclasses

4.28

9.59

2.7

2.2

1.56

1.52

g/l

0.06

Disorders of iron metabolism

151

3.02

9.59

1.6

2.4

1.22

1.47

g/l

0.89

131

Iridocyclitis in diseases classified elsewhere

220

2.64

9.55

1.5

2.2

1.38

1.47

g/l

0.30

193

Pemphigoid

418

2.17

9.55

2.0

1.9

1.49

1.55

g/l

0.22

367

Visual field defects

210

1329

1.62

9.54

1.6

1.7

1.56

1.53

g/l

0.18

184

1149

Cervicalgia

440

3211

1.39

9.53

1.7

1.50

1.55

g/l

0.43

373

2745

Benign neoplasm: Skin of trunk

449

2.09

9.52

1.9

1.8

1.50

1.47

g/l

0.12

392

Degenerative macular diseases

321

2227

1.47

9.46

1.6

1.62

1.57

g/l

0.43

274

1892

Lupus erythematosus

288

2.40

9.46

2.4

2.0

1.47

1.59

g/l

0.48

255

Macular pucker

386

2771

1.42

9.43

1.5

1.7

1.52

1.59

g/l

0.73

326

2376

Other and unspecified mood [affective] disorders

123

673

1.86

9.39

1.8

2.1

1.59

1.38

g/l

1.71

103

598

Benign neoplasm: Other and unspecified parts of small intestine

193

2.75

9.36

1.6

1.63

1.52

g/l

0.33

166

Asthma and allergy, excluding more controls

186

1127

1.65

9.36

1.6

1.8

1.53

1.32

g/l

3.09

167

960

Cushing syndrome

121

3.27

9.35

1.8

2.1

1.99

1.47

g/l

1.65

105

Restless leg syndrome

271

1822

1.52

9.32

1.7

1.47

1.54

g/l

0.71

231

1565

Trochanteric bursitis

279

1886

1.50

9.28

1.7

1.6

1.59

1.60

g/l

0.08

243

1593

Ingrowing nail

118

642

1.89

9.27

1.8

1.9

1.67

1.48

g/l

1.27

104

564

Other abnormal uterine and vaginal bleeding

484

2551

1.37

9.24

1.7

1.57

g/l

0.02

402

2145

Convalescence

108

572

1.94

9.20

1.8

1.7

1.53

1.49

g/l

0.18

505

Pain in thoracic spine

298

2043

1.48

9.20

2.0

1.7

1.50

1.52

g/l

0.11

254

1754

Ulcerative colitis (strict definition, all Crohn cases excluded)

287

1954

1.49

9.19

1.8

1.7

1.39

1.50

g/l

1.17

252

1693

Other disorders of amino-acid metabolism

4.81

9.18

7.0

2.6

0.89

1.54

g/l

2.62

Migraine with aura and triptan purchases

241

1581

1.54

9.18

1.6

1.9

1.55

1.42

g/l

1.01

202

1377

Conjunctivitis

1519

11206

1.19

9.17

1.8

1.49

g/l

0.07

1321

9599

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

109

582

1.93

9.13

1.5

1.6

1.68

1.52

g/l

1.21

503

Benign neoplasm of middle ear and respiratory system

173

1056

1.68

9.08

1.7

1.6

1.66

1.49

g/l

1.62

146

907

Injury of intra-abdominal organs

268

2.40

9.05

1.7

2.2

1.65

1.46

g/l

0.63

239

Other specified/unspecified soft tissue disorders

120

663

1.86

9.01

1.6

1.7

1.60

1.58

g/l

0.07

101

569

Follicular lymphoma, hilmo

120

666

1.87

9.00

1.5

1.9

1.82

1.56

g/l

1.28

577

Abdominal aortic aneurysm (AAA)

298

2043

1.48

8.96

1.8

1.7

1.67

1.50

g/l

2.26

255

1715

Other primary thrombocytopenia

5.15

8.92

2.1

1.25

1.41

g/l

0.28

Other symptoms and signs involving the urinary system

248

1654

1.53

8.91

1.7

1.56

1.54

g/l

0.15

210

1418

Leisure time condition

381

2750

1.41

8.90

1.7

1.49

1.52

g/l

0.26

327

2371

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

289

1988

1.48

8.88

1.6

1.5

1.74

1.54

g/l

2.55

251

1693

Schizophrenia or delusion

610

4717

1.30

8.86

1.5

1.8

1.70

1.49

g/l

5.57

513

4034

Status epilepticus

469

2.03

8.86

1.6

2.0

1.49

1.47

g/l

0.07

407

Benign neoplasm: Skin of other and unspecified parts of face

232

1526

1.55

8.86

2.4

1.6

1.54

1.52

g/l

0.10

181

1299

Acute and transient psychotic disorders

222

1446

1.56

8.81

1.7

1.8

1.66

1.51

g/l

1.48

186

1257

Focal epilepsy, mode (most common among epilepsy diagnosis)

407

2975

1.39

8.79

1.7

1.44

1.53

g/l

1.01

326

2561

Artificial joint re-operation

181

1131

1.65

8.78

1.5

1.7

1.75

1.57

g/l

1.35

148

977

Dementia in Alzheimer disease

270

3344

0.68

8.75

1.6

1.62

1.54

g/l

0.67

178

2826

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

132

3.11

8.75

1.9

1.6

2.01

1.49

g/l

1.55

113

Other and unspecified vascular occlusions

253

1705

1.52

8.72

1.7

1.54

1.55

g/l

0.09

210

1444

Other specified and unspecified retinal disorders

501

1.99

8.71

2.0

1.9

1.51

1.59

g/l

0.33

432

Other misadventures during surgical and medical care

255

2.43

8.70

1.8

2.1

1.74

1.47

g/l

0.93

224

Other disorders of eye and adnexa

275

1881

1.48

8.65

1.7

1.8

1.48

1.52

g/l

0.25

244

1622

Degeneration of nervous system due to alcohol

347

2.22

8.63

1.6

1.8

1.60

1.58

g/l

0.08

292

Lesion of lateral popliteal nerve

120

673

1.84

8.63

2.0

1.9

1.49

1.55

g/l

0.26

102

586

Necrobiosis lipoidica, not elsewhere classified

4.65

8.62

2.5

2.4

1.50

1.37

g/l

0.20

Nummular dermatitis

194

1236

1.61

8.61

1.6

1.7

1.61

1.52

g/l

0.66

164

1067

Disorders of optic nerve and visual pathways

193

1226

1.60

8.61

1.8

1.9

1.43

1.49

g/l

0.35

165

1072

conjunctival haemorrhage

187

1183

1.62

8.60

2.0

1.7

1.50

1.53

g/l

0.15

165

1017

Contact with heat and hot substances

113

622

1.86

8.59

1.8

2.0

1.36

1.50

g/l

0.87

539

Dental caries 2 and operation codes

1500

10131

1.18

8.54

2.1

1.8

1.39

1.50

g/l

4.34

1309

8731

Other specified and unspecified disorders of eye and adnexa

490

1.98

8.50

1.9

1.52

1.49

g/l

0.12

428

Viral infections of the central nervous system

151

906

1.70

8.49

1.7

1.8

1.50

1.52

g/l

0.08

128

792

Chorioretinal inflammation

342

2.19

8.43

1.7

2.0

1.58

1.57

g/l

0.03

294

Other erythematous conditions

430

2.05

8.40

1.5

2.0

1.38

1.52

g/l

0.79

374

Adhesive capsulitis of shoulder

362

2619

1.40

8.36

1.6

1.7

1.63

1.58

g/l

0.48

315

2214

Abnormal findings on antenatal screening of mother

108

589

1.86

8.35

1.9

2.0

1.16

1.19

g/l

0.14

516

Schizophrenia, schizotypal and delusional disorders

610

4759

1.29

8.31

1.6

1.8

1.70

1.49

g/l

5.46

513

4071

Acute lymphadenitis

114

635

1.83

8.31

2.0

1.53

1.51

g/l

0.08

108

554

Speech and linguistic disorders

147

842

1.70

8.31

1.9

2.1

1.59

1.30

g/l

2.72

127

740

Nonsuppurative otitis media

431

2761

1.36

8.30

2.3

2.0

1.46

1.37

g/l

1.25

379

2413

Other maternal disorders predominantly related to pregnancy

913

4657

1.24

8.27

2.1

1.8

1.32

1.50

g/l

6.86

788

4025

Benign neoplasm of urinary organs

122

698

1.81

8.26

2.1

1.9

1.56

1.53

g/l

0.15

103

606

Juvenile rheumatoid arthirtis

157

2.75

8.25

1.4

2.1

1.60

1.30

g/l

1.04

140

Other operation for atrial fibrillation

3.67

8.24

1.7

1.9

1.44

1.55

g/l

0.19

Ulcerative proctitis

122

696

1.79

8.23

1.6

1.9

1.60

1.48

g/l

0.64

105

607

Impacted cerumen

241

1628

1.51

8.21

1.5

1.7

1.56

1.52

g/l

0.24

186

1398

Faecal incontinence

193

1242

1.59

8.19

1.6

1.58

1.57

g/l

0.05

164

1057

Degeneration of the brain due to alcohol

355

2.17

8.16

1.6

1.9

1.60

1.57

g/l

0.11

301

Benign neoplasm: Anus and anal canal

340

2.17

8.16

1.6

1.8

1.63

1.51

g/l

0.41

291

Inguinal hernia

1439

8250

1.18

8.09

1.6

1.7

1.41

1.55

g/l

6.42

1211

7034

Postmenopausal bleeding

577

2439

1.31

8.06

1.6

1.7

1.61

1.62

g/l

0.03

489

2050

Migraine without aura

302

2128

1.43

8.05

1.8

1.9

1.31

1.38

g/l

0.68

252

1853

Twin gestation

120

684

1.78

8.04

2.5

1.8

1.10

1.42

g/l

4.04

108

582

Preterm labour and delivery

394

2904

1.37

8.03

2.5

1.8

1.22

1.54

g/l

10.26

337

2515

Vitamin D deficiency

172

2.67

8.01

1.9

2.5

1.45

1.46

g/l

0.01

152

Alcohol induced polyneuropathy

139

2.95

8.01

2.0

1.5

1.65

1.55

g/l

0.27

121

Melanocytic naevi, other sites/unspecified

144

867

1.69

8.00

2.3

1.7

1.36

1.47

g/l

0.86

136

747

Impetigo

395

2.05

7.99

2.3

2.1

1.27

1.40

g/l

0.79

347

Inflammatory disease of uterus

229

1534

1.51

7.99

1.9

1.8

1.44

1.46

g/l

0.09

195

1321

Other congenital malformations of skin

424

2.01

7.94

1.5

2.2

1.33

1.46

g/l

0.60

373

Other inflammation of eyelid

275

1916

1.46

7.93

1.8

1.61

1.54

g/l

0.52

228

1637

Chondrocostal junction syndrome [Tietze]

425

2.01

7.93

1.6

1.9

1.46

1.51

g/l

0.19

380

Mental and behavioural disorders due to cannabinoids

208

2.46

7.91

1.4

2.2

1.66

1.36

g/l

1.16

189

Embolic stroke

140

843

1.71

7.89

1.5

1.8

1.58

1.51

g/l

0.32

124

716

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

379

2.09

7.89

1.6

1.15

1.46

g/l

2.08

320

All dysplastic lesions of the vulva

439

1.99

7.89

2.5

1.9

1.59

1.55

g/l

0.16

383

Anorexia (incl.atypical)

111

623

1.81

7.88

2.0

2.1

1.29

1.35

g/l

0.32

548

Paraplegia, diplegia of upper limbs

273

2.29

7.87

1.8

1.79

1.50

g/l

1.29

239

Abnormal findings on diagnostic imaging of central nervous system

496

1.93

7.85

1.9

2.0

1.46

1.51

g/l

0.16

439

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1132

9299

1.20

7.82

1.8

1.7

1.57

1.53

g/l

0.69

952

7997

Event of undetermined intent

125

730

1.75

7.80

1.6

1.9

1.54

1.50

g/l

0.16

631

Haemorrhagic disorder due to circulating anticoagulants

176

2.68

7.80

1.5

1.6

1.80

1.67

g/l

0.37

160

Pediculosis, acariasis and other infestations

116

664

1.79

7.77

1.7

1.9

1.51

1.52

g/l

0.08

577

Other specified/unspecified inflammatory spondylopathies

490

1.92

7.76

1.8

2.0

1.45

1.47

g/l

0.07

425

Other bacterial agents as the cause of diseases classified to other chapters

119

3.05

7.72

2.2

1.67

1.54

g/l

0.33

102

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

315

2262

1.41

7.69

1.7

1.6

1.46

1.53

g/l

0.76

275

1926

Emphysema

192

1256

1.57

7.68

1.5

1.7

1.75

1.51

g/l

2.73

164

1060

Other/unspecified synovitis and tenosynovitis

240

1639

1.49

7.68

1.8

1.7

1.43

1.56

g/l

1.40

209

1391

Other general symptoms and signs

472

1.93

7.68

1.9

1.7

1.26

1.46

g/l

1.57

401

Medical treatment for female infertility

264

1828

1.45

7.65

2.1

2.0

1.13

1.31

g/l

3.16

244

1577

Dental caries 2

1525

10299

1.17

7.63

2.0

1.8

1.41

1.50

g/l

3.27

1326

8869

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

149

920

1.66

7.61

1.6

1.32

1.51

g/l

1.55

120

776

Multiple gestation

122

711

1.74

7.59

2.5

1.8

1.10

1.42

g/l

3.92

110

607

Fibroblastic disorders

552

4311

1.29

7.59

1.5

1.7

1.47

1.56

g/l

1.65

476

3642

Other congenital malformations of the digestive system

499

1.90

7.56

2.1

1.9

1.40

1.43

g/l

0.10

439

Intentional self-harm by sharp object

201

2.46

7.53

1.5

2.2

1.36

1.33

g/l

0.07

179

Cholera

526

1.88

7.50

1.8

1.7

1.41

1.61

g/l

1.03

462

Atopic dermatitis

990

7014

1.21

7.49

2.0

1.8

1.46

1.45

g/l

0.14

832

6065

Disorders of psychological development

183

1096

1.57

7.47

1.8

2.1

1.57

1.28

g/l

3.04

161

954

Atopic dermatitis, strict definition with reimbursement

485

3610

1.31

7.47

2.3

1.9

1.46

1.39

g/l

0.81

416

3146

Intrahepatic Cholestasis of Pregnancy (ICP)

546

1.84

7.46

2.2

1.9

1.14

1.36

g/l

1.47

470

Melanocytic naevi of lower limb, including hip

420

1.98

7.45

2.7

1.8

1.23

1.46

g/l

1.62

367

Other noninflammatory disorders of uterus, except cervix

464

2405

1.33

7.44

1.7

1.71

1.60

g/l

1.36

386

2022

Surgical ablation of atrial fibrillation

3.71

7.42

2.5

1.7

1.13

1.72

g/l

1.94

Mental disorders, not otherwise specified

148

915

1.64

7.42

1.9

2.0

1.35

1.43

g/l

0.50

129

801

Traction detachment of retina

111

3.10

7.42

2.7

2.3

1.70

1.45

g/l

0.81

Unspecified visual impairment (binocular)

174

2.60

7.37

1.3

2.3

1.48

1.59

g/l

0.27

156

Lung cancer and mesothelioma

431

2789

1.34

7.37

1.5

1.95

1.51

g/l

12.59

363

2339

Complications of genitourinary prosthetic devices, implants and grafts

307

2.17

7.37

2.0

1.8

1.86

1.56

g/l

1.59

267

Psychotic depression

125

742

1.72

7.36

1.7

1.9

1.57

1.47

g/l

0.56

110

643

Implicit parasitic Sepsis

4.16

7.35

3.0

2.0

1.60

1.45

g/l

0.26

Ectropion of eyelid

118

694

1.76

7.35

1.9

1.7

1.61

1.51

g/l

0.46

100

582

Primary coxarthrosis, bilateral

709

5732

1.25

7.33

1.6

1.63

1.58

g/l

0.55

607

4850

Fracture at wrist and hand level

683

5486

1.25

7.33

1.7

1.8

1.51

1.50

g/l

0.05

582

4696

Benign neoplasm: Oesophagus

128

2.89

7.32

1.9

1.8

1.30

1.61

g/l

1.16

111

Other abnormal immunological findings in serum

186

2.51

7.32

1.7

2.2

1.54

1.47

g/l

0.22

161

Seborrhoeic dermatitis

212

1429

1.51

7.31

1.6

1.7

1.62

1.53

g/l

0.65

179

1235

Agoraphobia

235

2.31

7.29

1.8

2.3

1.52

1.29

g/l

0.87

210

Other and unspecified erythematous conditions

390

2.02

7.28

1.5

2.0

1.40

1.52

g/l

0.60

341

Oesophageal obstruction

533

1.86

7.26

1.7

1.8

1.58

1.55

g/l

0.11

458

Other eating disorders

437

1.93

7.25

2.0

2.2

1.04

1.19

g/l

1.14

388

Ovarian cyst

700

3237

1.26

7.25

1.7

1.9

1.53

1.48

g/l

0.65

605

2760

Dislocation of lens

194

2.50

7.24

1.8

1.6

1.40

1.60

g/l

0.71

169

Other and unspecified injuries of lower leg

141

868

1.65

7.23

1.9

2.0

1.55

1.48

g/l

0.35

121

762

Benign neoplasm: Other and unspecified parts of mouth

384

2.01

7.21

1.7

1.55

1.52

g/l

0.14

332

Superficial injury of wrist and hand

354

2616

1.37

7.20

1.5

1.8

1.55

1.46

g/l

0.94

307

2246

Kela-code for severe mental illness

720

5833

1.24

7.18

1.5

1.8

1.68

1.49

g/l

5.34

612

4981

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

153

2.71

7.18

2.3

1.8

1.84

1.55

g/l

0.92

130

Other condition

271

1919

1.43

7.18

1.7

1.8

1.58

1.51

g/l

0.55

239

1659

Hidradenitis suppurativa

309

2.12

7.16

1.4

2.2

1.74

1.42

g/l

2.30

272

Follicular cysts of skin and subcutaneous tissue

373

2784

1.36

7.15

1.7

1.60

1.53

g/l

0.68

329

2397

Anogenital herpesviral [herpes simplex] infection

101

569

1.81

7.14

2.0

2.1

1.32

1.37

g/l

0.20

498

Infection due to other mycobacteria

177

2.55

7.11

2.2

1.8

1.63

1.60

g/l

0.07

150

Erythema intertrigo

299

2.16

7.08

1.7

1.8

1.67

1.52

g/l

0.59

265

Retinal haemorrhage

361

2.06

7.06

2.2

1.7

1.38

1.59

g/l

1.43

317

Melanocytic naevi of upper limb, including shoulder

227

2.33

7.04

1.7

1.9

1.34

1.45

g/l

0.47

199

Erythema nodosum

353

2.05

7.04

1.8

1.9

1.60

1.53

g/l

0.26

310

Autoimmune hyperthyroidism

102

579

1.79

7.04

1.8

1.5

1.48

1.53

g/l

0.25

498

Viral encephalitis, not elsewhere classified/unspecified

247

2.28

7.03

1.5

2.0

1.78

1.53

g/l

1.05

219

Cervical disc disorders

795

6528

1.23

7.01

1.7

1.55

g/l

0.00

658

5585

Post-traumatic wound infection, not elsewhere classified

293

2.16

7.00

1.7

2.0

1.67

1.44

g/l

1.08

262

Other disorders of patella

292

2101

1.40

7.00

1.6

1.7

1.64

1.45

g/l

2.34

254

1776

Acetic acid derivatives and related substances

774

3269

1.24

6.99

1.8

1.9

1.50

1.43

g/l

1.18

660

2790

Other surgical follow-up care

326

2.08

6.99

1.9

1.7

1.46

1.44

g/l

0.07

291

Exposure to other and unspecified inanimate mechanical forces

134

823

1.66

6.97

1.6

1.9

1.49

1.51

g/l

0.10

113

719

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

369

2.00

6.89

1.7

2.2

1.58

1.47

g/l

0.41

327

Neuroendocrine tumor and carcinoma of small intestine

187

2.50

6.87

1.3

2.0

1.49

1.53

g/l

0.10

167

Cysts of oral region, not elsewhere classified

526

1.83

6.87

1.5

1.8

1.46

1.50

g/l

0.17

451

Somnolence, stupor and coma

103

593

1.78

6.86

1.6

1.9

1.60

1.53

g/l

0.31

517

Benign neoplasm: Other and unspecified parts of small intestine

225

2.34

6.84

1.6

1.9

1.63

1.55

g/l

0.23

196

Toxic effects of substances chiefly nonmedicinal as to source

222

1530

1.47

6.84

1.7

1.8

1.53

1.49

g/l

0.25

191

1334

Other female pelvic inflammatory diseases

293

2121

1.40

6.83

1.6

1.7

1.62

1.57

g/l

0.29

241

1808

Disorders of ocular muscles, binocular movement, accommodation and refraction

901

7442

1.21

6.82

1.8

1.50

1.47

g/l

0.46

770

6397

Disorders of orbit

513

1.84

6.81

1.9

1.55

1.51

g/l

0.12

447

Other and specified injuries of hip and thigh

304

2.13

6.80

1.4

1.9

1.66

1.54

g/l

0.42

270

Systemic sclerosis,strict definition

3.22

6.79

2.0

2.1

1.80

1.62

g/l

0.37

Outcome of delivery

200

822

1.52

6.78

2.0

1.9

1.13

1.44

g/l

5.69

172

705

Other acute viral hepatitis

122

2.84

6.76

1.7

2.3

1.64

1.40

g/l

0.59

110

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

128

782

1.66

6.75

2.0

1.9

1.21

1.46

g/l

2.42

110

674

Focal brain injury

150

955

1.60

6.75

1.7

1.48

1.50

g/l

0.10

126

817

Arthropathy in ulcerative colitis

128

2.79

6.73

1.6

2.3

1.64

1.46

g/l

0.68

108

Corneal ulcer

352

2630

1.35

6.72

1.8

1.7

1.50

g/l

0.05

296

2268

Manic episode

304

2.10

6.71

1.8

2.2

1.45

1.40

g/l

0.14

268

Superficial injury of shoulder and upper arm

231

1611

1.46

6.70

1.6

1.8

1.53

1.51

g/l

0.11

188

1392

Unspecified event, undetermined intent

265

2.18

6.68

1.6

2.2

1.55

1.40

g/l

0.38

238

Sequelae of injuries of lower limb

184

1228

1.52

6.68

1.6

1.8

1.62

1.55

g/l

0.43

154

1066

Asthma and allergy

186

1225

1.51

6.67

1.6

1.8

1.53

1.34

g/l

2.72

167

1043

Other keratitis

214

1474

1.47

6.63

2.1

1.8

1.63

1.50

g/l

0.99

185

1277

Other/unspecified crystal arthropathies

3.38

6.57

1.8

1.9

1.60

1.62

g/l

0.03

Other disorders of conjunctiva

321

2378

1.37

6.57

1.9

1.7

1.50

1.58

g/l

0.77

280

2032

569

4305

1.27

6.55

1.6

1.53

1.57

g/l

0.58

473

3641

Other and unspecified mononeuropathies, also in other diseases

391

1.96

6.55

1.6

1.9

1.64

1.58

g/l

0.24

335

Symptoms and signs involving emotional state

287

2.11

6.53

1.9

2.1

1.36

1.47

g/l

0.38

249

Other and unspecified follicular disorders

455

1.87

6.52

1.9

2.0

1.63

1.47

g/l

0.78

395

Injuries to the wrist and hand

2219

14330

1.13

6.51

1.7

1.8

1.52

1.51

g/l

0.27

1922

12256

malignant neoplasm of male genital organs

1144

6184

1.19

6.51

1.6

1.7

1.63

1.53

g/l

2.66

968

5261

Palmar fascial fibromatosis [Dupuytren]

400

3064

1.32

6.51

1.5

1.6

1.43

1.56

g/l

2.50

340

2591

Social phobias

122

744

1.66

6.49

2.1

1.9

1.37

1.35

g/l

0.07

107

653

Other secondary gonarthrosis

124

764

1.67

6.47

1.5

1.8

1.75

1.57

g/l

1.34

103

659

Suppurative and unspecified otitis media

636

4553

1.25

6.46

1.9

1.40

g/l

0.00

553

3934

Burns and corrosions

263

1890

1.41

6.44

1.5

1.8

1.51

1.48

g/l

0.24

216

1631

Asthma and opportunity respiratory infection

120

736

1.68

6.42

1.5

1.7

1.77

1.55

g/l

1.87

633

Otitis externa, unspecified

206

1419

1.47

6.40

2.0

1.8

1.40

1.48

g/l

0.67

187

1229

Diseases of tongue

133

836

1.62

6.36

1.6

1.7

1.57

1.51

g/l

0.28

114

705

Calculus of kidney and ureter

706

5796

1.23

6.34

1.8

1.7

1.54

g/l

0.02

614

4941

Guillain-Barre syndrome

200

2.36

6.33

1.6

2.2

1.61

1.53

g/l

0.24

174

Sacroiliitis, not elsewhere classified

451

1.85

6.33

1.7

2.1

1.64

1.38

g/l

1.26

394

Antenatal screening

279

1124

1.41

6.32

2.0

1.8

1.20

1.48

g/l

5.83

248

976

Colonic or urogenital fistula

567

4548

1.26

6.31

1.9

1.7

1.59

1.54

g/l

0.50

480

3878

Blepharochalasis

656

5349

1.24

6.31

1.5

1.6

1.54

1.61

g/l

1.16

568

4532

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

147

949

1.58

6.29

1.4

1.6

2.01

1.51

g/l

4.85

128

811

Cramp and spasm

579

1.75

6.27

1.6

1.9

1.46

1.49

g/l

0.13

501

Benign neoplasm: Tongue

306

2.06

6.27

1.8

1.6

1.61

1.49

g/l

0.45

264

Dislocation, sprain and strain of joint and ligaments of hip

521

1.80

6.26

1.7

2.0

1.49

1.54

g/l

0.21

459

Cerebral palsy

121

2.73

6.24

1.9

2.8

1.19

1.21

g/l

0.06

105

Adenocarcinoma and Papillary adenocarcinoma of kidney

159

2.56

6.21

1.9

2.01

1.51

g/l

1.47

137

Retinal detachment with retinal break

297

2195

1.37

6.21

1.9

1.7

1.47

1.58

g/l

1.21

260

1875

Carbimazole or st.post thyroidectomy, condition for graves disease

380

2906

1.32

6.20

1.8

1.7

1.53

1.55

g/l

0.17

327

2481

Pneumothorax

170

1137

1.53

6.20

1.7

1.68

1.50

g/l

1.34

144

968

Complications of the puerperium, not elsewhere classified

299

2.04

6.20

3.3

2.1

0.97

1.33

g/l

3.69

260

All dysplastic lesions of the vagina

240

2.19

6.18

2.1

1.41

1.53

g/l

0.41

210

Car occupant injured in noncollision transport accident

398

1.91

6.18

2.3

2.1

1.44

1.41

g/l

0.08

350

Benign neoplasm: Kidney

494

1.82

6.18

2.3

1.9

1.56

1.51

g/l

0.21

436

Oral leukoplakia and related diseases

134

853

1.61

6.15

1.6

1.8

1.42

1.58

g/l

1.12

119

744

Bullous pemphigoid

331

2.03

6.14

1.4

2.0

1.54

1.60

g/l

0.19

294

Hyperhidrosis

247

2.15

6.12

1.8

1.23

1.43

g/l

0.83

213

Other and unspecified visual disturbances

190

1302

1.48

6.11

1.9

1.8

1.47

1.55

g/l

0.65

168

1131

Urolithiasis

770

6401

1.21

6.10

1.7

1.53

g/l

0.00

669

5454

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

128

805

1.61

6.06

2.0

1.9

1.21

1.35

g/l

1.04

110

700

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

583

1.72

6.05

2.2

2.0

1.14

1.26

g/l

0.62

511

Other maltreatment syndromes

303

2.03

6.02

1.8

1.9

1.39

1.48

g/l

0.26

267

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

990

8268

1.18

6.02

1.7

1.8

1.48

1.50

g/l

0.14

852

7100

Hyperaldosteronism

375

1.93

6.00

1.7

2.0

1.58

1.57

g/l

0.01

324

Anorexia

142

2.56

5.98

1.4

2.2

1.39

1.41

g/l

0.04

119

N06DA Anticholinesterases

612

6061

0.81

5.97

1.4

1.6

1.62

1.57

g/l

0.74

483

5115

Use of anticholinesterases

612

6061

0.81

5.97

1.4

1.6

1.62

1.57

g/l

0.74

483

5115

Haemangioma and lymphangioma, any site

154

1016

1.54

5.94

1.5

1.7

1.47

1.51

g/l

0.17

140

875

Diseases of middle ear and mastoid

1131

7951

1.17

5.94

2.1

1.8

1.42

1.46

g/l

0.66

972

6819

Other puerperal infections

107

647

1.68

5.93

2.9

2.1

1.24

1.25

g/l

0.02

563

Hypertrophic disorders of skin

101

603

1.71

5.91

1.9

2.0

1.37

1.47

g/l

0.45

533

Other disorders starting during childhood or adolecense, excluding more controls

326

1.95

5.91

2.0

2.1

1.27

1.10

g/l

0.83

285

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

578

4683

1.24

5.89

1.8

1.7

1.50

1.52

g/l

0.23

497

4012

Panniculitis, unspecified

114

2.77

5.89

1.6

1.7

1.39

1.53

g/l

0.40

Disorders of optic nerve, not elsewhere classified

287

2.07

5.88

2.1

1.49

1.52

g/l

0.08

255

Carcinoma in situ of skin of lip

4.61

5.87

2.7

2.0

1.76

1.57

g/l

0.36

Metatarsalgia

176

1197

1.49

5.87

1.6

1.7

1.62

1.57

g/l

0.29

148

1024

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

546

1.75

5.86

1.4

1.7

1.95

1.51

g/l

2.52

473

Burns and corrosions of external body surface, specified by site

207

1453

1.44

5.86

1.5

1.8

1.51

1.50

g/l

0.07

170

1261

Left hemicolectomy

372

1.93

5.85

1.5

1.9

1.69

1.57

g/l

0.49

327

Other specified/unspecified disorders of bone/cartilage

328

1.98

5.85

1.7

2.0

1.45

1.59

g/l

0.63

289

LSIL lesion of the vulva

266

2.08

5.82

2.9

2.1

1.35

1.49

g/l

0.52

236

Mantle cell lymphoma

140

2.62

5.79

1.5

1.7

1.62

1.54

g/l

0.14

123

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

173

1177

1.50

5.78

1.5

1.7

1.60

1.54

g/l

0.39

154

1005

Other and unspecified rosacea

163

1097

1.51

5.76

1.5

1.8

1.52

1.54

g/l

0.12

144

949

Oral leukoplakia and related diseases, including avohilmo

190

1320

1.47

5.74

1.6

1.8

1.50

1.56

g/l

0.34

166

1145

Neuralgia and neuritis, unspecified

101

609

1.69

5.73

1.7

1.8

1.67

1.52

g/l

0.84

527

Cerebral cysts

110

678

1.65

5.73

2.0

1.25

1.44

g/l

1.38

597

Acne

147

966

1.54

5.73

2.3

2.1

1.28

1.25

g/l

0.16

133

843

Other and unspecified epidermal thickening

338

1.96

5.72

1.3

2.2

1.55

1.52

g/l

0.10

302

Superficial injury of forearm

178

1220

1.48

5.72

1.8

1.9

1.42

1.45

g/l

0.20

154

1064

Other symptoms and signs involving general sensations and perceptions

505

1.77

5.71

1.6

1.9

1.42

1.56

g/l

0.73

437

Other mental disorders due to brain damage and dysfunction and to physical disease

278

2064

1.37

5.71

1.5

1.7

1.55

1.52

g/l

0.22

226

1773

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

104

633

1.68

5.70

1.6

1.5

1.97

1.51

g/l

2.69

527

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

220

1571

1.42

5.70

1.6

1.5

1.70

1.53

g/l

1.68

189

1346

Papilloedema, unspecified

242

2.13

5.69

2.3

2.4

1.33

1.41

g/l

0.21

213

Idiopathic pulmonary fibrosis

202

1425

1.45

5.69

1.7

1.62

1.52

g/l

0.82

165

1201

Other factor of the environment

140

2.55

5.68

1.3

2.1

1.90

1.42

g/l

1.78

121

Radiculopathy

366

2824

1.31

5.67

1.8

1.7

1.62

1.57

g/l

0.46

314

2405

Thyroiditis

132

852

1.58

5.67

1.7

1.8

1.54

1.52

g/l

0.07

110

742

Antepartum haemorrhage, not elsewhere classified

107

655

1.65

5.66

2.4

1.9

1.28

1.37

g/l

0.47

569

Congenital malformations of great arteries

186

2.29

5.66

1.6

2.1

1.31

1.33

g/l

0.05

162

Other nonscarring hair loss

3.13

5.65

1.9

2.0

1.47

1.42

g/l

0.09

Superficial injury of ankle and foot

196

1371

1.45

5.64

1.7

1.9

1.50

1.43

g/l

0.54

175

1190

Specific development disorders of speech and language

100

580

1.69

5.63

1.7

2.0

1.76

1.35

g/l

3.05

512

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

319

1.98

5.63

1.5

1.70

1.51

g/l

0.97

278

Blood alcohol or alcohol intoxication level

243

2.12

5.61

1.8

2.1

1.36

1.44

g/l

0.27

215

Disorders of lysine and hydroxylysine metabolism

+∞

5.59

21.8

0.0

0.47

—

g/l

—

Other and unspecified nonscarring hair loss

3.66

5.57

1.7

2.2

1.51

1.39

g/l

0.22

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

272

2.06

5.56

1.5

1.6

1.89

1.50

g/l

2.19

232

Enthesopathies of lower limb, excluding foot

409

3207

1.29

5.56

1.7

1.52

1.53

g/l

0.07

347

2746

Malignant neoplasm of stomach

131

851

1.58

5.55

1.4

1.8

1.51

1.54

g/l

0.15

117

726

Allergic conjunctivitis

1032

8721

1.17

5.55

1.8

1.48

1.49

g/l

0.11

886

7504

Chondropathies

289

2164

1.35

5.53

1.5

1.8

1.49

1.50

g/l

0.03

248

1883

Other prurigo

130

2.59

5.52

1.5

2.0

1.53

1.44

g/l

0.20

114

Dissociative [conversion] disorders

348

1.90

5.52

1.5

2.0

1.63

1.38

g/l

1.32

305

Injuries involving multiple body regions

421

1.82

5.51

1.5

2.1

1.69

1.46

g/l

1.10

372

Other and unspecified iridocyclitis

518

1.74

5.50

2.1

1.9

1.51

1.47

g/l

0.18

452

Benign neoplasm: Skin of ear and external auricular canal

511

1.75

5.50

1.9

1.7

1.28

1.52

g/l

1.98

437

Benign neoplasm: Oesophagus

149

2.47

5.48

1.9

1.8

1.30

1.52

g/l

0.74

127

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

246

2.11

5.48

1.5

1.6

1.56

1.48

g/l

0.29

210

Hydrocele

295

2223

1.35

5.47

2.1

1.6

1.41

1.53

g/l

1.59

250

1901

Other bullous disorders

358

1.90

5.47

2.0

1.28

1.47

g/l

0.95

319

Prepatellar bursitis

603

1.68

5.45

1.6

1.7

1.67

1.52

g/l

0.69

511

Secondary parkinsonism, excluding more controls

337

1.93

5.44

1.4

1.8

1.59

1.55

g/l

0.12

288

Other bursitis of elbow

102

2.82

5.42

3.3

1.9

1.40

1.52

g/l

0.25

Varicella [chickenpox]

482

1.76

5.42

2.9

2.1

1.37

1.42

g/l

0.19

415

Benign neoplasm: Liver/bile ducts

213

2.17

5.41

1.9

1.51

1.44

g/l

0.19

184

Migraine without aura and triptan purchases

224

1615

1.40

5.41

1.7

2.0

1.33

1.40

g/l

0.60

183

1407

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

469

1.77

5.38

2.0

1.6

1.63

1.49

g/l

0.64

405

Otalgia

144

959

1.53

5.38

1.5

1.9

1.48

1.52

g/l

0.18

116

836

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

326

2451

1.32

5.37

1.7

1.6

1.75

1.62

g/l

1.18

257

2078

Panniculitis affecting regions of neck and back

469

1.77

5.37

2.3

2.0

1.54

1.52

g/l

0.07

405

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

212

1522

1.42

5.36

1.6

1.5

1.70

1.53

g/l

1.50

182

1305

Benign neoplasm of ovary

289

2176

1.34

5.34

1.8

1.6

1.59

1.61

g/l

0.13

250

1851

Polyp of the female genital tract

591

2801

1.24

5.34

1.7

1.55

1.56

g/l

0.05

505

2366

Rosacea

210

1505

1.41

5.33

1.6

1.8

1.51

1.53

g/l

0.12

182

1297

Other bursitis of hip

249

2.08

5.32

1.6

1.7

1.47

1.51

g/l

0.11

216

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

494

1.75

5.31

3.2

1.9

1.56

1.52

g/l

0.11

437

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

289

1.97

5.31

2.7

2.1

1.26

1.30

g/l

0.11

255

Ptosis of eyelid

246

1814

1.38

5.31

1.4

1.7

1.55

g/l

0.01

212

1546

Other specified/unspecified dorsopathies

434

1.79

5.30

1.5

1.8

1.46

1.57

g/l

0.48

370

False labour

365

1766

1.31

5.30

2.0

1.09

1.36

g/l

10.75

319

1529

Melanocytic naevi of upper limb, including shoulder

256

2.06

5.30

1.7

2.1

1.34

1.50

g/l

0.79

224

Other hearing loss

686

5628

1.21

5.28

1.8

1.6

1.51

1.59

g/l

1.30

568

4788

Hypertrophic scar

546

1.70

5.28

1.9

2.0

1.40

1.45

g/l

0.17

482

Disorders of speech understanding and production

426

1.79

5.25

1.8

2.0

1.77

1.36

g/l

2.39

370

Hyperfunction of pituitary gland

464

1.75

5.24

1.6

2.0

1.51

1.45

g/l

0.18

409

Haemangioma, any site

143

957

1.52

5.22

1.5

1.7

1.49

1.50

g/l

0.04

129

827

Monoarthritis, not elsewhere classified

503

1.73

5.22

1.6

1.9

1.84

1.46

g/l

1.63

431

Other infective otitis externa

124

807

1.57

5.19

2.1

1.9

1.62

1.51

g/l

0.72

111

704

Benign neoplasm: Skin of trunk

550

1.69

5.19

1.9

1.50

1.51

g/l

0.05

482

HSIL lesion of the vagina

128

2.52

5.16

1.7

2.4

1.55

1.51

g/l

0.07

112

Abrasion of teeth

479

2827

1.25

5.16

1.7

1.6

1.47

1.53

g/l

0.62

409

2419

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

122

2.55

5.14

1.3

2.7

1.79

1.44

g/l

0.92

107

Injury of other and unspecified intrathoracic organs

141

946

1.52

5.14

1.6

1.8

1.69

1.50

g/l

1.30

123

811

Carcinoma in situ of other and unspecified genital organs

153

2.37

5.13

1.6

2.0

1.79

1.53

g/l

0.60

136

Bronchitis, not specified as acute or chronic

182

1282

1.44

5.12

1.8

1.6

1.36

1.53

g/l

1.79

150

1076

Viral agents as the cause of diseases classified to other chapters

246

2.06

5.10

1.6

2.2

1.58

1.46

g/l

0.44

214

HSIL lesion of the cervix uteri, vagina or vulva

264

1974

1.35

5.10

2.2

1.9

1.49

1.38

g/l

0.92

225

1716

Corneal scars and opacities

345

1.89

5.09

1.9

2.0

1.51

1.56

g/l

0.13

304

Other enthesopathy of foot (+metatarsalgia)

184

1300

1.43

5.08

1.6

1.7

1.61

1.57

g/l

0.23

156

1112

Other menopausal disorders

298

2252

0.76

5.05

1.7

1.53

1.59

g/l

0.48

253

1908

Dermatopolymyositis, unspecified

3.46

5.04

1.6

1.17

1.63

g/l

1.94

Noninflammatory disorders of female genital tract

806

3414

1.19

5.04

1.9

1.42

1.46

g/l

0.70

701

2911

Traumatic subarachnoid haemorrhage

494

1.72

5.04

1.8

1.48

1.55

g/l

0.26

425

Sleep disorders, other/unspecified

302

1.93

5.04

1.4

2.2

1.46

1.41

g/l

0.17

264

Alzheimer’s disease (Early onset)

764

0.47

5.02

1.3

1.6

1.66

1.55

g/l

0.21

639

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

2.88

5.01

1.5

1.6

2.04

1.55

g/l

1.21

Protein-energy malnutrition of moderate and mild degree

107

2.69

4.96

1.4

1.9

1.35

1.55

g/l

0.50

Erectile dysfunction

223

1642

1.39

4.95

1.9

1.7

1.53

1.54

g/l

0.08

187

1408

Oligomenorrhoea

340

1.86

4.93

2.2

2.0

1.22

1.41

g/l

0.90

302

Melanoma in situ

560

1.67

4.90

2.2

1.6

1.43

1.51

g/l

0.40

478

Family history of certain disabilities and chronic diseases leading to disablement

355

1.83

4.89

2.0

2.1

1.20

1.38

g/l

1.05

313

Car occupant injured in other and unspecified transport accidents

336

2620

1.29

4.84

1.9

1.8

1.54

1.48

g/l

0.59

291

2255

Lesion of radial nerve

477

1.72

4.83

1.6

1.9

1.47

1.56

g/l

0.38

407

Glaucoma

1352

10496

1.14

4.83

1.6

1.55

1.57

g/l

0.40

1129

8908

Other/unspecified disorders of vestibular function

531

1.68

4.83

1.6

1.9

1.64

1.53

g/l

0.53

463

Carcinoma in situ of vulva

3.10

4.83

1.3

2.2

2.15

1.71

g/l

0.67

Ulcerative rectosigmoiditis

151

1040

1.47

4.81

1.8

1.54

1.51

g/l

0.12

137

917

Other disorders of pigmentation

554

1.66

4.81

1.8

1.9

1.51

1.54

g/l

0.07

479

Other and unspecified glaucoma

172

1218

1.44

4.80

1.5

1.7

1.67

1.53

g/l

1.28

145

1041

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

141

959

1.49

4.79

1.9

1.6

1.56

1.53

g/l

0.14

121

822

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

389

1.80

4.79

1.7

1.6

1.78

1.53

g/l

1.11

333

Exfoliative dermatitis

146

2.38

4.79

1.5

2.3

1.63

1.50

g/l

0.30

129

Vulvovaginal ulceration/inflammation in other diseases

538

1.66

4.78

1.9

2.2

1.32

1.39

g/l

0.22

475

Allergic urticaria

144

985

1.48

4.76

1.7

1.9

1.57

1.49

g/l

0.56

129

863

Viral meningitis

352

1.83

4.74

2.0

2.1

1.35

1.39

g/l

0.14

314

Ocular pain

140

954

1.49

4.72

1.8

1.9

1.44

1.50

g/l

0.35

124

829

Carcinoma in situ of vulva

3.05

4.71

1.3

2.6

2.15

1.55

g/l

1.00

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

2.75

4.69

1.4

1.8

1.80

1.43

g/l

0.84

Disorders of vestibular function (Vertigo)

1017

8792

1.16

4.69

1.6

1.7

1.54

1.57

g/l

0.58

855

7462

Carcinoma in situ of skin of lip

3.85

4.68

2.7

2.1

1.76

1.66

g/l

0.17

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

5.33

4.68

1.5

1.8

1.46

1.76

g/l

—

Other and unspecified paralytic syndromes

160

2.27

4.68

1.8

2.4

1.10

1.51

g/l

1.88

143

Hyperkinetic disorders, excluding more controls

112

708

1.55

4.66

1.8

2.2

1.25

1.16

g/l

0.48

615

Inflammatory disorders of male genital organs, not elsewhere classified

187

2.18

4.66

1.6

1.8

1.50

g/l

0.01

164

Biomechanical lesions, not elsewhere classified

103

661

1.59

4.66

1.7

1.8

1.45

1.53

g/l

0.41

573

Other and unspecified abdominal hernia

583

1.63

4.65

1.5

1.8

1.65

1.58

g/l

0.30

508

Other secondary coxarthrosis

460

1.72

4.65

1.5

2.0

1.65

1.55

g/l

0.41

401

Malignant neoplasm of prostate

1108

6111

1.15

4.64

1.5

1.7

1.64

1.53

g/l

2.86

933

5197

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

249

1877

1.34

4.61

1.8

1.9

1.34

1.44

g/l

0.83

211

1613

Separation of retinal layers (serosa)

522

1.67

4.60

2.1

1.9

1.48

1.58

g/l

0.45

448

Benign neoplasm: Larynx

371

1.80

4.60

1.5

1.6

1.74

1.51

g/l

1.05

318

Malignant neoplasm of bronchus and lung

311

3712

0.78

4.60

1.4

1.6

1.99

1.56

g/l

8.81

257

3121

Hallux rigidus

264

2012

1.33

4.57

1.5

1.7

1.48

1.58

g/l

0.98

226

1704

Impotence

134

915

1.50

4.57

1.6

1.44

1.54

g/l

0.68

116

783

Maltreatment syndromes

476

1.68

4.55

1.6

2.0

1.56

1.40

g/l

0.90

418

Toxic effect of other and unspecified substances

2.61

4.54

1.5

2.0

1.72

1.35

g/l

1.29

Lack of expected normal physiological development

111

2.39

4.53

2.8

2.2

1.04

1.11

g/l

0.18

Other disorders of penis

209

1543

1.37

4.53

1.6

1.7

1.61

1.53

g/l

0.54

173

1327

Senility

105

2.56

4.52

1.5

1.4

1.58

1.60

g/l

0.03

Benign neoplasm: Skin of eyelid, including canthus

327

2570

1.29

4.52

1.4

1.7

1.52

1.57

g/l

0.47

278

2190

Urethral stricture

146

1016

1.47

4.51

1.4

1.7

1.67

1.48

g/l

1.67

123

865

Golimumab

279

1.90

4.46

1.6

2.1

1.60

1.49

g/l

0.31

249

Benign neoplasm of middle ear and respiratory system

173

1242

1.42

4.46

1.7

1.8

1.66

1.52

g/l

1.18

146

1068

Thyrotoxicosis with toxic multinodular goitre

128

871

1.50

4.43

1.5

1.7

1.70

1.58

g/l

0.85

108

746

Schizoaffective disorder

126

853

1.50

4.41

1.4

1.9

1.73

1.51

g/l

1.99

741

Superficial injuries involving multiple body regions

281

1.90

4.40

1.6

2.1

1.62

1.42

g/l

0.67

250

Contact with other hot metals

171

2.18

4.39

1.7

1.8

1.43

1.45

g/l

0.04

148

Acne vulgaris

110

724

1.54

4.38

2.3

2.1

1.33

1.24

g/l

0.47

633

Parkinson's disease, excluding more controls

316

2420

1.29

4.37

1.5

1.6

1.58

1.56

g/l

0.13

261

2057

HSIL lesion of the vulva

178

2.15

4.37

1.6

2.4

1.82

1.53

g/l

0.85

160

Complications peculiar to reattachment and amputation

2.72

4.37

2.5

1.8

2.14

1.62

g/l

0.87

Behavioural disorders, excluding more controls

125

2.36

4.36

1.8

2.3

1.68

1.21

g/l

1.31

114

Other salmonella infections

461

1.68

4.34

1.7

1.9

1.79

1.52

g/l

1.09

402

Use of donepezil

338

4072

0.79

4.33

1.5

1.6

1.62

1.55

g/l

0.58

270

3425

Burn and corrosion of trunk

356

1.79

4.33

1.5

2.1

1.49

1.52

g/l

0.08

311

Other specified/unspecified spondylopathies

372

1.77

4.31

1.5

1.8

1.50

1.54

g/l

0.13

324

Sequelae of injuries of head

101

657

1.57

4.31

1.6

1.9

1.70

1.53

g/l

0.80

567

Parkinson's disease, strict definition, excluding more controls

294

2251

1.30

4.29

1.5

1.6

1.54

1.56

g/l

0.13

242

1916

Atopic dermatitis, strict definition

445

3563

1.23

4.29

2.4

1.9

1.44

1.38

g/l

0.70

386

3100

Carcinoma in situ of other and unspecified sites

534

1.64

4.28

1.6

1.75

1.49

g/l

1.73

447

Nontraumatic intracranial haemmorrhage

462

3797

1.23

4.28

1.6

1.52

1.56

g/l

0.34

390

3217

Scabies

470

1.67

4.27

1.8

2.1

1.56

1.48

g/l

0.30

409

Benign neoplasm: Anus and anal canal

426

1.72

4.27

1.6

2.0

1.63

1.52

g/l

0.40

377

Other and unspecified nerve root and plexus disorders, also in other diseases

338

2685

1.27

4.26

1.6

1.7

1.55

1.54

g/l

0.07

300

2304

Other orthopaedic follow-up care

101

659

1.56

4.24

1.8

1.7

1.62

1.48

g/l

0.74

569

HSIL lesion of the cervix uteri

228

1719

1.34

4.24

2.2

1.9

1.44

1.37

g/l

0.46

198

1493

Specific development disorders of scholastic skills

316

1.81

4.24

2.1

2.0

1.31

1.26

g/l

0.13

283

Melanocytic naevi, other sites/unspecified

144

1010

1.45

4.23

2.3

1.8

1.36

1.52

g/l

1.55

136

877

Glucosamine medication

1212

8571

1.14

4.23

1.6

1.58

1.59

g/l

0.19

1029

7266

Malignant neoplasm of head and neck

192

1419

1.38

4.19

1.7

1.74

1.52

g/l

2.62

164

1216

Other disorders of the genitourinary system

255

1962

1.32

4.19

1.8

1.7

1.59

g/l

0.01

214

1683

Anuria and oliguria

2.72

4.19

1.6

1.9

1.68

1.45

g/l

0.30

Toxic effect of ethanol

442

1.68

4.19

1.5

2.0

1.47

1.50

g/l

0.13

385

Open wound of wrist and hand

862

7407

1.16

4.17

1.7

1.8

1.53

1.50

g/l

0.44

743

6349

Hemiplegia

106

703

1.53

4.16

1.8

1.9

1.55

1.51

g/l

0.15

616

Benign neoplasm: Liver

188

2.07

4.15

2.1

1.9

1.49

1.43

g/l

0.15

164

Myocardial infarction, unclassifiable

606

4567

1.19

4.15

1.6

1.65

1.55

g/l

2.00

510

3828

Scleritis and episcleritis

104

687

1.54

4.14

2.2

1.9

1.56

1.51

g/l

0.20

599

Other sleep disorders

215

1617

1.35

4.14

1.4

1.8

1.54

1.52

g/l

0.13

180

1398

Causalgia

142

2.24

4.12

1.3

2.1

1.27

1.48

g/l

0.70

125

Maternal care for known or suspected malpresentation of fetus

210

1165

1.35

4.10

2.2

2.0

1.18

1.29

g/l

1.15

189

1002

Evidence of alcohol involvement determined by blood alcohol level

149

2.22

4.10

1.9

2.6

1.47

1.45

g/l

0.03

131

Melanocytic naevi of lower limb, including hip

507

1.63

4.10

2.7

2.0

1.23

1.47

g/l

1.70

444

Osteomyelitis of vertebra

3.44

4.10

2.1

1.49

1.58

g/l

0.13

Benign neoplasm: Other and unspecified parts of mouth

462

1.66

4.08

1.7

2.0

1.55

1.50

g/l

0.23

406

All dysplastic lesions of the cervix uteri, vagina or vulva

388

3125

1.24

4.06

2.0

1.9

1.48

1.40

g/l

0.85

330

2699

Other enthesopathies

540

4525

1.20

4.06

1.6

1.7

1.60

1.54

g/l

0.92

460

3866

Unspecified parasitic disease

112

2.45

4.05

1.7

1.8

1.54

1.64

g/l

0.28

Labour and delivery complicated by fetal stress [distress]

275

1418

1.30

4.05

2.1

2.0

1.15

1.27

g/l

1.54

238

1238

Open wound of hip and thigh

371

1.73

4.03

1.7

2.1

1.53

1.44

g/l

0.27

327

Flat foot [pes planus] (acquired)

157

1129

1.41

4.01

1.9

1.8

1.49

1.54

g/l

0.32

133

972

D07AA Corticosteroids, weak (group I)

260

2014

1.30

4.00

1.6

1.8

1.51

1.44

g/l

0.72

231

1735

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

695

3873

1.18

4.00

1.5

1.7

1.67

1.58

g/l

1.28

570

3301

Disorders of refraction and accommodation

441

3617

1.22

4.00

1.8

1.48

1.47

g/l

0.06

374

3126

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

695

3873

1.18

4.00

1.5

1.7

1.67

1.58

g/l

1.24

570

3301

Contusion of other and unspecified parts of foot

463

1.64

3.99

1.8

2.1

1.56

1.39

g/l

0.95

405

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

251

1759

1.31

3.99

1.7

2.2

1.34

1.22

g/l

1.34

219

1539

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

465

1.65

3.98

1.7

1.6

1.81

1.52

g/l

1.57

391

Disorder of external ear, unspecified

396

1.71

3.97

1.9

2.1

1.66

1.53

g/l

0.45

345

Childhood asthma (age<16), excluding more controls

161

917

1.40

3.97

2.3

1.23

1.09

g/l

1.51

142

809

Benign neoplasm: Appendix

113

2.40

3.95

1.4

1.7

1.47

1.48

g/l

0.02

100

Measles

2.71

3.95

1.5

2.3

1.49

1.41

g/l

0.14

Other endocrine disorders

529

1.59

3.95

2.5

2.0

1.24

1.42

g/l

0.89

470

Aneurysms, operations, SAH

336

2696

1.26

3.94

1.8

1.6

1.59

1.57

g/l

0.19

297

2307

Acute laryngitis and tracheitis

167

1196

1.38

3.94

1.8

2.0

1.52

1.34

g/l

1.38

146

1041

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

343

2759

1.26

3.94

1.4

1.6

1.96

1.55

g/l

7.17

283

2350

Poisoning by narcotics and psychodysleptics [hallucinogens]

145

2.20

3.93

1.3

2.3

2.07

1.33

g/l

3.03

132

Other and unspecified injuries of ankle and foot

396

1.69

3.93

1.6

2.1

1.43

g/l

0.02

350

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

458

1.63

3.92

2.0

2.2

1.26

1.21

g/l

0.20

411

Malignant melanoma

326

2612

1.26

3.91

1.9

1.7

1.47

1.57

g/l

1.06

279

2244

Other noninflammatory disorders of vagina

136

959

1.44

3.90

2.1

1.7

1.40

1.54

g/l

1.16

117

816

Carcinoma in situ, bladder

500

1.63

3.90

1.6

1.70

1.47

g/l

1.52

417

Benign neoplasm: Skin of upper limb, including shoulder

200

2.01

3.90

1.3

1.7

1.48

1.51

g/l

0.09

178

Hypothermia

243

1.92

3.90

1.5

1.9

1.52

1.53

g/l

0.03

210

Lichen simplex chronicus

421

1.68

3.89

1.9

1.80

1.54

g/l

1.56

370

Female infertility, associated with anovulation

100

663

1.52

3.89

2.5

2.0

1.13

1.25

g/l

0.92

584

Strabismus

480

3992

1.21

3.87

1.7

1.8

1.51

1.49

g/l

0.10

414

3437

Pathological resorption of teeth

323

1.77

3.87

1.5

1.8

1.53

1.46

g/l

0.23

273

Benign neoplasm of major salivary glands

179

1325

1.37

3.87

1.6

1.69

1.52

g/l

1.41

151

1133

Abnormal blood-pressure reading, without diagnosis

499

1.61

3.86

2.5

1.8

1.41

1.55

g/l

0.66

426

Other noninflammatory disorders of vulva and perineum

149

1070

1.41

3.85

1.7

1.55

1.50

g/l

0.24

128

915

Testicular dysfunction

430

1.66

3.85

1.5

1.8

1.51

1.53

g/l

0.07

367

Perioral dermatitis

180

2.05

3.84

1.7

2.3

1.42

1.36

g/l

0.18

157

Eustachian salpingitis and obstruction

110

747

1.49

3.83

2.2

2.0

1.39

1.41

g/l

0.14

650

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

524

3690

1.20

3.83

1.5

1.93

1.53

g/l

13.08

441

3133

Benign neoplasm: Pancreas

318

1.78

3.81

1.9

1.6

1.41

1.52

g/l

0.39

274

Pyoderma

216

1.95

3.80

1.7

2.1

1.57

1.47

g/l

0.27

191

Chronic Coagulation defects

237

1.90

3.80

1.5

2.1

1.38

1.45

g/l

0.21

208

Unknown and unspecified causes of morbidity

122

848

1.46

3.79

1.6

1.53

1.51

g/l

0.09

110

726

Benign neoplasm: Skin of other and unspecified parts of face

232

1790

1.31

3.78

2.4

1.7

1.54

1.55

g/l

0.03

181

1534

Alcoholic gastritis

203

1.99

3.78

1.4

1.8

1.56

g/l

0.00

174

Respiratory conditions due to other external agents

290

1.82

3.77

2.1

1.8

1.59

1.54

g/l

0.14

255

Injury of blood vessels at abdomen, lower back and pelvis level

3.34

3.76

1.1

2.2

1.61

1.59

g/l

—

Benign neoplasm: Skin of scalp and neck

260

1.85

3.75

1.4

1.8

1.35

1.51

g/l

0.88

226

Other fall from one level to another

420

3469

1.22

3.72

1.8

1.44

1.49

g/l

0.68

373

2984

Female infertility

474

2430

1.21

3.72

2.3

2.0

1.29

1.42

g/l

2.61

433

2093

Other abnormal findings in urine

212

1.96

3.69

2.3

2.0

1.56

1.55

g/l

0.01

187

Malignant neoplasm of bladder

187

1408

1.35

3.68

1.5

1.7

1.82

1.54

g/l

3.15

163

1197

Leiomyoma of uterus

1099

5538

1.13

3.67

1.7

1.57

1.56

g/l

0.08

928

4722

Bulimia nervosa (incl. atypical)

276

1.80

3.66

2.4

2.2

1.32

1.13

g/l

0.95

242

Tooth agenesis EXCLUDE clefts and syndromes

298

1.77

3.66

1.8

2.4

1.07

1.27

g/l

1.05

271

Benign neoplasm of other and unspecified intrathoracic organs

111

2.34

3.63

2.0

1.6

1.83

1.44

g/l

0.79

Alzheimer’s disease, wide definition

447

4469

0.83

3.63

1.5

1.6

1.60

1.54

g/l

0.69

332

3776

Psoriasis (vulgaris), strict definition

360

1.70

3.63

1.6

2.2

1.52

1.53

g/l

0.03

312

Algoneurodystrophy

292

1.78

3.62

1.7

2.1

1.41

1.44

g/l

0.08

255

Paralytic strabismus

150

1094

1.39

3.61

1.7

1.8

1.59

1.52

g/l

0.38

128

948

Crushed, pushed or stepped on by crowd or human stampede

109

749

1.47

3.61

1.9

2.0

1.46

1.44

g/l

0.08

657

Testicular hypofunction

361

1.70

3.60

1.5

1.8

1.49

1.55

g/l

0.19

312

Diseases of inner ear

1184

10379

1.12

3.59

1.6

1.7

1.54

1.56

g/l

0.28

1000

8827

Pedestrian injured in collision with car, pick-up truck or van

301

1.77

3.59

1.7

1.9

1.74

1.53

g/l

0.94

266

Contact with other hot fluids

308

1.76

3.59

1.5

2.2

1.35

1.39

g/l

0.09

274

Postpartum haemorrhage

299

2078

1.26

3.58

2.3

1.9

1.15

1.40

g/l

5.76

259

1815

Thyroiditis, unspecified

158

2.09

3.57

2.1

1.9

1.76

1.50

g/l

0.64

138

Excessive vomiting in pregnancy

106

726

1.47

3.57

2.9

1.8

1.19

1.47

g/l

2.82

626

Alzheimer’s disease (Early onset), excluding more controls

640

0.54

3.56

1.3

1.6

1.66

1.56

g/l

0.18

542

Dental pulpitis 3

169

897

1.37

3.56

2.5

2.4

1.17

1.11

g/l

0.31

145

808

Malignant neoplasm of oral cavity

504

1.59

3.54

1.5

1.9

1.69

1.56

g/l

0.62

437

Urethritis and urethral syndrome

236

1.87

3.53

1.4

2.1

1.61

1.47

g/l

0.27

206

Scar conditions and fibrosis of skin

409

1.64

3.52

1.5

2.0

1.48

1.51

g/l

0.06

359

Acute bronchiolitis

500

1.54

3.52

2.0

2.2

1.41

1.27

g/l

0.72

430

Generalized epilepsy

440

1.62

3.52

1.7

2.1

1.22

1.39

g/l

0.72

394

Astigmatism

107

737

1.47

3.52

1.7

1.9

1.61

1.44

g/l

1.19

656

Carcinoma in situ of skin, other sites/unspecified

167

2.07

3.51

1.8

1.44

1.60

g/l

0.56

144

Tuberculosis, IBD comorbidity

173

1297

1.35

3.51

1.5

1.7

1.48

1.53

g/l

0.26

149

1093

Childhood asthma (age<16)

161

939

1.37

3.50

2.3

1.23

1.09

g/l

1.51

142

829

Other specific arthropathies, wide

230

1.87

3.48

1.6

1.7

1.40

1.44

g/l

0.08

195

Macular cyst

389

1.67

3.48

1.7

1.8

1.56

1.61

g/l

0.17

338

Tongue abnormality

122

865

1.43

3.48

1.6

1.9

1.57

g/l

0.00

105

742

Burns and corrosions of multiple and unspecified body regions

252

1.83

3.48

1.6

1.8

1.56

1.51

g/l

0.14

224

Injury of nerves and spinal cord at neck level

297

1.77

3.48

1.6

1.9

1.53

1.54

g/l

0.02

259

Use of rivastigmine

227

2885

0.78

3.47

1.3

1.6

1.58

1.54

g/l

0.23

176

2420

Other disorders starting during childhood or adolescence

399

1.63

3.45

2.0

2.2

1.27

1.21

g/l

0.21

358

Perforation of tympanic membrane

193

1473

1.33

3.44

1.9

1.8

1.45

1.52

g/l

0.57

164

1276

Meningitis

603

1.52

3.43

1.5

2.0

1.58

1.54

g/l

0.15

529

Sudden idiopathic hearing loss

210

1623

1.31

3.43

1.7

1.55

1.56

g/l

0.07

180

1399

Dental caries 2 and operation codes, only avohilmo

1249

8617

0.90

3.42

1.9

1.8

1.42

1.50

g/l

2.17

1080

7398

Demyelinating diseases of the central nervous system

132

951

1.40

3.40

1.5

1.9

1.39

1.48

g/l

0.70

113

827

Unspecified/other endometriosis

124

883

1.42

3.40

1.9

1.8

1.38

1.43

g/l

0.23

108

760

Other diseases of spinal cord

375

1.66

3.40

1.4

2.1

1.79

1.54

g/l

0.91

329

Anankastic personality disorder

336

1.69

3.38

2.1

1.44

1.42

g/l

0.05

292

Impingement syndrome of shoulder

476

4019

1.19

3.38

1.8

1.7

1.58

1.57

g/l

0.03

408

3442

Pustular psoriasis

573

1.53

3.38

1.3

1.9

1.84

1.57

g/l

1.59

500

Thyrotoxicosis with diffuse goitre

229

1791

1.29

3.37

2.0

1.7

1.48

1.55

g/l

0.55

194

1544

Scleritis

128

2.18

3.37

3.6

2.2

1.85

1.48

g/l

0.58

111

Cervicocranial syndrome

193

1477

1.32

3.36

1.7

1.8

1.59

1.54

g/l

0.30

167

1267

Benign paroxysmal vertigo

585

5028

1.17

3.36

1.5

1.7

1.51

1.58

g/l

0.95

500

4291

Dislocation, sprain and strain of joints and ligaments at neck level

238

1872

1.28

3.35

1.7

1.9

1.46

g/l

0.03

209

1622

Family history of other specific disorders

102

2.32

3.34

2.5

2.9

1.23

1.33

g/l

0.22

Non-small cell lung cancer, squamous, helper endpoint

913

0.61

3.34

1.5

1.7

1.92

1.54

g/l

2.14

765

Non-small cell lung cancer, squamous

913

0.61

3.34

1.5

1.7

1.92

1.54

g/l

2.14

765

Monoamine oxidase A inhibitors

221

1724

1.29

3.34

1.5

1.8

1.57

1.56

g/l

0.08

186

1480

Combined immunodeficiencies

122

2.21

3.34

1.9

2.1

1.78

1.50

g/l

0.61

107

Certain conditions originating in the perinatal period

108

665

1.45

3.34

2.7

2.1

1.23

1.22

g/l

0.07

581

Sequelae of injuries of neck and trunk

362

1.67

3.32

1.4

2.2

1.53

1.52

g/l

0.03

308

Alzheimer disease

594

5189

0.86

3.30

1.5

1.6

1.60

1.55

g/l

0.54

447

4392

Benign neoplasm: Lip

242

1.82

3.30

1.4

1.6

1.39

1.50

g/l

0.41

209

Obsessive-compulsive disorder

575

1.51

3.29

1.9

2.1

1.44

1.31

g/l

0.70

506

Other sexually transmitted chlamydial diseases

567

1.51

3.29

2.0

2.1

1.15

1.25

g/l

0.64

506

Benign neoplasm: Liver/bile ducts

257

1.79

3.28

1.9

2.2

1.51

1.47

g/l

0.09

222

Optic neuritis

409

1.61

3.28

1.4

2.1

1.53

1.44

g/l

0.29

359

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

295

1.74

3.27

2.1

1.5

1.65

1.44

g/l

0.98

257

L02BX Other hormone antagonists and related agents

144

1066

1.38

3.27

1.4

1.7

1.88

1.50

g/l

3.20

116

910

Other disorders of cornea

179

1363

1.33

3.27

1.6

1.8

1.55

1.54

g/l

0.05

158

1178

Inguinal or femoral hernia, bilateral

252

2007

1.27

3.27

1.5

1.7

1.45

1.56

g/l

1.03

209

1732

Short stature, not elsewhere classified

133

2.08

3.26

4.0

2.1

0.80

1.18

g/l

2.35

122

Female infertility, cervigal, vaginal, other or unspecified origin

420

2344

1.21

3.25

2.3

1.9

1.29

1.42

g/l

2.44

383

2015

Recurrent dislocation and subluxation of joint

675

1.47

3.24

2.2

1.8

1.79

1.46

g/l

1.98

587

Other protozoal intestinal diseases

144

2.07

3.22

1.5

2.5

1.23

1.35

g/l

0.32

126

Secondary parkinsonism

397

1.63

3.22

1.4

2.0

1.59

1.54

g/l

0.14

346

Assault by blunt object

144

2.07

3.22

2.5

2.0

1.43

g/l

0.00

128

Inguinal hernia, bilateral

248

1976

1.27

3.21

1.5

1.7

1.45

1.56

g/l

1.00

206

1705

Benign neoplasm of male genital organs

282

1.75

3.21

1.3

1.6

1.73

1.49

g/l

0.93

239

Other acquired deformities of musculoskeletal system and connective tissue

613

1.49

3.20

1.4

1.8

1.52

1.55

g/l

0.11

532

Benign neoplasm: Pituitary gland, craniopharyngeal duct

556

1.51

3.19

1.5

1.8

1.47

1.46

g/l

0.04

480

Poisoning by medicine, drug-induced

131

2.12

3.18

1.3

2.2

1.51

1.44

g/l

0.14

116

391

1.63

3.18

1.4

1.9

1.85

1.53

g/l

1.97

341

Other demyelinating diseases of the central nervous system

327

1.68

3.18

1.3

1.9

1.47

1.43

g/l

0.14

284

Melanocytic naevi of other and unspecified parts of face

605

1.49

3.17

2.4

1.8

1.25

1.50

g/l

2.09

523

Polyhydramnios

319

1.68

3.17

1.9

2.0

1.18

1.29

g/l

0.34

272

Embedded teeth, including avohilmo

127

921

1.39

3.16

1.9

2.0

1.34

1.32

g/l

0.08

112

812

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

125

2.15

3.15

2.5

1.7

1.16

1.41

g/l

0.90

108

Dermatitis herpetiformis

246

1.80

3.15

1.6

1.9

1.26

1.49

g/l

1.00

217

Personal history of malignant neoplasm

398

1.61

3.15

1.9

1.59

1.51

g/l

0.21

349

Single spontaneous delivery

614

3778

0.86

3.13

1.7

1.8

1.44

1.56

g/l

2.60

531

3241

Other, unspecified and serous retinal detachments

448

1.58

3.11

1.9

1.40

1.60

g/l

1.00

386

Viral haemorrhagic fevers, not elsewhere classified/unspecified

154

1157

1.35

3.11

1.6

1.8

1.43

1.51

g/l

0.43

139

1004

Pustulosis palmaris et plantaris

503

1.54

3.11

1.3

1.9

1.84

1.61

g/l

1.13

440

Cluster headache, strict

345

1.65

3.09

1.3

2.0

1.40

1.49

g/l

0.39

299

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

106

750

1.43

3.08

1.6

1.91

1.58

g/l

1.82

642

Prolonged pregnancy

1161

0.69

3.07

1.7

2.0

1.16

1.31

g/l

0.95

1002

Optic atrophy

204

1.86

3.05

1.6

2.1

1.61

1.50

g/l

0.24

180

109

775

1.42

3.05

1.7

2.0

1.28

1.21

g/l

0.30

679

Benign neoplasm of breast

185

1429

1.31

3.05

2.0

1.6

1.59

1.56

g/l

0.17

157

1219

Lagophthalmos

169

1.97

3.04

1.5

2.0

1.68

1.45

g/l

0.52

147

Benign neoplasm: Tongue

387

1.61

3.04

1.8

1.9

1.61

1.54

g/l

0.25

338

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

112

801

1.41

3.04

2.2

1.9

1.78

1.44

g/l

2.41

697

Alzheimer disease, including avohilmo

714

5861

0.87

3.04

1.5

1.6

1.60

1.56

g/l

0.49

554

4960

Hyperosmolality and hypernatraemia

169

1.96

3.03

1.3

1.9

1.76

1.47

g/l

0.85

149

Other and unspecified tonsillitis

517

3758

1.17

3.02

1.7

1.9

1.40

1.39

g/l

0.09

457

3268

Polycystic ovarian syndrome, broad definition

134

988

1.37

3.02

2.4

2.1

1.17

1.21

g/l

0.23

120

866

Other otitis externa (chronic)

120

872

1.40

3.01

1.8

1.9

1.59

1.52

g/l

0.30

106

760

Other/unspecified soft tissue disorders related to use, overuse and pressure

302

1.69

3.00

1.5

1.9

1.20

1.60

g/l

3.20

259

Benign neoplasm: Skin, unspecified

427

1.57

3.00

1.6

1.7

1.57

1.48

g/l

0.33

369

Herpesviral keratitis and keratoconjunctivitis

566

1.49

2.97

2.0

1.9

1.54

1.47

g/l

0.25

492

Benign neoplasm: Parotid gland

139

1037

1.36

2.96

1.6

1.65

1.49

g/l

1.20

114

895

Foreign body in alimentary tract

106

758

1.42

2.94

1.9

2.0

1.49

1.53

g/l

0.15

664

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

185

1.89

2.94

1.4

1.6

2.31

1.56

g/l

2.50

162

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

178

1.91

2.93

1.4

1.6

1.97

1.61

g/l

0.82

153

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

207

1.83

2.93

2.2

1.6

1.27

1.47

g/l

0.74

181

Other/unspecified enthesopathies, not elsewhere classified

168

1290

1.32

2.93

1.7

1.58

1.56

g/l

0.07

142

1097

Tinnitus

450

3837

1.18

2.92

1.6

1.7

1.54

1.57

g/l

0.24

385

3294

Other contact dermatitis

139

1040

1.35

2.89

1.7

1.8

1.64

1.52

g/l

0.67

115

909

Exophthalmic conditions

116

2.14

2.89

1.9

2.3

1.62

1.41

g/l

0.31

104

Other acute skin changes due to ultraviolet radiation

480

1.53

2.89

1.6

1.7

1.67

1.56

g/l

0.46

423

Burns and corrosions confined to eye and internal organs

275

1.70

2.88

1.3

2.3

1.58

1.45

g/l

0.34

244

Spinal instabilities

337

1.63

2.88

1.5

1.9

1.62

1.50

g/l

0.37

290

Other and unspecified acute skin changes due to ultraviolet radiation

377

1.60

2.88

1.6

1.7

1.67

1.57

g/l

0.35

328

Delayed milestone in childhood

104

2.13

2.87

2.7

1.9

1.06

1.14

g/l

0.15

Dependent personality disorder

223

1.79

2.87

2.1

1.58

1.49

g/l

0.25

196

Malignant neoplasm of tongue

269

1.72

2.86

1.5

2.1

1.68

1.53

g/l

0.48

234

Achalasia of cardia

231

1.78

2.86

1.6

2.1

1.65

1.56

g/l

0.25

201

Procedures for purposes other than remedying health state

223

1.78

2.85

1.6

1.7

1.34

1.49

g/l

0.45

196

Other congenital malformations of heart

2.64

2.84

2.4

2.2

1.08

1.30

g/l

—

Other and unspecified injuries of wrist and hand

385

1.58

2.84

2.2

1.63

1.43

g/l

0.93

338

Acute nasopharyngitis (common cold)

181

1400

1.29

2.83

1.6

1.8

1.54

1.52

g/l

0.05

159

1199

Benign neoplasm: Tonsil

117

2.12

2.83

1.3

1.8

1.37

1.44

g/l

0.18

100

Exposure to other and unspecified animate mechanical forces

269

1.70

2.82

1.7

2.1

1.54

1.43

g/l

0.31

239

Secondary parkinsonism+Parkinsonism in other disease

419

1.56

2.82

1.4

2.0

1.61

1.55

g/l

0.17

366

Malignant neoplasm of larynx

248

1.75

2.81

1.6

1.7

1.95

1.56

g/l

1.81

213

Pilonidal cyst

123

908

1.37

2.79

1.9

1.52

1.44

g/l

0.42

104

787

Other proliferative retinopathy

2.76

2.79

1.4

2.7

1.51

1.48

g/l

0.04

Other and unspecified injuries of shoulder and upper arm

348

1.61

2.78

1.5

2.1

1.53

1.50

g/l

0.09

303

Malignant neoplasm of respiratory system and intrathoracic organs

390

4225

0.84

2.77

1.4

1.6

1.97

1.55

g/l

11.11

328

3556

Mental retardation, wide definition

427

1.54

2.77

1.6

2.1

1.54

1.42

g/l

0.42

374

Benign neoplasm: Pharynx, unspecified

2.51

2.76

1.1

2.1

1.84

1.39

g/l

—

Ovarian dysfunction, other/unspecified

2.71

2.76

1.6

2.6

1.78

1.38

g/l

0.52

Subacute thyroiditis

404

1.56

2.76

1.6

1.9

1.39

1.52

g/l

0.55

352

Unspecific neurodegenerative disorder

866

6667

0.89

2.75

1.4

1.6

1.60

1.57

g/l

0.44

674

5664

Benign neoplasm: Skin of lower limb, including hip

279

1.68

2.75

1.3

1.7

1.53

1.43

g/l

0.30

245

Ganglion

345

2893

1.20

2.73

1.5

1.7

1.42

1.51

g/l

1.13

296

2469

Tuberculosis, wide

176

1376

1.30

2.72

1.6

1.7

1.49

1.53

g/l

0.30

152

1163

Bitten or struck by other mammals

169

1312

1.30

2.72

2.0

1.9

1.59

1.48

g/l

0.67

150

1147

All dysplastic lesions of the cervix uteri

317

2631

1.21

2.72

2.2

1.9

1.42

1.36

g/l

0.52

273

2273

Other intracranial haemorrhages

529

1.49

2.72

1.8

1.9

1.48

1.53

g/l

0.18

462

Myopia

185

1453

1.28

2.71

1.8

1.9

1.40

1.46

g/l

0.39

161

1271

Other disorders of binocular movement

197

1.81

2.71

1.4

2.4

1.43

1.30

g/l

0.27

173

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

243

1.73

2.69

2.3

1.5

1.38

1.43

g/l

0.15

210

Convergent concomitant strabismus

586

1.45

2.68

2.3

2.0

1.35

1.43

g/l

0.36

522

Varicose veins of other sites

123

917

1.36

2.67

1.8

1.26

1.55

g/l

3.01

106

793

Burn and corrosion of wrist and hand

392

1.55

2.65

1.3

2.2

1.46

1.45

g/l

0.01

344

Chromosomal abnormalities, not elsewhere classified

155

1.90

2.62

2.2

2.3

1.57

1.27

g/l

0.56

130

Postpartum hemorraghe, all women as controls

299

2472

1.21

2.62

2.3

2.0

1.15

1.32

g/l

3.15

259

2148

Trigeminal neuralgia

101

732

1.40

2.62

1.4

1.8

1.60

1.55

g/l

0.22

633

Brain meningioma, excluding all cancers (controls excluding all cancers)

623

1.43

2.62

1.8

1.6

1.63

1.53

g/l

0.31

532

Mixed conductive and sensorineural hearing loss

257

2108

1.23

2.62

1.7

1.60

1.56

g/l

0.23

207

1812

Other specified/unspecified hearing loss

165

1288

1.30

2.60

1.7

1.45

1.54

g/l

0.65

150

1103

Dysplasia of cervi uteri

352

2292

1.19

2.59

2.1

1.9

1.46

1.43

g/l

0.27

302

1969

Use of galantamine

100

1360

0.72

2.59

1.4

1.6

1.69

1.53

g/l

0.94

1135

Recurrent dislocation of patella

434

1.51

2.58

2.1

2.3

1.59

1.29

g/l

1.31

387

Carcinoma in situ of other and unspecified genital organs

201

1.79

2.58

1.6

2.1

1.79

1.54

g/l

0.59

176

Exposure to unspecified smoke, fire and flames

115

2.07

2.57

1.5

2.0

1.53

1.56

g/l

0.04

Benign neoplasm of other and unspecified intrathoracic organs

129

2.00

2.57

2.0

1.9

1.83

1.44

g/l

0.79

112

Universal erythroderma, KELA reimbursement

187

1.82

2.55

1.8

1.7

1.60

1.53

g/l

0.14

163

Behavioural disorders

157

1.88

2.55

1.8

2.3

1.68

1.30

g/l

1.01

143

Tooth eruption problems

182

1425

1.27

2.53

1.9

2.1

1.33

1.27

g/l

0.38

164

1261

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

195

1.79

2.53

2.0

1.7

1.48

1.55

g/l

0.17

171

Chronic diseases of tonsils and adenoids

1361

9379

0.92

2.53

1.9

1.8

1.49

g/l

0.03

1176

8086

Alzheimer’s disease (Late onset)

423

4204

0.86

2.52

1.5

1.6

1.60

1.55

g/l

0.61

314

3565

Benign neoplasm: Liver

225

1.72

2.51

2.1

2.2

1.49

1.47

g/l

0.03

193

Cerebral aneurysm, nonruptured

155

1206

1.30

2.51

1.8

1.7

1.66

1.55

g/l

0.71

139

1046

Carcinoma in situ of skin of eyelid, including canthus

3.70

2.50

1.3

2.0

1.31

1.62

g/l

—

Episcleritis

570

1.44

2.50

1.9

1.45

1.50

g/l

0.16

500

Oxicams

603

3011

1.14

2.50

1.6

1.9

1.53

1.46

g/l

0.99

499

2558

MS-disease / Multiple Sclerosis

104

764

1.37

2.49

1.5

1.9

1.33

1.46

g/l

1.00

667

Epiphora

288

1.64

2.48

1.8

1.40

1.49

g/l

0.28

251

Benign neoplasm: Skin of ear and external auricular canal

623

1.42

2.47

1.9

1.28

1.53

g/l

2.20

550

Postpartum haemorrhage due to anatomy

132

1006

1.32

2.46

2.5

2.3

1.13

1.14

g/l

0.08

118

896

Atypical facial pain

597

1.43

2.46

1.5

1.9

1.43

1.57

g/l

0.88

521

Malignant melanoma of skin

237

1943

1.23

2.46

1.7

1.46

1.57

g/l

1.02

208

1666

Transient global amnesia

119

1566

0.75

2.46

1.8

1.7

1.35

1.56

g/l

1.62

1363

Fourth [trochlear] nerve palsy

305

1.61

2.45

1.8

2.0

1.66

1.46

g/l

0.86

273

Endometriosis

600

3138

1.14

2.44

1.7

1.8

1.47

1.49

g/l

0.24

510

2669

Hirsprung

6.90

2.44

1.2

1.9

2.04

1.25

g/l

—

Salpingitis and oophoritis

271

2250

1.21

2.44

1.7

1.54

1.58

g/l

0.32

234

1920

Carcinoma in situ of skin of eyelid, including canthus

3.56

2.41

1.3

2.2

1.31

1.47

g/l

—

Mastocytosis

2.61

2.41

1.5

2.7

1.00

1.48

g/l

1.47

Flatulence and related conditions

104

2.08

2.41

2.1

2.3

1.52

1.45

g/l

0.12

Alzheimer’s disease (Atypical or mixed)

142

1813

0.77

2.40

1.8

1.6

1.65

1.52

g/l

0.84

103

1529

Ovarian dysfunction

659

1.39

2.38

2.1

1.40

1.26

g/l

0.72

573

Melanoma in situ

663

1.40

2.37

2.2

1.8

1.43

1.52

g/l

0.47

572

Schizophrenia

259

2149

1.21

2.36

1.5

1.8

1.85

1.50

g/l

6.30

218

1872

Conduct disorder

169

1.80

2.35

1.7

2.4

1.75

1.28

g/l

1.31

154

Malignant neoplasm of other and unspecified parts of tongue

185

1.78

2.34

1.5

2.1

1.45

1.49

g/l

0.08

160

Haemangioma and lymphangioma, any site

154

1209

1.29

2.34

1.5

1.9

1.47

1.55

g/l

0.45

140

1051

Major anomalies of jaw size

245

1.66

2.34

1.5

2.2

1.25

1.42

g/l

0.45

214

Sequelae of infectious and parasitic diseases

135

1042

1.31

2.34

1.9

1.8

1.39

1.54

g/l

0.93

116

893

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

679

1.38

2.34

1.7

1.6

1.45

1.50

g/l

0.17

592

Cluster headache, wide

396

1.51

2.33

1.3

2.0

1.37

1.50

g/l

0.66

340

Disorders of synovium and tendon in diseases classified elsewhere

238

1.67

2.33

1.6

1.8

1.56

1.62

g/l

0.09

203

Dronedarone medication

381

1.53

2.33

1.6

1.36

1.61

g/l

1.39

329

Other inflammation of vagina/vulva

300

1.59

2.32

1.8

2.3

1.41

1.36

g/l

0.11

261

Use of biperiden

681

1.38

2.31

1.5

1.9

1.78

1.54

g/l

1.53

587

LSIL lesion of the cervix uteri, vagina or vulva

173

1378

1.26

2.31

2.2

1.8

1.44

1.45

g/l

0.03

151

1189

Deviated nasal septum

684

6110

1.12

2.31

1.6

1.7

1.53

1.54

g/l

0.05

578

5242

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

505

1.45

2.31

1.2

1.6

1.59

1.50

g/l

0.46

430

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

201

1.73

2.30

2.4

1.5

1.35

1.42

g/l

0.20

172

Benign neoplasm: Appendix

142

1.90

2.30

1.4

2.1

1.47

1.56

g/l

0.18

127

Unspecified abortion

430

1.48

2.29

2.3

1.7

1.43

1.60

g/l

0.65

368

Other disorders of Eustachian tube

326

1.56

2.28

1.7

2.1

1.44

1.53

g/l

0.30

287

Chronic conjunctivitis

334

1.55

2.28

1.9

1.7

1.58

1.53

g/l

0.10

294

Contact with sharp glass

366

1.52

2.27

1.7

2.2

1.46

1.42

g/l

0.10

324

Fenamates

352

2024

1.18

2.26

1.6

2.0

1.53

1.42

g/l

1.69

308

1744

Atrophic disorders of skin

229

1887

1.22

2.26

1.6

1.7

1.57

1.58

g/l

0.01

187

1611

Inflammatory disorders of breast

632

1.39

2.26

1.8

1.9

1.30

1.45

g/l

0.99

551

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

111

838

1.34

2.26

2.0

1.6

1.54

1.52

g/l

0.06

726

Benign neoplasm of meninges

165

1313

1.27

2.26

1.7

1.6

1.57

1.55

g/l

0.09

143

1111

Malignant neoplasm of thymus

2.80

2.26

1.5

2.1

2.03

1.69

g/l

0.35

Congenital malformations of uterus and cervix

164

1.80

2.26

1.3

2.4

1.35

1.30

g/l

0.08

143

Gonococcal infection

351

1.53

2.25

1.5

1.9

1.55

1.58

g/l

0.08

312

Arthropod-borne viral fevers and viral haemorrhagic fevers

180

1448

1.25

2.25

1.6

1.8

1.49

1.52

g/l

0.16

162

1248

Appendectomy

1230

10907

1.09

2.25

1.7

1.8

1.56

1.50

g/l

1.34

1049

9392

Problems related to social environment

335

1.55

2.25

1.4

2.0

1.84

1.45

g/l

1.28

299

Laparoscopic left hemicolectomy

234

1.67

2.23

1.3

1.9

1.85

1.58

g/l

0.98

203

2.19

2.23

1.2

2.5

1.70

1.46

g/l

0.28

Abscess of external ear

143

1.86

2.23

1.8

2.2

1.45

1.37

g/l

0.16

128

Spirochaetal infections, other/unspecified

152

1202

1.28

2.21

1.8

1.42

1.54

g/l

0.91

126

1045

Benign neoplasm: Cerebral meninges

148

1166

1.28

2.21

1.8

1.6

1.53

1.54

g/l

0.04

128

989

Benign lipomatous neoplasm

507

4465

1.14

2.20

1.7

1.6

1.51

1.55

g/l

0.35

421

3825

Malignant neoplasm of pancreas

1072

0.72

2.20

1.3

1.7

1.61

1.53

g/l

0.32

905

Complications predominantly related to the puerperium

344

2947

1.17

2.19

2.3

1.8

1.39

1.44

g/l

0.44

311

2533

Embedded and impacted teeth

355

2588

1.17

2.18

2.3

2.1

1.28

1.30

g/l

0.14

314

2267

Other and unspecified trigeminal disorders

159

1.80

2.17

1.3

2.3

1.50

1.49

g/l

0.02

141

Contusion of ankle

370

1.50

2.17

1.8

2.2

1.50

1.45

g/l

0.19

327

Achilles tendinitis

181

1463

1.25

2.17

1.8

1.54

1.53

g/l

0.02

153

1274

Tuberculosis of other organs

331

1.55

2.17

1.6

1.7

1.49

1.61

g/l

0.37

295

Family history of malignant neoplasm

136

1062

1.29

2.17

1.5

1.8

1.44

1.53

g/l

0.52

110

917

Chronic suppurative otitis media, including avohilmo

145

1143

1.28

2.17

1.8

1.47

g/l

0.02

128

998

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

588

1.40

2.16

2.0

1.8

1.63

1.56

g/l

0.29

514

Bursitis of shoulder

291

1.57

2.15

1.5

1.8

1.94

1.56

g/l

1.55

252

Benign neoplasm: Skin of upper limb, including shoulder

244

1.63

2.15

1.3

2.0

1.48

1.53

g/l

0.13

214

Anti-inflammatory and antirheumatic products, non-steroids

750

3388

1.12

2.12

1.8

2.0

1.51

1.42

g/l

1.79

649

2894

Dislocation, sprain and strain of joints and ligaments of head

397

1.48

2.11

1.7

2.1

1.49

1.44

g/l

0.15

349

Asthma mixed form (mode), excluding more controls

555

1.40

2.11

1.4

1.7

1.59

1.50

g/l

0.37

466

Severe visual impairment, monocular

110

1.98

2.11

2.0

2.5

1.50

1.49

g/l

0.02

Other strabismus

347

2977

1.17

2.11

1.7

1.8

1.47

g/l

0.03

299

2559

Hordeolum and other deep inflammation of eyelid

667

1.36

2.10

2.2

1.9

1.21

1.50

g/l

2.70

583

Correction of physiology of bite - demanding therapy visit

744

1.34

2.10

1.6

1.9

1.43

1.50

g/l

0.31

652

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

161

1.78

2.10

1.4

1.9

1.60

1.63

g/l

0.07

140

Congenital malformations and deformations of the musculoskeletal system

118

904

1.31

2.10

2.3

2.0

1.38

1.40

g/l

0.10

101

792

Third [oculomotor] nerve palsy

246

1.62

2.09

1.8

2.0

1.51

1.46

g/l

0.13

220

Examination and encounter for administrative purposes

515

1.42

2.09

1.6

1.7

1.44

1.51

g/l

0.23

436

Toxic effect of contact with venomous animals

482

1.43

2.08

1.6

2.1

1.48

1.47

g/l

0.05

422

Bell's palsy

209

1724

1.22

2.08

1.9

1.7

1.56

1.54

g/l

0.12

180

1487

Melanoma in situ of upper limb, including shoulder

2.19

2.08

1.4

1.9

1.09

1.52

g/l

0.89

Entropion and trichiasis of eyelid

193

1583

1.23

2.06

1.6

1.7

1.53

g/l

0.02

172

1329

Other/unspecified enthesopathies of lower limb, excluding foot

111

851

1.32

2.06

1.6

1.8

1.62

1.57

g/l

0.20

734

Disorders of pituitary gland, other and/or unspecified

2.31

2.06

1.1

2.2

1.69

1.50

g/l

0.25

Infectious mononucleosis

105

799

1.32

2.04

2.1

2.0

1.35

1.31

g/l

0.17

705

Other and unspecified corneal deformities and disorders

368

1.49

2.04

1.4

2.0

1.74

1.49

g/l

1.07

322

Intracerebral haemorrhage

279

2370

1.19

2.03

1.5

1.6

1.50

1.54

g/l

0.30

229

2011

Other symptoms and signs involving the nervous and musculoskeletal systems

796

7230

1.10

2.03

1.6

1.7

1.54

1.52

g/l

0.28

675

6188

Undefined dementia

195

2172

0.82

2.02

1.5

1.6

1.74

1.53

g/l

2.12

155

1792

Benign neoplasm of ovary

289

2463

1.18

2.01

1.8

1.6

1.59

1.60

g/l

0.03

250

2086

Bacterial meningitis

419

1.45

2.00

1.4

2.2

1.76

1.51

g/l

1.06

367

Other deformities of toe(s)

419

1.45

2.00

1.7

1.8

1.49

1.54

g/l

0.16

361

Premature separation of placenta [abruptio placentae]

148

1.78

2.00

2.0

1.31

1.37

g/l

0.10

127

Maternal care related to the fetus and amniotic cavity and possible delivery problems

573

3000

1.13

2.00

2.1

1.9

1.25

1.46

g/l

6.61

490

2601

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

457

4028

1.14

1.99

1.5

1.9

1.51

1.49

g/l

0.16

404

3457

Hyperkinetic disorders (excl. ADHD)

125

1.85

1.99

1.4

2.4

1.17

1.24

g/l

0.16

118

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

225

1.62

1.99

2.0

1.8

1.37

1.51

g/l

0.51

198

Other specified and unspecified disorders of choroid

2.58

1.99

3.1

2.2

1.52

1.70

g/l

0.24

Malignant neoplasm of other connective and soft tissue

330

1.52

1.99

1.4

2.0

1.96

1.54

g/l

1.12

290

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

117

909

1.30

1.98

1.8

1.7

1.66

1.50

g/l

0.94

777

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

113

1.93

1.98

2.8

2.0

1.68

1.52

g/l

0.37

Pedestrian injured in transport accident

121

945

1.29

1.98

1.7

1.9

1.57

1.51

g/l

0.27

101

829

Abnormal spermatozoa

199

2395

0.82

1.97

1.6

1.7

1.56

1.54

g/l

0.13

169

2048

Carcinoma in situ of other and unspecified sites

635

1.36

1.96

1.6

1.9

1.75

1.51

g/l

1.47

544

Dermatographic urticaria

710

1.34

1.95

2.0

1.9

1.40

1.48

g/l

0.37

620

Haemangioma, any site

143

1142

1.26

1.95

1.5

1.9

1.49

1.54

g/l

0.28

129

993

Benign neoplasm: Larynx

464

1.42

1.95

1.5

1.9

1.74

1.51

g/l

1.07

410

Impacted teeth

235

1834

1.20

1.95

2.6

2.2

1.23

1.26

g/l

0.20

208

1620

Benign lipomatous neoplasm of other sites/unspecified

153

1233

1.25

1.93

2.0

1.5

1.55

1.54

g/l

0.08

126

1047

Sequelae of injuries of upper limb

163

1323

1.24

1.93

1.5

1.8

1.63

1.55

g/l

0.57

143

1153

Anisometropia and aniseikonia

365

1.47

1.92

2.7

1.9

1.46

1.53

g/l

0.27

328

Benign neoplasm: Tonsil

136

1.81

1.91

1.3

2.2

1.37

1.54

g/l

0.50

117

Vascular syndromes of brain in cerebrovascular disorders

104

802

1.32

1.91

1.4

1.8

1.56

1.51

g/l

0.20

694

Otitis media, unspecified

159

1184

1.24

1.90

1.7

2.0

1.36

1.39

g/l

0.16

139

1039

Uterine polyps

151

1217

1.25

1.90

1.7

1.37

1.57

g/l

2.07

128

1040

Hereditary motor and sensory neuropathy

100

1.96

1.90

1.7

1.9

1.22

1.53

g/l

0.68

Benign neoplasm of brain and other parts of central nervous system

102

784

1.31

1.89

1.6

1.7

1.61

1.52

g/l

0.46

679

Pain and other conditions associated with female genital organs and menstrual cycle

268

2187

1.18

1.89

1.9

1.46

1.41

g/l

0.40

226

1883

Other osteochondropathies

116

907

1.29

1.89

1.5

1.8

1.54

1.53

g/l

0.04

102

793

Chronic iridocyclitis

646

1.35

1.88

1.5

1.9

1.46

1.51

g/l

0.17

566

Juvenile Open Angle Glaucoma

2.28

1.88

2.2

1.9

1.25

1.41

g/l

0.36

Subarachnoid haemorrhage

208

1737

1.21

1.87

1.7

1.53

1.55

g/l

0.15

181

1479

Other melanin hyperpigmentation

294

1.53

1.87

1.8

1.9

1.48

1.54

g/l

0.15

259

Radial styloid tenosynovitis [de Quervain]

586

1.36

1.86

1.4

1.7

1.40

1.54

g/l

0.71

510

Peroneal tendinitis

152

1.74

1.86

1.5

1.8

1.37

1.38

g/l

0.02

131

Other specified disorders of muscle

351

1.47

1.86

2.3

1.8

1.45

1.56

g/l

0.39

299

Juvenile osteochondrosis

318

1.50

1.85

1.9

2.0

1.38

1.41

g/l

0.07

284

Use of other anti-dementia drugs

508

4946

0.89

1.85

1.5

1.6

1.59

1.55

g/l

0.40

376

4181

Use of memantine

508

4946

0.89

1.85

1.5

1.6

1.59

1.55

g/l

0.40

376

4181

Normal-pressure hydrocephalus

912

0.72

1.85

1.4

1.7

1.60

1.54

g/l

0.26

777

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

302

1.51

1.85

1.5

2.3

1.65

1.46

g/l

0.82

268

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

122

963

1.28

1.85

1.5

1.7

1.37

1.52

g/l

0.93

101

833

Postpartum hemorraghe, parous women as controls

299

2250

1.17

1.85

2.3

2.1

1.15

1.29

g/l

2.17

259

1971

Carcinoma in situ, bladder

590

1.37

1.84

1.6

1.9

1.70

1.51

g/l

1.13

507

Sequelae of other and unspecified infectious and parasitic diseases

596

1.35

1.84

2.0

1.9

1.31

1.52

g/l

1.21

519

Lichen planus

235

1987

1.19

1.84

1.6

1.7

1.45

1.58

g/l

1.28

196

1697

Acute alcohol intoxication ICD-9

495

1.39

1.83

1.6

1.9

1.54

1.55

g/l

0.04

421

Other diseases of peritoneum

607

1.35

1.82

1.6

1.8

1.38

1.54

g/l

0.76

535

Malignant neoplasm of rectosigmoid junction

240

1.58

1.81

1.4

1.8

1.95

1.55

g/l

1.44

209

Exposure to smoke, fire and flames

304

1.51

1.81

1.3

1.8

1.47

1.53

g/l

0.14

267

Assault by sharp object

161

1.71

1.81

1.4

2.0

1.52

1.39

g/l

0.27

146

Carcinoma in situ of skin, other sites/unspecified

209

1.63

1.80

1.8

1.44

1.65

g/l

0.82

186

Other specified and unspecified disorders of lens

140

1.77

1.78

2.5

1.8

1.78

1.75

g/l

0.05

121

Ulcer of vagina/vulva

257

1.54

1.76

1.5

2.2

1.53

1.46

g/l

0.15

225

Injury of eye and orbit

232

1968

1.19

1.75

1.6

1.8

1.41

1.49

g/l

0.67

201

1701

Conductive hearing loss, unspecified

144

1168

1.24

1.75

1.7

1.8

1.62

1.53

g/l

0.54

130

1020

Diffuse brain injury

448

1.40

1.74

1.8

1.9

1.41

1.53

g/l

0.50

385

Other congenital malformations of female genitalia

2.18

1.74

2.5

2.9

1.54

1.18

g/l

0.86

Lichen planus, including avohilmo

333

2909

1.15

1.73

1.6

1.7

1.46

1.58

g/l

1.54

287

2490

Benign neoplasm: Skin of scalp and neck

324

1.47

1.73

1.4

2.0

1.35

1.51

g/l

0.89

286

Presbycusis

335

2917

1.15

1.71

1.9

1.6

1.50

1.56

g/l

0.61

261

2483

Other disorders of carbohydrate metabolism

2.47

1.71

9.6

1.7

1.31

1.57

g/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

122

973

1.26

1.71

2.2

1.8

1.33

1.45

g/l

0.79

111

834

Benign neoplasm of other and unspecified female genital organs

450

1.39

1.71

1.7

1.63

1.57

g/l

0.13

391

Other benign neoplasms of connective and other soft tissue

146

1190

1.24

1.70

1.8

1.6

1.45

1.52

g/l

0.41

122

1028

Other peripheral vertigo

173

1436

1.22

1.70

1.5

1.8

1.52

1.55

g/l

0.16

137

1237

Other specified/unspecified deforming dorsopathies

180

1.64

1.69

1.6

1.9

1.63

1.46

g/l

0.33

157

Other and unspecified injuries of abdomen, lower back and pelvis

173

1.65

1.67

2.0

2.3

1.25

1.38

g/l

0.32

153

Injury of muscle and tendon at wrist and hand level

235

2006

1.18

1.67

1.6

1.8

1.55

1.53

g/l

0.11

213

1733

Other neurotic disorders

677

1.31

1.67

1.9

1.8

1.52

1.54

g/l

0.07

582

Dislocation, sprain and strain of joints and ligaments of knee

1068

9215

1.08

1.66

1.8

1.49

1.48

g/l

0.09

914

7929

Pleural plaque

246

2113

1.18

1.66

1.6

1.7

1.50

1.54

g/l

0.30

207

1798

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

118

944

1.26

1.65

1.6

1.93

1.49

g/l

3.54

100

800

Temporomandibular joint disorders, including avohilmo

645

5862

1.10

1.64

1.6

1.8

1.43

1.44

g/l

0.08

556

5057

Nonspecific lymphadenitis

643

1.32

1.64

1.5

1.8

1.46

1.56

g/l

0.51

556

Haemorrhage in early pregnancy

356

3058

1.14

1.64

1.9

1.8

1.35

1.48

g/l

1.91

304

2632

Unspecified dementia

195

2081

0.84

1.63

1.5

1.6

1.74

1.51

g/l

2.44

155

1740

Hereditary corneal dystrophies

455

1.38

1.63

1.4

1.8

1.47

1.56

g/l

0.36

394

Benign neoplasm: Pancreas

396

1.42

1.63

1.9

1.41

1.55

g/l

0.55

348

Hypersomnia

151

1.69

1.63

1.4

2.2

1.94

1.37

g/l

1.66

133

Personality and behavioural disorders due to brain disease, damage and dysfunction

198

1.60

1.63

2.5

1.7

1.57

1.48

g/l

0.21

178

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

477

3467

1.12

1.62

1.4

1.6

1.71

1.60

g/l

1.22

385

2953

Benign neoplasm of male genital organs

338

1.45

1.61

1.3

1.8

1.73

1.53

g/l

0.72

300

Suggestive for eosinophilic asthma

172

1436

1.21

1.60

1.5

1.7

1.73

1.52

g/l

2.21

145

1233

Injury of muscle and tendon at ankle and foot level

255

1.51

1.60

1.4

2.2

1.32

1.50

g/l

0.40

216

Vertigo of central origin

224

1.55

1.58

1.4

2.0

1.72

1.53

g/l

0.73

195

Small kidney of unknown cause

2.57

1.58

1.5

1.29

1.50

g/l

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

240

1.53

1.58

1.6

1.5

1.46

1.55

g/l

0.22

201

Malignant neoplasm of breast, HER-positive

469

5142

0.90

1.58

1.4

1.7

1.71

1.61

g/l

1.05

380

4370

Vascular dementia (other)

108

1.84

1.57

1.5

1.6

1.44

1.70

g/l

0.72

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

159

1322

1.21

1.55

1.8

1.6

1.74

1.61

g/l

0.63

120

1133

Meralgia paraesthetica

391

1.40

1.54

1.7

2.0

1.46

1.58

g/l

0.38

334

Tuberculosis of other organs, strict

392

1.40

1.54

1.7

1.6

1.49

1.58

g/l

0.30

348

Mixed disorders of conduct and emotions, excluding more controls

161

1.63

1.53

1.8

2.3

1.49

1.14

g/l

0.62

140

Additional codes for the location of defect, injury or illness

748

1.28

1.53

1.8

1.9

1.36

1.54

g/l

1.08

655

Benign neoplasm of eye and adnexa

161

1343

1.21

1.52

1.5

1.6

1.65

1.52

g/l

0.87

135

1139

Melanoma in situ, other sites/unspecified

2.57

1.52

2.2

1.8

1.38

1.72

g/l

—

Other bursitis, not elsewhere classified

116

1.77

1.52

1.4

1.8

1.67

1.57

g/l

0.19

105

Moderate mental retardation

2.06

1.52

1.4

1.9

1.43

1.29

g/l

0.25

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

2.35

1.52

2.1

1.4

1.24

1.40

g/l

—

Malignant neoplasm of endocrine gland

115

928

1.25

1.51

2.0

1.8

1.54

1.55

g/l

0.04

812

Renal cell carcinoma of kidney

575

1.32

1.50

1.7

1.8

1.81

1.55

g/l

1.33

495

Abnormal findings in secretions and smears from cervix uteri vagina vulva

688

4957

1.09

1.48

2.0

1.8

1.41

1.46

g/l

0.64

594

4272

Hyperprolactinaemia

285

1.45

1.46

1.7

2.0

1.41

1.42

g/l

0.03

245

Injury of muscle and tendon at lower leg level

261

2275

1.15

1.45

1.8

1.7

1.63

1.52

g/l

1.07

228

1965

Use of antiglaucoma preparations and miotics

181

1536

1.19

1.45

1.8

1.7

1.53

1.52

g/l

0.07

150

1303

Maternal care for cervical incompetence

430

1.36

1.45

1.8

2.0

1.24

1.50

g/l

1.46

383

Cerebral atherosclerosis

180

1.59

1.45

1.5

1.8

1.66

1.67

g/l

0.03

160

Benign neoplasm: Pharynx, unspecified

1.87

1.45

1.1

2.5

1.84

1.44

g/l

—

125

1.70

1.45

3.5

2.0

1.34

1.12

g/l

0.40

116

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

254

1.48

1.43

1.9

1.8

1.36

1.50

g/l

0.49

222

Hypertrophy of breast

162

1922

0.84

1.43

1.7

1.52

1.54

g/l

0.07

141

1636

Other and/or unspecified nontoxic goitre

142

1180

1.21

1.42

1.5

1.7

1.53

1.59

g/l

0.42

129

1008

Propionic acid derivatives

733

3388

1.09

1.41

1.8

2.0

1.52

1.42

g/l

2.07

641

2894

Pregnancy with abortive outcome

1187

5814

1.07

1.41

1.8

1.52

1.50

g/l

0.41

1013

4982

Unspecified lump in breast

244

2122

1.16

1.41

1.5

1.6

1.46

1.59

g/l

1.47

211

1796

Hypermetropia

106

855

1.25

1.41

1.3

1.8

1.46

1.47

g/l

0.04

744

Hypermobility syndrome

423

1.36

1.41

1.6

2.0

1.23

1.37

g/l

0.60

370

Male infertility

441

1.35

1.40

1.7

1.8

1.32

1.49

g/l

0.88

381

Dental pulpitis 3, only avohilmo

141

853

1.21

1.39

2.5

2.4

1.10

1.11

g/l

0.03

123

764

Lichen ruber planus, wide definition including periferal and oral lichen planus

378

3386

1.12

1.39

1.7

1.6

1.46

1.59

g/l

1.87

323

2905

Nontoxic multinodular goitre

366

3274

1.12

1.38

1.6

1.65

1.60

g/l

0.40

311

2793

Other disorders of bone density and structure

256

1.46

1.38

1.3

2.4

1.54

1.42

g/l

0.33

225

Sixth [abducent] nerve palsy

487

1.33

1.37

1.8

1.9

1.61

1.50

g/l

0.33

434

Benign neoplasm: Lip

307

1.42

1.37

1.4

1.9

1.39

1.50

g/l

0.43

268

Carcinoma in situ of cervix uteri

786

1.25

1.37

1.8

2.0

1.45

1.35

g/l

0.43

679

Schizoid personality disorder

191

1.54

1.37

1.3

2.4

1.91

1.44

g/l

1.33

167

Chronic suppurative otitis media

122

1004

1.22

1.36

1.8

1.49

1.48

g/l

0.03

106

874

Other diseases of gallbladder

664

1.28

1.35

1.9

1.7

1.30

1.50

g/l

1.22

577

Postmenopausal atrophic vaginitis

351

2368

0.89

1.35

1.7

1.47

1.61

g/l

1.92

306

1994

Melanoma in situ, other sites/unspecified

2.20

1.34

2.2

1.9

1.38

1.76

g/l

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

427

3215

1.11

1.34

1.5

1.93

1.54

g/l

10.39

357

2721

Sacrococcygeal disorders, not elsewhere classified

308

1.41

1.33

2.0

1.9

1.41

1.48

g/l

0.22

261

Perineal laceration during delivery

171

1294

1.18

1.33

1.9

2.0

1.12

1.29

g/l

2.14

149

1138

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

297

2479

1.14

1.33

1.5

1.95

1.53

g/l

8.56

252

2098

Foreign body or object entering through skin

791

1.25

1.32

1.5

1.9

1.46

1.51

g/l

0.23

695

Oral lichen ruber planus wide, hypothyreosis or thyroxin

711

1.26

1.32

2.0

1.7

1.35

1.58

g/l

1.93

622

Tuberculosis

140

1173

1.20

1.32

1.5

1.7

1.47

1.54

g/l

0.43

120

990

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

197

1697

1.17

1.32

1.6

1.54

g/l

0.00

163

1456

Graves disease, strict definition

135

1126

1.21

1.31

1.7

1.8

1.46

1.51

g/l

0.33

112

974

Bruxism

153

1.59

1.30

1.6

2.5

1.64

1.36

g/l

0.65

133

Female infertility, tubal origin

421

1.34

1.29

2.1

1.8

1.44

1.46

g/l

0.07

367

Crossbite

593

1.27

1.29

1.4

2.1

1.39

1.34

g/l

0.19

521

Inflammatory diseases of prostate (prostatitis)

267

2356

1.14

1.29

1.4

1.6

1.55

1.54

g/l

0.03

217

2013

Disorders of lacrimal system and orbit in diseases classified elsewhere

277

1.43

1.28

1.6

1.7

1.43

1.47

g/l

0.13

240

Dental caries 2, only avohilmo

1364

10173

1.06

1.28

2.0

1.8

1.41

1.49

g/l

2.85

1182

8772

Femoral hernia, unilateral

371

1.37

1.28

1.4

1.9

1.60

1.62

g/l

0.03

327

Inguinal hernia, unilateral

371

1.37

1.28

1.4

1.9

1.60

1.62

g/l

0.03

327

Inguinal of femoral hernia, unilateral

371

1.37

1.28

1.4

1.9

1.60

1.62

g/l

0.03

327

Cluster headache, strict, including avohilmo

492

1.31

1.28

1.4

2.0

1.40

1.47

g/l

0.28

431

Other congenital malformations of circulatory system

286

1.42

1.27

1.6

2.1

1.13

1.51

g/l

2.07

251

Ill-defined and unknown causes of mortality

101

1232

0.81

1.26

1.6

1.7

1.55

1.52

g/l

0.12

1028

Perichondritis of external ear

262

1.44

1.26

1.6

1.9

1.56

1.61

g/l

0.08

233

Acute appendicitis, with complications

361

3248

1.12

1.25

2.0

1.7

1.59

1.55

g/l

0.37

311

2774

Benign neoplasm: salivary glands, exclude unknown (D119)

160

1364

1.18

1.25

1.5

1.8

1.67

1.54

g/l

0.93

133

1181

Fall on and from ladder

153

1300

1.19

1.25

2.1

1.8

1.43

1.53

g/l

0.79

128

1127

Medial epicondylitis

416

1.33

1.24

1.5

1.8

1.49

1.60

g/l

0.41

356

Sequelae of tuberculosis

314

1.39

1.23

1.9

1.7

1.37

1.53

g/l

0.46

279

Cervicobrachial syndrome

358

3224

1.11

1.22

1.6

1.7

1.49

1.54

g/l

0.46

303

2745

Malignant neoplasm, without specification of site

488

1.31

1.22

1.9

1.7

1.83

1.56

g/l

0.73

420

Postprocedural disorders of eye and adnexa, not elsewhere classified

2.21

1.22

2.1

3.3

1.35

1.31

g/l

—

L02BA Anti-estrogens

192

2211

0.86

1.22

1.5

1.6

1.78

1.61

g/l

1.16

157

1876

Allergic contact dermatitis

195

1692

1.16

1.21

1.7

1.8

1.55

1.54

g/l

0.04

171

1461

Hydrocephalus

109

1312

0.82

1.20

1.4

1.8

1.60

1.52

g/l

0.45

1114

Burn and corrosion of shoulder and upper limb, except wrist and hand

231

1.45

1.19

1.6

2.0

1.52

1.44

g/l

0.17

207

Toxic effect of corrosive substances

2.06

1.19

1.3

2.2

1.45

1.28

g/l

—

Retinal breaks without detachment

280

2494

1.13

1.18

1.7

1.49

1.59

g/l

1.09

237

2132

Persistent delusional disorders

127

1067

1.20

1.18

1.4

1.8

1.75

1.53

g/l

1.71

115

921

Generalized epilepsy, mode (most common among epilepsy diagnosis)

316

1.37

1.18

1.7

2.2

1.26

1.38

g/l

0.26

283

Degenerative diseases of the nervous system

720

5819

0.93

1.17

1.5

1.6

1.60

1.56

g/l

0.52

552

4931

L02BB Anti-androgens

221

1943

1.15

1.17

1.4

1.7

1.78

1.54

g/l

2.46

185

1639

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

1.85

1.17

1.2

1.3

1.45

1.54

g/l

0.14

Deep bite

144

1069

1.18

1.17

1.9

2.0

1.23

1.43

g/l

2.37

122

932

Retained placenta and membranes, without haemorrhage

153

1307

1.18

1.17

1.8

1.7

1.44

1.58

g/l

1.07

133

1123

Hyperkinetic disorders

112

918

1.21

1.17

1.8

2.1

1.25

1.23

g/l

0.09

808

Congenital malformations of genital organs

113

934

1.21

1.16

1.7

1.9

1.33

1.40

g/l

0.35

816

Polycystic ovarian syndrome

464

1.30

1.16

2.4

2.1

1.29

1.17

g/l

0.55

403

Deep endometriosis

101

1221

0.82

1.16

1.6

1.8

1.48

1.51

g/l

0.10

1043

Placenta praevia

317

1.36

1.15

2.7

1.9

1.23

1.32

g/l

0.30

264

Vascular dementia (subcortical)

502

1.29

1.15

1.4

1.7

1.45

1.53

g/l

0.31

425

Tonsillectomy and adenotomy

750

5602

0.93

1.15

2.2

1.9

1.37

1.40

g/l

0.35

649

4846

Delivery

665

3792

0.93

1.14

1.8

1.44

1.56

g/l

2.95

580

3252

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

732

0.77

1.14

1.5

1.92

1.49

g/l

2.54

607

Contracture of muscle

2.06

1.14

1.1

1.6

1.38

1.50

g/l

—

Contact with and exposure to communicable diseases

344

3790

0.90

1.13

2.1

1.9

1.29

1.36

g/l

0.71

283

3302

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

520

1.28

1.13

1.7

1.9

1.36

1.53

g/l

0.79

450

Peritonsillar abscess

321

2890

1.11

1.12

1.8

1.54

1.45

g/l

0.98

280

2490

Hypersensitivity pneumonitis due to organic dust

226

1.44

1.12

1.4

2.2

1.72

1.46

g/l

0.58

201

Explosion of other materials

2.34

1.12

4.0

2.5

1.55

1.62

g/l

—

Open bite

423

1.31

1.12

1.7

2.2

1.22

1.33

g/l

0.32

380

Acute appendicitis

1356

12163

1.05

1.11

1.7

1.52

1.51

g/l

0.29

1171

10434

Emotional disorders and disorders of social functioning with onset specific to childhood

409

1.31

1.11

2.5

2.3

1.19

1.11

g/l

0.32

367

Endocrine disorders, other/unspecified

218

1.44

1.11

1.8

2.1

1.47

g/l

0.00

193

Benign neoplasm: Skin, unspecified

522

1.28

1.11

1.6

1.9

1.57

1.53

g/l

0.12

457

Preparation and fitting of bite rail to mouth

191

1669

1.15

1.10

1.8

1.47

1.53

g/l

0.43

164

1442

Melanoma in situ of upper limb, including shoulder

1.70

1.10

1.4

2.1

1.09

1.52

g/l

0.88

Contraceptive management

475

3637

0.92

1.10

2.1

1.8

1.33

1.54

g/l

5.61

413

3139

Benign neoplasm: Pituitary gland, craniopharyngeal duct

675

1.24

1.09

1.5

1.9

1.48

1.50

g/l

0.09

591

Benign neoplasm of breast

185

1614

1.15

1.09

2.0

1.7

1.59

1.58

g/l

0.03

157

1367

Benign neoplasm of major salivary glands

179

1559

1.16

1.09

1.6

1.7

1.69

1.54

g/l

1.19

151

1338

Anomalies of dental arch relationship, including avohilmo

259

2073

1.13

1.08

1.8

1.9

1.36

1.45

g/l

0.87

217

1793

Graves ophthalmopathy

270

1.39

1.08

1.6

1.8

1.46

1.49

g/l

0.10

234

TMD related pain

304

1.36

1.08

1.6

2.1

1.46

1.40

g/l

0.14

271

Oral lichen ruber planus

305

1.36

1.07

2.3

2.1

1.38

1.53

g/l

0.50

270

Infections of genitourinary tract in pregnancy

119

1004

1.19

1.07

1.8

1.9

1.44

1.48

g/l

0.19

104

866

Malignant neoplasm of oropharynx

220

1.43

1.07

2.5

2.2

1.28

1.50

g/l

0.79

189

Acute poliomyelitis

162

1.51

1.06

1.5

2.3

1.69

1.48

g/l

0.44

144

Glaucoma suspect

744

6970

1.07

1.06

1.6

1.52

1.59

g/l

1.27

628

5934

Other acute disseminated demyelination

1.69

1.05

2.0

2.3

1.37

1.34

g/l

0.07

Postprocedural disorders of nervous system

714

1.22

1.05

1.7

2.0

1.41

g/l

0.01

631

Lesion of medial popliteal nerve

1.98

1.04

1.3

2.4

1.54

g/l

—

Injury of nerves at wrist and hand level

447

1.29

1.03

2.2

2.1

1.54

1.48

g/l

0.16

382

Bicipital tendinitis

635

1.24

1.03

2.0

1.7

1.50

1.55

g/l

0.18

543

Cluster headache, wide,, including avohilmo

536

1.26

1.03

1.4

2.0

1.37

1.48

g/l

0.47

466

Residual foreign body in soft tissue

581

1.25

1.03

1.4

1.8

1.54

1.52

g/l

0.07

494

Melanocytic naevi of other and unspecified parts of face

735

1.22

1.03

2.4

1.9

1.25

1.53

g/l

2.51

642

Otorrhoea

2.07

1.02

1.9

2.0

1.46

1.59

g/l

—

Drug-induced headache, not elsewhere classified

1.92

1.02

1.4

2.3

1.02

1.29

g/l

—

Burn and corrosion confined to eye and adnexa

239

1.40

1.02

1.3

2.3

1.55

1.45

g/l

0.19

210

Effects of foreign body entering through natural orifice

412

3780

1.09

1.02

1.7

1.8

1.57

1.50

g/l

0.84

338

3264

malignant neoplasm of female genital organs

256

2296

1.12

1.01

1.8

1.6

1.74

1.61

g/l

1.12

203

1959

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

203

1797

1.14

1.00

1.6

1.7

1.73

1.55

g/l

1.56

174

1541

Mouth breathing

752

7057

1.07

1.00

1.5

1.7

1.52

1.54

g/l

0.21

659

6043

Graves ophthalmopathy, strict

240

1.39

1.00

1.7

1.8

1.43

1.53

g/l

0.33

206

Contact with other sharp object(s)

719

1.22

1.00

1.8

2.0

1.30

1.45

g/l

0.93

623

Foreign body in respiratory tract

656

1.23

1.00

1.6

2.1

1.54

1.45

g/l

0.32

573

Respiratory tuberculosis

115

977

1.19

0.99

1.5

1.7

1.46

1.56

g/l

0.63

100

828

Endometriosis of rectovaginal septum and vagina

1036

0.83

0.99

1.4

1.8

1.56

1.54

g/l

0.06

880

TMD related operations

236

2108

1.12

0.99

1.8

1.48

1.52

g/l

0.25

201

1831

Alzheimer disease, excluding more controls

400

2446

1.10

0.99

1.5

1.7

1.56

1.58

g/l

0.10

302

2082

Crowding of teeth, including avohilmo

637

1.21

0.99

2.9

2.1

1.03

1.24

g/l

2.51

566

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

767

1.21

0.99

1.6

1.8

1.37

1.53

g/l

0.97

649

Respiratory tuberculosis, confirmed and not-confirmed

115

978

1.19

0.98

1.5

1.7

1.46

1.56

g/l

0.63

100

829

Apocrine sweat disorders, other sweat gland disorders

1.85

0.98

1.3

3.1

1.81

1.44

g/l

—

Asthma mixed form (mode)

630

1.23

0.98

1.4

1.6

1.59

1.50

g/l

0.36

531

Other conjunctival vascular disorders and cysts

302

1.34

0.97

1.5

1.8

1.60

1.54

g/l

0.14

271

Obstructed labour due to maternal pelvic abnormality

155

1776

0.87

0.97

1.9

1.7

1.67

1.61

g/l

0.32

136

1533

Benign neoplasm: Skin of lower limb, including hip

355

1.31

0.96

1.3

1.9

1.53

1.49

g/l

0.11

311

Malignant neoplasm of tonsil

200

1.42

0.96

2.7

2.2

1.27

1.46

g/l

0.59

172

Parkinson's disease, including avohilmo

340

3108

1.10

0.94

1.5

1.7

1.59

1.57

g/l

0.15

283

2659

Convergence insufficiency and excess

109

1.58

0.94

1.1

1.9

1.38

1.27

g/l

0.14

Diseases of appendix

1470

12825

1.05

0.94

1.7

1.8

1.53

1.51

g/l

0.36

1264

10991

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

343

3012

1.10

0.93

1.6

1.62

g/l

0.02

282

2551

Disturbance of activity and attention

101

842

1.19

0.93

1.8

2.1

1.28

1.21

g/l

0.35

738

Femoral hernia

672

1.22

0.92

1.4

1.8

1.48

1.58

g/l

0.32

585

Stenosis and insufficiency of lacrimal passages

160

1404

1.15

0.92

1.4

1.8

1.50

1.53

g/l

0.16

132

1204

Other and unspecified hypertrophic disorders of skin

1.78

0.92

2.0

2.8

1.08

1.36

g/l

0.64

Gluteal tendinitis

402

1.28

0.91

1.5

1.9

1.55

1.56

g/l

0.01

348

Other specified disorders of external ear

592

1.23

0.91

1.7

1.9

1.53

1.52

g/l

0.01

513

Disorders of aromatic amino-acid metabolism

2.13

0.91

1.3

1.4

1.31

1.41

g/l

—

Benign leiomyoma with endometriosis

226

2029

1.12

0.90

1.5

1.6

1.61

1.60

g/l

0.01

184

1731

Amblyopia ex anopsia

439

1.26

0.89

2.4

2.0

1.23

1.48

g/l

1.69

402

Appendicitis, broad definition

1453

12737

1.04

0.89

1.7

1.53

1.51

g/l

0.38

1250

10917

Pollen allergy

226

2007

1.12

0.89

1.8

2.0

1.28

1.38

g/l

1.05

195

1722

Idiopathic peripheral autonomic neuropathy

1.92

0.89

2.4

1.7

1.52

1.56

g/l

—

Non-allergic asthma

151

1324

1.15

0.88

1.5

1.8

1.52

1.51

g/l

0.06

133

1148

Dementia in other diseases classified elsewhere

768

1.20

0.88

1.4

1.8

1.51

1.50

g/l

0.02

659

Benign neoplasm of other and unspecified sites

351

1.29

0.88

1.6

1.8

1.53

1.46

g/l

0.19

307

Muscle strain

351

1.29

0.88

2.4

1.9

1.90

1.52

g/l

1.14

297

Foreign body entering into or through eye or natural orifice

128

1110

1.16

0.88

2.0

1.9

1.46

1.52

g/l

0.29

110

961

Spermatocele

161

1420

1.14

0.88

1.4

1.6

1.48

1.53

g/l

0.31

137

1217

Endometriosis of ovary

242

2178

1.11

0.88

1.9

1.8

1.40

1.54

g/l

1.35

207

1849

Benign neoplasm: Parotid gland

139

1214

1.15

0.87

1.6

1.8

1.65

1.53

g/l

0.77

114

1063

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

299

1.32

0.87

2.1

1.6

1.85

1.58

g/l

0.79

263

Disorders of male genital organs in diseases classified elsewhere

1.70

0.87

1.3

1.5

1.40

1.59

g/l

0.47

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

997

0.84

0.86

1.6

1.8

1.62

1.54

g/l

0.36

864

Cholesteatoma of middle ear

866

0.83

0.86

2.0

1.8

1.53

1.54

g/l

0.01

754

Mixed disorders of conduct and emotions

187

1.40

0.85

1.8

2.5

1.49

1.19

g/l

0.52

170

Adenomyosis (Endometriosis of uterus)

208

1867

1.12

0.84

1.6

1.7

1.48

1.59

g/l

0.92

171

1579

248

1.34

0.84

1.9

2.0

1.60

1.54

g/l

0.11

217

Scissor bite

187

1.39

0.84

4.2

2.2

1.03

1.26

g/l

0.67

171

Other ill-defined and unspecified causes of mortality

1079

0.85

0.83

1.6

1.7

1.54

1.53

g/l

0.03

904

Oesophagitis, drug-induced

1.94

0.83

1.2

2.1

1.94

1.64

g/l

—

Other benign neoplasms of uterus

773

1.19

0.83

1.8

1.6

1.63

1.58

g/l

0.20

663

Acute appendicitis, no complications

995

9459

1.05

0.82

1.6

1.8

1.50

1.49

g/l

0.10

860

8134

Prolapse and hernia of ovary and fallopian tube

675

1.20

0.82

1.4

1.7

1.66

1.60

g/l

0.20

550

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

198

1.39

0.82

1.3

1.9

1.42

1.59

g/l

0.54

173

Schizotypal disorder

206

1.37

0.82

1.6

2.2

1.72

1.41

g/l

0.88

181

Adenocarcinoma of pancreas

442

0.76

0.82

1.3

1.9

1.62

1.59

g/l

0.07

389

Undescended testicle

1.59

0.81

1.6

1.9

1.03

1.29

g/l

0.79

Pregnancy, childbirth and the puerperium

586

2875

1.07

0.81

1.8

1.7

1.48

1.55

g/l

1.00

499

2438

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.76

0.81

1.4

1.7

1.66

1.59

g/l

—

Injury of muscle and tendon at hip and thigh level

149

1316

1.14

0.81

1.9

1.8

1.63

1.52

g/l

0.66

135

1125

Other degenerative diseases of the basal ganglia

251

1.34

0.80

1.3

2.2

1.41

1.52

g/l

0.33

221

Vascular dementia

194

1684

1.12

0.80

1.5

1.6

1.52

1.51

g/l

0.09

156

1420

Adenocarcinoma and papilloma adenocarcinoma of rectum

192

1725

1.12

0.79

1.6

1.7

1.72

1.55

g/l

1.35

165

1477

Atopic conjunctivitis

456

1.24

0.79

2.0

1.9

1.40

1.46

g/l

0.20

408

Malignant neoplasm of rectum

191

1717

1.12

0.78

1.6

1.7

1.71

1.55

g/l

1.25

164

1470

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

376

1.26

0.78

1.6

1.7

1.90

1.60

g/l

0.76

329

Other disorders affecting eyelid function

107

1.52

0.78

1.3

1.9

1.39

1.43

g/l

0.10

Other abnormal products of conception

369

2274

1.08

0.77

2.0

1.30

1.34

g/l

0.46

330

1975

Benign neoplasm: Brain, unspecified

1.73

0.77

1.2

2.2

1.62

1.53

g/l

—

Other and unspecified mononeuropathies of lower limb

359

1.27

0.77

1.5

1.8

1.73

1.59

g/l

0.40

313

Heterophoria

110

956

1.16

0.76

1.5

1.9

1.48

1.47

g/l

0.06

843

Vasomotor rhinitis (mode)

114

994

1.15

0.76

1.5

1.9

1.48

1.53

g/l

0.20

858

Any dementia

847

6267

0.95

0.76

1.5

1.6

1.61

1.57

g/l

0.79

655

5340

LSIL lesion of the cervix uteri

118

1031

1.15

0.75

1.8

1.9

1.41

1.42

g/l

0.03

103

887

Triptan medication for migraine, single purchase ok

1227

8650

0.96

0.74

1.9

1.8

1.39

1.49

g/l

3.57

1050

7450

Migraine, single triptan purchase ok & required. ICD-code if available is included

1227

8650

0.96

0.74

1.9

1.8

1.39

1.49

g/l

3.57

1050

7450

Allergic rhinitis

429

3968

1.07

0.74

1.7

1.8

1.39

1.43

g/l

0.47

367

3422

Presbyopia

708

1.18

0.74

1.9

1.8

1.63

1.57

g/l

0.21

615

Amoebiasis

1.63

0.73

1.4

1.7

2.16

1.52

g/l

—

Persons encountering health services in circumstances related to reproduction

872

5631

1.05

0.73

2.0

1.8

1.34

1.54

g/l

8.12

740

4843

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.61

0.73

1.4

1.7

1.72

1.50

g/l

0.54

Hydatidiform mole

109

0.55

0.73

4.5

2.1

0.90

1.39

g/l

—

Medicines for HER+ breast cancer

522

5400

0.94

0.72

1.5

1.7

1.69

1.60

g/l

0.96

427

4597

Hepatocellular carcinoma

345

1.26

0.72

1.6

1.9

1.12

1.53

g/l

2.64

298

Dementia, including avohilmo

1012

7287

0.96

0.72

1.4

1.6

1.60

1.57

g/l

0.50

799

6215

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

109

1.49

0.72

3.0

2.5

1.45

1.53

g/l

0.11

Benign neoplasm: Cranial nerves

318

1.27

0.71

1.6

1.7

1.75

1.51

g/l

0.85

277

Childhood allergy (age < 16)

165

1217

1.12

0.71

2.7

2.3

1.15

1.13

g/l

0.11

145

1084

Other and unspecified disorders of vitreous body

783

7423

1.05

0.70

1.8

1.6

1.49

1.60

g/l

2.69

679

6323

Intermittent heterotropia

582

1.19

0.70

1.7

2.0

1.43

1.38

g/l

0.18

515

Malignant neoplasm of breast, HER-negative

295

3187

0.92

0.70

1.7

1.6

1.59

1.62

g/l

0.20

245

2712

Use of levodopa decarboxylase inhibitor

283

2613

1.09

0.69

1.5

1.7

1.55

g/l

0.05

239

2232

Vasomotor and allergic rhinitis

600

5596

1.06

0.69

1.6

1.8

1.40

1.46

g/l

0.98

511

4817

conjunctival degenerations and deposits

284

1.28

0.69

2.4

1.7

1.54

1.55

g/l

0.02

253

Unattended death

120

0.57

0.69

1.4

2.1

1.75

1.44

g/l

—

106

Dementia

948

6832

0.96

0.68

1.4

1.6

1.60

1.57

g/l

0.56

740

5827

Calcific tendinitis of shoulder

696

1.17

0.67

1.7

1.74

1.61

g/l

0.54

598

Certain zoonotic bacterial diseases

223

1.31

0.67

1.9

2.1

1.26

1.47

g/l

0.46

199

Other specified and unspecified disorders of conjunctiva

111

1.46

0.67

3.0

1.9

1.52

1.58

g/l

0.11

Adenocarcinoma and ductal carcinoma of pancreas

548

0.81

0.66

1.2

1.9

1.65

1.55

g/l

0.33

480

Allergic colitis

162

1.36

0.66

2.9

2.5

1.01

1.16

g/l

0.34

145

Other disorders of amniotic fluid and membranes

126

1109

1.13

0.65

1.8

1.9

1.29

1.34

g/l

0.25

110

951

Benign neoplasm: Other/unspecified site

163

1.36

0.65

1.8

1.7

1.78

1.54

g/l

0.55

144

Hypertrophy of breast in women and men

224

2441

0.92

0.65

1.7

1.51

1.53

g/l

0.11

196

2083

Pedal cyclist injured in other and unspecified transport accidents

171

1548

1.11

0.65

1.6

1.8

1.46

1.51

g/l

0.22

145

1337

Embolism and thrombosis of abdominal aorta

1.78

0.65

1.0

1.4

1.89

1.71

g/l

—

Foreign body in ear

198

1.33

0.65

1.8

2.2

1.79

1.39

g/l

0.98

174

Dislocation, sprain and strain of joints and ligaments of elbow

690

1.16

0.64

1.7

1.8

1.44

g/l

0.00

601

Brain meningioma

700

1.16

0.64

1.9

1.8

1.63

1.54

g/l

0.25

608

Glaucoma-related operations

109

963

1.14

0.64

1.6

1.7

1.56

1.54

g/l

0.07

824

Contact with blunt object, undetermined intent

1.58

0.63

1.9

2.4

1.33

1.46

g/l

0.21

Increased muscle tone

1.57

0.63

1.4

2.3

1.57

1.45

g/l

0.14

Oher contracture of tendon (sheath)

1.64

0.62

1.3

2.0

1.19

1.35

g/l

—

Malignant neoplasm of corpus uteri

136

1220

1.12

0.62

1.9

1.6

1.66

1.60

g/l

0.23

105

1035

Other specified transport accidents

1.63

0.62

1.6

1.9

1.15

1.42

g/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

576

0.83

0.61

1.4

2.0

1.51

1.55

g/l

0.11

499

Alcoholic cardiomyopathy

1.56

0.60

1.5

1.36

1.42

g/l

0.11

Exposure to noise

0.00

0.60

0.0

1.4

—

1.44

—

Benign neoplasm: Brain, unspecified

1.59

0.59

1.2

2.2

1.62

1.57

g/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.59

0.59

1.4

1.8

1.67

1.61

g/l

—

Other and unspecified degenerative diseases of nervous system

373

1.22

0.59

1.3

1.7

1.67

1.57

g/l

0.28

321

Traumatic amputation of wrist and hand

659

0.84

0.59

1.7

1.9

1.51

1.55

g/l

0.11

570

Cerebral amyloid angiopathy

1.51

0.58

1.6

1.07

1.60

g/l

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

136

1303

0.90

0.58

1.8

1.6

1.65

1.57

g/l

0.44

101

1105

Injury of nerves at hip and thigh level

1.51

0.58

4.1

2.1

1.56

1.67

g/l

—

Medical abortion

1093

5724

1.04

0.58

1.8

1.55

1.50

g/l

0.98

935

4907

Benign neoplasm of other and unspecified female genital organs

530

1.18

0.58

1.7

1.8

1.63

1.58

g/l

0.10

459

Other bursitis of knee

158

1.34

0.58

1.6

1.9

1.48

1.46

g/l

0.03

136

Malignant neoplasm of mesothelium and soft tissue

708

1.15

0.58

1.4

1.9

2.07

1.52

g/l

3.02

614

Carcinoma in situ of breast, other/unspecified

172

0.69

0.57

1.9

2.1

1.57

1.61

g/l

—

152

Other and unspecified intracranial injuries

402

1.20

0.57

1.6

2.0

1.89

1.52

g/l

2.13

356

Benign neoplasm: Floor of mouth

1.65

0.56

1.3

2.2

1.44

1.38

g/l

—

Malignant neoplasm of eye, brain and central nervous system

569

0.84

0.55

1.9

1.47

1.51

g/l

0.11

508

Vertical strabismus

394

1.20

0.55

1.8

2.1

1.32

1.47

g/l

0.57

356

Retinoschisis and retinal cysts

367

1.21

0.55

1.4

1.9

1.52

1.58

g/l

0.14

320

Hyperprolactinaemia, drug-induced

1.52

0.55

1.3

3.0

1.29

1.53

g/l

—

Benign neoplasm: Rectum/anal canal icd-9

116

1.40

0.55

2.1

1.6

1.65

1.62

g/l

—

103

Carcinoma in situ of cervix uteri

870

1.13

0.55

1.8

2.0

1.45

1.37

g/l

0.34

760

Spinal enthesopathy

449

1.18

0.55

1.4

1.6

1.44

1.56

g/l

0.39

373

Benign neoplasm of thyroid gland

416

0.81

0.55

2.2

1.8

1.53

1.51

g/l

0.02

361

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

1.51

0.54

1.4

1.9

1.71

1.59

g/l

0.14

Calcific tendinitis

108

1.41

0.54

1.7

1.6

1.40

1.56

g/l

0.29

Dental caries 1 and operation codes, only avohilmo

561

2960

0.95

0.53

1.7

1.9

1.51

1.49

g/l

0.21

486

2545

Benign neoplasm: Choroid

907

0.88

0.53

1.5

1.9

1.53

1.54

g/l

0.01

782

Phakomatoses, not elsewhere classified

117

1.38

0.53

1.4

2.4

1.29

1.35

g/l

0.20

103

Divergent concomitant strabismus

104

930

1.12

0.53

1.6

1.9

1.53

1.51

g/l

0.09

818

Malignant neoplasm of hypopharynx

1.44

0.53

1.1

1.6

1.67

1.52

g/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

522

0.84

0.52

1.8

1.35

1.61

g/l

0.88

464

Status post-ami

141

1269

0.91

0.52

1.3

1.7

1.74

1.54

g/l

1.51

115

1062

Benign neoplasm of brain and other parts of central nervous system

102

913

1.12

0.52

1.6

1.9

1.61

1.52

g/l

0.45

791

Desensitization to allergens

471

1.17

0.51

1.8

2.0

1.30

1.37

g/l

0.27

422

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

306

1.22

0.51

1.9

2.0

1.36

1.53

g/l

0.68

275

Malignant neoplasm of ovary

594

1.15

0.50

1.5

1.8

2.09

1.61

g/l

2.13

517

Contact with other and unspecified heat and hot substances

1.51

0.50

3.9

1.9

1.03

1.38

g/l

—

Dystonia

670

1.14

0.49

2.0

1.9

1.48

1.55

g/l

0.23

588

Papillary adenocarcinoma of thyroid gland

642

1.14

0.49

1.8

1.35

1.57

g/l

1.16

558

Allergic contact dermatitis due to drugs in contact with skin

280

1.22

0.49

1.6

2.0

1.67

1.50

g/l

0.46

244

Contact with machinery

165

1791

0.92

0.49

1.5

1.8

1.52

1.51

g/l

0.02

142

1546

Other disorders of prostate

624

1.15

0.49

1.4

1.5

1.59

1.54

g/l

0.18

525

Disorder of the sleep-wake schedule

172

1.29

0.48

2.1

2.2

1.68

1.37

g/l

0.73

145

Non-small cell lung cancer

297

3152

0.94

0.48

1.5

1.6

1.95

1.56

g/l

7.42

252

2660

Parkinson's disease

316

2983

1.06

0.48

1.5

1.7

1.58

1.57

g/l

0.09

261

2557

Ménière disease

164

1512

1.09

0.48

1.6

1.7

1.59

1.55

g/l

0.23

140

1295

Benign neoplasm: Cerebral meninges

148

1359

1.09

0.47

1.8

1.7

1.53

1.58

g/l

0.20

128

1161

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

579

1.14

0.47

1.9

1.7

1.76

1.45

g/l

1.44

500

Spontaneous abortion

614

4351

0.96

0.46

1.9

1.8

1.35

1.47

g/l

2.43

536

3752

Labour and delivery complicated by umbilical cord complications

421

1.17

0.46

2.0

1.9

1.64

1.50

g/l

0.31

368

Melanocytic naevi of ear and external auricular canal

1.41

0.45

1.3

1.9

1.10

1.53

g/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

962

7602

1.03

0.45

1.9

1.8

1.45

1.48

g/l

0.62

822

6542

Prophylactic surgery

1.41

0.45

1.0

2.0

1.99

1.29

g/l

—

Glaucoma, exfoliation

206

2205

0.93

0.45

1.8

1.6

1.50

1.54

g/l

0.20

175

1854

Early lumbar disc prolapse operation

990

0.90

0.45

1.6

1.8

1.54

1.40

g/l

0.62

854

Pedestrian injured in collision with pedal cycle

404

1.17

0.44

2.0

2.1

1.37

1.55

g/l

0.61

358

Noise effects on inner ear

640

0.87

0.44

1.4

1.8

1.45

1.55

g/l

0.40

552

Single delivery by forceps and vacuum extractor

133

884

0.91

0.44

1.6

2.1

1.17

1.32

g/l

1.15

118

764

Severe bullous disorders, KELA reimbursement

1.66

0.44

1.4

2.0

1.07

1.93

g/l

—

Parkinson's disease, strict definition

294

2780

1.06

0.44

1.5

1.7

1.54

1.56

g/l

0.16

242

2382

Benign neoplasm of meninges

165

1530

1.08

0.43

1.7

1.57

g/l

0.03

143

1301

Other vitreous opacities

556

1.14

0.43

1.3

1.8

1.48

1.53

g/l

0.16

481

Malignant neoplasm of liver and intrahepatic bile ducts

547

1.14

0.43

1.6

1.9

1.27

1.53

g/l

1.61

471

Injury of blood vessels at lower leg level

1.40

0.42

1.3

1.9

1.49

1.46

g/l

—

Other appendicitis

123

1128

1.09

0.42

1.7

1.8

1.63

1.56

g/l

0.27

104

977

Juvenile dermatomyositis

0.00

0.42

0.0

1.5

—

1.14

—

Other obstructed labour

727

1.12

0.42

1.9

1.8

1.40

1.58

g/l

0.95

633

Endometriosis of fallopian tube

1.37

0.41

1.7

2.8

1.28

1.35

g/l

—

Cyst of Bartholin Gland

361

1.17

0.41

1.3

2.1

1.12

1.50

g/l

2.62

316

Mandibular retrognathia

612

0.88

0.40

1.5

2.2

1.19

1.40

g/l

1.30

547

Other congenital malformations of upper alimentary tract

104

0.66

0.40

1.1

2.4

1.32

1.47

g/l

—

Benign neoplasm of bone and articular cartilage

882

1.10

0.40

1.8

1.7

1.42

1.51

g/l

0.57

763

Benign neoplasm: Bones of skull and face

101

0.69

0.40

1.3

2.3

1.18

1.39

g/l

—

Other superficial injuries of ankle and foot

1.32

0.40

1.9

2.1

1.28

1.54

g/l

—

Use of amantadine

187

1.24

0.39

1.5

2.0

1.37

1.54

g/l

0.51

161

Adrenomedullary hyperfunction

1.41

0.39

2.4

2.1

1.48

1.61

g/l

—

Carcinoma in situ of breast, intraductal

895

1.10

0.38

1.5

1.6

1.71

1.62

g/l

0.32

756

Systemic atrophies primarily affecting the central nervous system

631

0.88

0.38

1.8

1.9

1.45

1.54

g/l

0.30

553

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

122

1127

1.09

0.37

1.5

1.8

1.37

1.56

g/l

1.36

101

983

Benign neoplasm: Retina

0.64

0.36

1.4

2.1

0.88

1.61

g/l

—

128

1379

0.92

0.36

1.6

1.7

1.15

1.54

g/l

5.33

1169

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

1.45

0.36

2.3

2.6

1.28

1.48

g/l

—

Mucinous and mucinous cystic tumor

1.45

0.36

2.2

2.1

2.38

1.69

g/l

—

Lyme disease

401

4176

0.96

0.35

1.7

1.36

1.56

g/l

5.40

330

3584

Triptan medication for migraine, min. 3 purchases

744

6047

0.97

0.35

1.7

1.9

1.42

1.43

g/l

0.15

626

5253

Injury of muscle and tendon at forearm level

209

1.20

0.34

1.6

2.0

1.55

1.46

g/l

0.22

187

Meningitis, viral

1.35

0.34

1.2

2.9

0.96

1.33

g/l

—

Nontoxic goitre/thyroid nodule

530

5123

1.04

0.34

1.6

1.61

1.59

g/l

0.28

455

4346

Lumbosacral plexus disorders

1.32

0.33

1.3

1.9

2.10

1.73

g/l

—

Benign neoplasm: Floor of mouth

1.32

0.33

1.3

2.1

1.44

1.56

g/l

—

Postpartum haemorrhage due to retained placenta

121

1124

1.08

0.33

2.2

2.1

1.00

1.30

g/l

4.96

103

985

Calculus of lower urinary tract

104

962

1.09

0.33

1.5

1.7

1.53

1.51

g/l

0.08

823

Nasal polyp

349

3349

1.04

0.33

1.6

1.7

1.59

1.54

g/l

0.48

294

2883

Normotensive glaucoma

162

1524

1.07

0.32

1.4

1.7

1.50

1.53

g/l

0.17

135

1309

Mumps

284

0.84

0.32

1.3

1.8

1.46

1.55

g/l

0.20

249

Mandibular hypoplasia

1.33

0.31

1.6

2.8

0.85

1.26

g/l

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

1.31

0.31

4.1

2.7

0.82

1.60

g/l

—

Long labour

246

2047

1.05

0.31

2.2

1.9

1.36

1.41

g/l

0.35

219

1779

Occlusion and stenosis of arteries, not leading to stroke

212

1.19

0.30

1.6

1.8

1.80

1.55

g/l

0.63

185

Supervision of normal pregnancy

200

1082

1.06

0.30

1.8

1.22

1.49

g/l

4.42

173

939

Inflammation of lacrimal passages (chronic)

207

0.82

0.30

1.2

1.8

1.45

1.56

g/l

0.21

182

Accidental poisoning by and exposure to other gases and vapours

1.26

0.30

4.4

2.2

1.34

1.55

g/l

—

Benign neoplasm: Scapula and long bones of upper limb

108

0.74

0.29

1.6

1.9

1.58

1.45

g/l

—

Inflammatory disease of cervix uteri

815

0.92

0.28

1.4

1.8

1.59

g/l

0.00

702

Alzheimer’s disease, wide definition, excluding more controls

341

2231

1.04

0.28

1.5

1.7

1.61

1.58

g/l

0.21

257

1892

Lichen sclerosus et atrophicus

138

1300

1.06

0.28

1.6

1.7

1.69

1.59

g/l

0.51

109

1113

Primary open-angle glaucoma, strict

535

5495

0.97

0.28

1.5

1.6

1.59

g/l

0.01

430

4659

Complications of labour and delivery

919

5007

1.02

0.28

1.9

1.8

1.36

1.53

g/l

5.70

787

4310

Pterygium

480

0.89

0.28

1.4

1.8

1.35

1.54

g/l

0.83

422

Foreign body on external eye

201

2108

0.95

0.27

1.6

1.8

1.62

1.50

g/l

1.00

170

1822

Other lesions of median nerve

385

1.12

0.27

2.1

1.7

1.63

1.60

g/l

0.10

332

Other and unspecified disease of Bartholin gland

347

1.13

0.27

1.5

2.0

1.73

1.55

g/l

0.48

302

Use of levodopa decarbox-comt-inhibitor

531

0.90

0.27

1.4

1.9

1.83

1.56

g/l

1.71

460

Abnormalities of forces of labour

846

1.08

0.27

1.6

1.7

1.36

1.47

g/l

0.63

731

Carcinoma in situ of breast, lobular

0.69

0.26

1.2

2.1

1.99

1.56

g/l

—

Congenital malformations of eye, ear, face and neck

728

0.92

0.26

2.6

2.0

1.40

1.38

g/l

0.06

639

Dementia due to Parkinson's disease

404

0.89

0.26

1.4

2.0

1.46

1.52

g/l

0.17

351

Benign neoplasm of bone and articular cartilage

1038

0.93

0.26

1.8

1.42

1.53

g/l

0.76

906

Plantar fascial fibromatosis

131

1237

1.06

0.25

1.5

1.8

1.53

1.58

g/l

0.25

114

1051

Premature rupture of membranes

210

1475

1.05

0.25

1.8

2.0

1.22

1.35

g/l

1.62

177

1279

Foreign object accidentally left in body during surgical and medical care

1.37

0.24

7.0

2.5

1.42

g/l

—

Sequelae of inflammatory diseases of the central nervous system

1.37

0.24

1.8

1.7

1.31

1.65

g/l

—

Oral lichen ruber planus, including avohilmo

755

1.08

0.24

2.3

1.8

1.46

1.60

g/l

0.66

655

Endometriosis of pelvic peritoneum

192

1813

1.05

0.23

1.9

1.8

1.39

1.48

g/l

0.68

165

1546

Carcinoma in situ of breast, intraductal

1043

0.94

0.23

1.5

1.7

1.71

1.61

g/l

0.37

895

Benign neoplasm: Other/unspecified site

190

1.16

0.23

1.8

2.1

1.78

1.65

g/l

0.25

164

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.25

0.23

1.4

2.3

1.72

1.56

g/l

0.36

Erosion and ectropion of cervix uteri

361

1.11

0.23

1.5

1.8

1.69

1.64

g/l

0.10

311

Alzheimer’s disease (Late onset), excluding more controls

326

2103

1.04

0.23

1.5

1.6

1.60

1.58

g/l

0.09

246

1786

Other benign neoplasm of uterus: Other parts/unspecified

721

0.93

0.22

1.3

1.7

1.48

1.61

g/l

0.57

616

Accident to powered aircraft causing injury to occupant

0.00

0.22

0.0

3.6

—

1.24

—

Primary open-angle glaucoma

670

6668

0.98

0.22

1.6

1.56

1.59

g/l

0.35

545

5663

Endovascular or surgical operations to intracerebral aneurysms

875

1.07

0.22

2.0

1.7

1.64

1.57

g/l

0.31

763

Toxic effect of pesticides

0.00

0.21

0.0

2.8

—

1.56

—

Intracranial injury with prolonged coma

0.00

0.21

0.0

1.4

—

1.37

—

Retained (old) intraocular foreign body

0.00

0.21

0.0

3.2

—

1.57

—

Carcinoma in situ of breast, other/unspecified

145

0.82

0.21

1.9

1.7

1.57

1.58

g/l

—

130

Endometriosis ASRM stages 3,4

300

3095

0.97

0.21

1.8

1.7

1.43

1.52

g/l

0.95

252

2632

Malignant neoplasm of thyroid gland

877

1.06

0.21

2.1

1.8

1.52

1.54

g/l

0.09

767

Complications following abortion and ectopic and molar pregnancy

412

1.10

0.20

1.8

1.65

1.58

g/l

0.17

362

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.20

0.0

3.2

—

1.74

—

Other adrenocortical overactivity

1.26

0.20

3.8

2.6

1.72

1.32

g/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

118

1122

1.05

0.20

1.6

1.7

1.93

1.53

g/l

3.01

100

957

Non-small cell lung cancer, adenocarcinoma

118

1122

1.05

0.20

1.6

1.7

1.93

1.53

g/l

3.01

100

957

Brachial plexus disorders

985

0.94

0.20

1.6

1.9

1.39

1.54

g/l

1.00

853

Delayed puberty

1.23

0.20

4.7

2.7

0.97

1.05

g/l

—

Adenocarcinomas of cervix

1.18

0.19

2.3

2.6

1.28

1.42

g/l

—

Nontoxic single thyroid nodule

103

977

1.06

0.19

1.8

1.7

1.50

1.56

g/l

0.26

841

Benign lipomatous neoplasm of other sites/unspecified

153

1467

1.04

0.19

2.0

1.7

1.55

g/l

0.00

126

1261

Viral infections of central nervous system, not elsewhere classified/unspecified

109

1.20

0.18

1.2

2.2

1.28

1.41

g/l

0.35

Female genital prolapse

452

2671

0.98

0.18

1.5

1.7

1.60

1.57

g/l

0.26

391

2248

Other noninflammatory disorders of cervix uteri

668

1.07

0.18

1.7

1.62

1.61

g/l

0.01

563

Other and unspecified atrophic disorders of skin

0.76

0.17

4.0

2.9

0.81

1.42

g/l

—

Mesial bite

1.23

0.17

1.0

2.9

1.97

1.24

g/l

—

Neurofibromatosis, type 1

0.75

0.17

1.2

1.9

1.27

1.50

g/l

—

Carcinoma in situ of breast, lobular

0.71

0.17

1.2

1.9

1.99

1.64

g/l

—

Degenerative conditions of globe

1.18

0.17

3.8

1.7

1.81

1.52

g/l

—

Puerperal sepsis

143

1486

0.96

0.16

1.7

1.65

1.60

g/l

0.26

128

1278

Other benign neoplasm of uterus: Other parts/unspecified

632

1.06

0.16

1.3

1.5

1.48

1.60

g/l

0.54

545

Benign neoplasm: Endocrine pancreas

1.10

0.16

1.4

1.9

1.70

1.53

g/l

—

Benign neoplasm of eye and adnexa

161

1556

1.04

0.15

1.5

1.7

1.65

1.54

g/l

0.64

135

1337

Malignant neoplasm of breast, HER2-negative

763

5690

0.98

0.15

1.5

1.7

1.66

1.59

g/l

0.88

624

4843

Benign neoplasm: Choroid

761

1.05

0.15

1.4

1.6

1.53

1.52

g/l

0.05

655

FESS (DNB20)

167

1724

0.97

0.14

1.9

1.8

1.68

1.52

g/l

1.16

143

1487

Vestibular neuronitis

139

1342

1.04

0.14

1.7

1.8

1.44

1.54

g/l

0.73

120

1153

Malignant neoplasm of breast

784

5734

0.99

0.14

1.5

1.7

1.67

1.59

g/l

1.17

639

4884

Other benign neoplasms of connective and other soft tissue

146

1412

1.04

0.14

1.8

1.45

1.55

g/l

0.71

122

1224

Loose body in joint

294

0.92

0.13

1.3

1.9

1.77

1.54

g/l

0.30

247

Otosclerosis

113

1172

0.96

0.13

1.6

1.8

1.67

1.57

g/l

0.47

1009

Other benign neoplasms of uterus

873

1.04

0.13

1.8

1.7

1.63

1.57

g/l

0.24

745

Pneumoconiosis due to asbestos and other mineral fibres

417

0.93

0.13

1.7

1.56

1.47

g/l

0.30

355

Benign neoplasm of other and unspecified sites

423

1.07

0.13

1.6

1.9

1.53

1.50

g/l

0.07

372

Pedal cyclist injured in transport accident

333

3265

1.02

0.13

1.6

1.8

1.44

1.50

g/l

0.44

278

2805

Pedal cyclist injured in noncollision transport accidents

152

1475

1.03

0.12

1.5

1.8

1.45

1.51

g/l

0.28

122

1287

Chalazion

165

1605

1.03

0.12

2.0

1.8

1.53

1.51

g/l

0.12

139

1373

Other spirochaetal diseases

415

4218

0.98

0.12

1.8

1.7

1.36

1.57

g/l

5.56

342

3616

Benign mammary dysplasia

204

2088

0.98

0.11

1.7

1.53

1.59

g/l

0.47

174

1773

Obstructed labour due to malposition and malpresentation of fetus

210

1935

1.02

0.10

2.1

1.9

1.20

1.39

g/l

2.76

183

1682

Malignant neoplasm of lip

115

1.14

0.10

1.5

2.0

1.78

1.54

g/l

0.46

105

Communicating hydrocephalus

280

1.07

0.10

1.3

2.0

1.47

1.53

g/l

0.13

248

Benign lipomatous neoplasm

507

5137

0.99

0.10

1.7

1.51

1.55

g/l

0.45

421

4383

Struck by thrown, projected or falling objec

564

1.05

0.10

1.9

2.0

1.42

1.50

g/l

0.27

481

Lesion of sciatic nerve

779

0.96

0.10

1.9

1.8

1.55

g/l

0.01

662

Multiple delivery

939

1.03

0.10

2.2

1.8

1.24

1.52

g/l

2.45

808

Motorcycle rider injured in other and unspecified transport accidents

634

1.04

0.09

2.0

1.9

1.47

1.50

g/l

0.11

544

Chondromalacia

330

0.94

0.09

1.3

1.9

1.56

1.51

g/l

0.11

288

Lateral epicondylitis

164

1677

0.98

0.09

1.6

1.8

1.64

1.54

g/l

0.67

147

1434

Benign neoplasm of thyroid gland

360

0.94

0.09

2.2

1.7

1.53

1.51

g/l

0.03

315

Occupant of pick-up truck or van injured in other and unspecified transport accidents

1.04

0.08

1.7

0.72

1.46

g/l

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.81

0.08

1.6

1.5

1.61

1.35

g/l

—

Serous carcinoma of ovary

450

1.05

0.08

1.6

1.9

1.90

1.60

g/l

0.75

393

Macular hole

924

1.03

0.08

1.6

1.8

1.40

1.57

g/l

1.05

795

Polypectomy (DHB20)

103

1057

0.97

0.08

1.6

1.8

1.74

1.52

g/l

1.71

910

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

358

0.95

0.08

1.3

1.6

1.62

1.54

g/l

0.19

312

Left side

0.81

0.08

1.5

2.8

1.03

1.45

g/l

—

Early lumbar disc prolapse, operated

875

0.97

0.08

1.6

1.8

1.56

1.40

g/l

0.70

754

Caught, crushed, jammed or pinched in or between objects

559

1.04

0.08

1.7

2.0

1.43

1.48

g/l

0.18

480

Neuroendocrine tumor and carcinoma of lung

1.12

0.06

1.4

2.1

1.71

1.60

g/l

0.14

Disorders of breast

722

6738

0.99

0.06

1.7

1.8

1.51

1.53

g/l

0.21

618

5765

L02BG Aromatase inhibitors

439

4431

0.99

0.06

1.5

1.7

1.69

1.61

g/l

0.79

360

3782

Occupational exposure to risk-factors

477

0.96

0.06

2.1

2.0

1.33

1.51

g/l

0.65

410

Endometriosis ASRM stages 1,2

198

1952

1.01

0.06

1.9

1.8

1.40

1.49

g/l

0.71

171

1672

Maternal care for known or suspected disproportion

286

1.05

0.06

1.8

1.18

1.37

g/l

0.57

243

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

197

1943

1.01

0.06

1.6

1.7

1.54

1.56

g/l

0.08

163

1675

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

821

1.02

0.05

1.6

1.7

1.62

1.52

g/l

0.52

708

Congenital malformations of ovaries, fallopian tubes and broad ligaments

494

1.03

0.05

1.9

2.0

1.43

1.42

g/l

0.03

429

Unspecified chronic bronchitis

564

1.03

0.05

1.7

1.60

1.54

g/l

0.15

476

Contact with nonpowered hand tool

584

1.03

0.05

1.9

2.0

1.63

1.54

g/l

0.27

506

Benign leiomyoma with endometriosis

226

2286

0.99

0.05

1.5

1.6

1.61

g/l

0.02

184

1950

Injury of muscle and tendon at shoulder and upper arm level

673

6769

0.99

0.05

2.0

1.6

1.61

1.56

g/l

0.69

590

5813

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

506

1.03

0.04

1.6

1.7

1.45

1.57

g/l

0.42

436

Use of rasagiline

413

0.97

0.04

1.3

1.9

1.55

1.60

g/l

0.14

358

Benign neoplasm: Rectum/anal canal icd-9

150

1.07

0.04

2.1

2.0

1.65

1.58

g/l

—

131

Vascular dementia (undefined)

679

1.02

0.04

1.1

1.6

1.71

1.55

g/l

0.82

567

Intussusception

210

1.05

0.03

1.5

2.1

1.49

g/l

0.00

181

Dental caries 3 and operation codes, only avohilmo

666

3359

1.00

0.03

1.7

1.9

1.50

1.47

g/l

0.33

574

2902

Simple and mucopurulent chronic bronchitis

668

1.02

0.03

1.8

1.7

1.46

1.49

g/l

0.12

573

Lesion of plantar nerve

828

1.02

0.02

1.5

1.7

1.80

1.61

g/l

0.82

711

Ectopic pregnancy

196

1975

0.99

0.02

1.7

1.49

g/l

0.03

160

1694

Primary angle-closure glaucoma

740

1.01

0.02

1.3

1.8

1.51

1.54

g/l

0.11

641

Other disorders of breast

151

1522

0.99

0.02

1.8

1.7

1.63

1.54

g/l

0.40

128

1299

Delivery, wide proxy

608

3242

1.00

0.01

1.9

1.7

1.41

1.57

g/l

3.86

525

2769

Other complications of labour and delivery, not elsewhere classified

875

0.99

0.01

2.0

2.1

1.21

1.20

g/l

0.04

762

Peripheral retinal degeneration

393

1.02

0.01

1.4

1.9

1.43

1.59

g/l

0.52

343

Use of selegiline

797

0.99

0.01

1.6

1.8

1.63

1.54

g/l

0.38

682

Burn and corrosion of head and neck

234

1.03

0.00

1.6

1.9

1.72

1.43

g/l

0.78

200

Other obstetric trauma

376

0.98

0.00

1.8

1.9

1.29

1.36

g/l

0.20

325

Benign neoplasm: Cranial nerves

394

1.02

0.00

1.6

1.8

1.75

1.55

g/l

0.67

347

Any dementia, excluding more controls

802

5565

1.00

0.00

1.5

1.7

1.61

1.56

g/l

0.68

618

4727

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

481

1.00

0.00

1.4

1.8

1.51

1.52

g/l

0.02

413

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

126

1265

1.00

0.00

1.3

1.5

1.66

1.51

g/l

0.96

110

1075

Ethmoidectomy

178

1785

1.00

0.00

1.9

1.8

1.67

1.53

g/l

1.09

153

1542

Other and unspecified spinal muscular atrophies

122

0.98

0.00

1.3

1.8

1.76

1.46

g/l

0.53

110

Dementia due to Parkinsons disease, excluding more controls

357

1.01

0.00

1.4

1.7

1.46

1.53

g/l

0.22

304

Varus deformity, not elsewhere classified

121

0.99

0.00

5.7

2.0

1.50

1.43

g/l

0.11

104

847

1.00

0.00

1.3

1.8

1.38

1.55

g/l

0.78

692

Respiratory tuberculosis, not confirmed

707

1.00

0.00

1.5

1.8

1.46

1.55

g/l

0.37

602

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

445

1.01

0.00

1.2

1.6

1.65

1.52

g/l

0.44

380

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

0.0

1.7

—

0.83

—

Intrauterine hypoxia

0.00

0.0

2.4

—

1.04

—

Microcephaly

0.00

0.0

4.5

—

0.99

—

Typhus fever

0.00

0.0

2.0

—

0.86

—

Spotted fever [tick-borne rickettsioses]

0.00

0.0

5.3

—

1.55

—

Disorders of branched-chain amino-acid metabolism, other/unspecified

0.00

0.0

1.0

—

1.54

—

Neuropathic heredofamilial amyloidosis

0.00

0.0

1.0

—

1.17

—

Benign neoplasm: Endocrine pancreas

0.89

0.00

1.4

2.0

1.70

1.52

g/l

—

Cholinergic urticaria

1.00

0.00

1.6

2.2

1.16

1.39

g/l

—

Miliaria crystallina

0.00

0.0

1.2

—

1.30

—

Atrophoderma of Pasini and Pierini

0.00

0.0

1.4

—

1.94

—

Right side

0.98

0.00

1.3

2.6

0.97

1.62

g/l

—

Granuloma faciale [eosinophilic granuloma of skin]

0.00

0.0

2.4

—

1.62

—

Dental invagination

0.00

0.0

2.4

—

1.50

—

Benign neoplasm: Retina

0.84

0.00

1.4

1.5

0.88

1.52

g/l

—

Use of ropinirole

580

1.00

0.00

1.6

1.9

1.38

1.57

g/l

0.81

509

Carcinoma in situ of trachea

0.00

0.0

1.4

—

1.97

—

Benign neoplasm: Bones of skull and face

0.90

0.00

1.3

2.1

1.18

1.43

g/l

—

Other conditions of integument specific to fetus and newborn

0.00

0.0

1.1

—

0.81

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.0

1.7

—

1.63

—

Toxic effect of metals

0.00

0.0

1.7

—

1.58

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

0.0

2.0

—

1.71

—

Benign neoplasm: Scapula and long bones of upper limb

0.96

0.00

1.6

1.7

1.58

1.37

g/l

—

Exposure to vibration

0.00

0.0

2.4

—

1.46

—

Birth injury to skeleton

0.00

0.0

4.2

—

0.93

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs

0.00

0.0

1.5

—

1.31

—

Carcinoma in situ of other/unspecified digestive organs

0.00

0.0

1.1

—

1.48

—

Carcinoma in situ of other/unspecified digestive organs

0.00

0.0

1.0

—

1.32

—

Melanocytic naevi of ear and external auricular canal

0.96

0.00

1.3

1.9

1.10

1.57

g/l

—

Bacterial vaccines

0.00

0.0

1.2

—

2.24

—

Defects in post-translational modification of lysosomal enzymes

0.00

0.0

6.4

—

1.00

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.93

0.00

1.3

2.4

1.63

1.52

g/l

—

Myxoedema coma

0.00

-0.00

0.0

4.2

—

1.41

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Haptoglobin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS